Modified Fusarium Mycotoxins : A Threat in Disguise? by Nathanail, Alexis
University of Helsinki 
Faculty of Agriculture and Forestry 
Department of Food and Nutrition 
 
Finnish Food Authority (Ruokavirasto) 
Laboratory and Research Division 
Chemistry Unit 
 
EKT series 1906 
 
 
MODIFIED FUSARIUM MYCOTOXINS: 
A THREAT IN DISGUISE? 
 
 
 
ALEXIS V. NATHANAIL 
 
 
 
DOCTORAL DISSERTATION 
 
To be presented for public examination with the permission of the Faculty of 
Agriculture and Forestry, University of Helsinki, in Walter Hall, Viikki, on the 16th of 
December, 2019 at 12 o’clock noon. 
 
 
 
 
 
 
Helsinki 2019 
Custos:   Professor Vieno Piironen 
Department of Food and Nutrition 
University of Helsinki 
Helsinki, Finland 
 
Supervisors:  Professor Kimmo Peltonen 
Finnish Safety and Chemicals Agency (Tukes) 
Helsinki, Finland 
 
Docent Marika Jestoi 
Finnish Food Authority (Ruokavirasto) 
Helsinki, Finland 
 
Reviewers:  Professor Chiara Dall’Asta 
Department of Food and Drug 
University of Parma  
Parma, Italy 
 
Doctor Peter Have Rasmussen 
National Food Institute  
Technical University of Denmark (DTU) 
Kgs. Lyngby, Denmark 
 
Opponent:   Professor Sarah De Saeger 
Department of Bioanalysis  
Ghent University 
Ghent, Belgium 
 
 
 
 
ISBN 978-951-51-5660-0 (paperback) 
ISBN 978-951-51-5661-7 (pdf; http://ethesis.helsinki.fi) 
ISSN 0355-1180 
 
The Faculty of Agriculture and Forestry uses the Urkund system (plagiarism recognition) 
to examine all doctoral dissertations. 
 
Unigrafia 
Helsinki 2019 
 3 
ABSTRACT 
 
Fungi are capable of producing an array of heterogenous toxic secondary metabolites, 
i.e. mycotoxins, which may acutely or chronically impact human and animal health 
following the consumption of contaminated agricultural commodities. Mycotoxins, like 
most xenobiotics, are prone to structural alterations via metabolic processes in living 
organisms but can also undergo changes during food manufacturing. The resulting 
compounds, defined as “modified mycotoxins”, possess distinct chemical properties, 
with potentially unique toxicological characteristics, and often coexist with their 
precursor forms in food- and feedstuffs. 
The impetus of this Ph.D. thesis largely stems from the dearth of evidence 
available on these compounds and aspires to contribute evidence for addressing the 
underlying debate: Are modified mycotoxins relevant to food/feed safety?  
In this context, liquid chromatography–tandem mass spectrometric methods, 
employing fit-for-purpose sample preparation approaches, were developed and 
validated for the simultaneous determination of Fusarium mycotoxins and their modified 
forms. At first, conventional sample preparation techniques commonly utilised in 
mycotoxin analyses were evaluated against automated on-line sample clean-up. On-line 
clean-up and the standard “extract and shoot” approach offered optimal overall 
performance and achieved compliance with legislative criteria. The natural occurrence 
of the Fusarium mycotoxins HT-2 toxin, T-2 toxin, deoxynivalenol, nivalenol, zearalenone 
and derivatives thereof was investigated by conducting a nationwide survey of Finnish 
barley, oats and wheat grains. Deoxynivalenol was the most abundant mycotoxin (in 93% 
of the cereal samples), and at unusually high levels compared to adjacent years, followed 
by the modified mycotoxin deoxynivalenol-3-glucoside (81%). All 10 additional modified 
mycotoxins included in the method were detectable at widely varying concentrations. 
The relative proportions of modified/parent mycotoxins were mostly between 15–55%. 
Furthermore, the metabolism of HT-2 toxin and T-2 toxin was studied in barley 
and wheat. Specifically, tracing of their metabolism was accomplished by untargeted 
metabolomics based on stable isotopic labelling and liquid chromatography–high 
resolution mass spectrometry. Structural elucidation of the detected compounds 
indicated the presence of several novel modified mycotoxins, including glucoside, 
malonyl-glucoside, acetyl and feruloyl conjugates of the parent toxins. Time course 
kinetics of the in planta metabolites revealed the HT-2 toxin-3-glucoside as the primary 
detoxification product, which was rapidly formed in both crops. The experiments also 
determined the extent of metabolism of the parent toxins, while highlighting those 
modified forms present at harvest. Lastly, the metabolic fate of HT-2 toxin, T-2 toxin, 
deoxynivalenol and deoxynivalenol-3-glucoside was investigated during a four-day beer 
brewing fermentation with lager yeast. Yeast tolerated high toxin levels and was able to 
remove 9–34% of dosed toxins from wort by adsorption and/or biotransformation.  
The original contribution of this work can be summarised as the discovery of 
several novel modified Fusarium mycotoxins and related metabolic pathways, 
generation of essential natural occurrence data and gaining of further insight into 
mycotoxin-plant/fungal interactions, all of which were facilitated by state-of-the-art 
analytical tools. 
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1 INTRODUCTION 
 
The consumption of contaminated commodities with naturally abundant toxins and/or 
synthetic chemical toxicants may lead to disease outbreaks and chronic adverse health 
effects. Microorganisms are capable of producing a bewildering array of compounds 
that are toxic to humans and animals. One of the most important categories of microbial 
toxins, negatively impacting food and feed safety, is of fungal origin. Such toxic agents 
are defined as “mycotoxins” and are poisonous secondary metabolites produced by 
filamentous fungi (or moulds). Unlike man-made chemicals (e.g. synthetic pesticides), 
mycotoxins are naturally present and cannot be completely eliminated from the food 
chain. 
Mycotoxins are low-molecular weight (below 1000 Da), chemically diverse, 
organic compounds that can induce a broad range of toxic effects in vertebrates, 
including acute toxicity, mutagenicity, carcinogenicity and immunotoxicity, as well as 
reproductive and specific target organ toxicities (nephrotoxicity, hepatotoxicity, 
neurotoxicity, etc.) (Steyn, 1995). The mycotoxin producers most relevant to food safety 
are Aspergillus spp., Penicillium spp. and Fusarium spp., but also members of the genera 
Alternaria, Trichothecium, Cladosporium, Byssochlamys and Sclerotinia are also of 
importance in food, because of potential mycotoxin production (Bullerman, 1979). 
Depending on a number of factors such as the temperature, relative humidity, water 
activity, geographic location, commodity and agricultural practices, favourable 
conditions for fungal invasion will most likely result in mycotoxin contamination of crops 
(Bhat et al., 2010). It has been hypothesised that many of these compounds may confer 
substantial selective advantages to fungi against other competing microorganisms 
(Magan and Aldred, 2007). Moreover, certain Fusarium mycotoxins such as the 
trichothecenes have been found to play an important role in plant pathogenesis 
(Desjardins and Hohn, 1997) and to act as virulence factors towards living plants by 
promoting infection (Harris et al., 1999; Proctor et al., 2002; Maier et al., 2006). Besides 
the ability of moulds to invade living plants in the field, they can also cause post-harvest 
infection of susceptible crops during storage and processing periods. 
Survey studies have reported significantly high contamination estimates, with 
approximately 70% of food and feed cereal grain samples containing detectable 
amounts of at least one mycotoxin and 38% being co-contaminated with multiple 
mycotoxins (Schatzmayr and Streit, 2013). A very recent extensive metadata analysis, of 
more than 500,000 samples, revealed that 60–80% of cereals and nuts were found to 
contain detectable levels of mycotoxins (Eskola et al., 2019). Furthermore, according to 
the European Commission (EC), 5–10% of global crop production is lost annually 
because of severe mycotoxin contamination (EC, 2015). Due to the ubiquitous presence 
of mycotoxins in certain foods (e.g. cereals, nuts, vegetables and fruits) and feed, many 
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countries have established food legislation and regulatory limits that permit small 
mycotoxin concentrations assessed as low risk. In 2017, the Rapid Alert System for Food 
and Feed (RASFF) indicated that mycotoxins were the most frequently reported 
chemical hazard in the European Union (EU), a trend already appearing in earlier RASFF 
annual reports. More specifically, 29% of total border rejections in that year were 
because of mycotoxin contamination (predominantly aflatoxins) exceeding the EU’s 
legislative limits (EC, 2018). These compounds are indisputably unavoidable 
contaminants in agricultural commodities that not only represent a direct risk to food 
and feed safety but can also have serious implications for food security and international 
trade (Krska et al., 2016). 
However, exposure of humans and animals to mycotoxins is not the only risk 
factor associated with these compounds, as they may also exist in altered forms, the so-
called “modified mycotoxins” (Rychlik et al., 2014), previously mainly referred to as 
“masked mycotoxins”. Following its inception, the overarching term modified 
mycotoxins has been used to describe derivatives formed via phase I and II metabolic 
processes of plants, animals and fungi, as well as via the interaction of mycotoxins with 
food matrix components (Berthiller et al., 2013). 
The issue of modified mycotoxins began to attract scientific attention after 
several mysterious cases of mycotoxicosis during the mid-1980s, in which toxicity 
symptoms in affected animals did not correlate with the low mycotoxin content detected 
in their feed. Around the same period, the in planta metabolic biotransformation of the 
Fusarium trichothecene mycotoxin deoxynivalenol (DON) to less toxic derivatives was 
for the first time hypothesised to occur in field corn inoculated with F. graminearum 
(Miller et al., 1983), and in naturally infected winter wheat (Scott et al., 1984). 
Deoxynivalenol-3-glucoside (DON3Glc) was later structurally characterised as the main 
phase II metabolite (Savard, 1991). Eventually, the two series of events were connected 
by associating clinical observations of the intoxicated animals with the existence of 
mycotoxin conjugates in animal feed, and the on-going research quest to study modified 
mycotoxins was thus initiated. Zearalenone (ZEN), another Fusarium mycotoxin, was the 
next piece to find its place in the modified mycotoxin puzzle when maize cell cultures 
were found capable of transforming ZEN to zearalenone-14-glucoside (ZEN14Glc) and 
other metabolites (Engelhardt et al., 1988). 
These findings were first put into a toxicological perspective by Gareis et al., 
(1990), who described the complete in vivo release of the aglycone in pigs fed with 
ZEN14Glc-contaminated feed. Although research on modified mycotoxins since that 
time has grown considerably, the toxicological relevance of these compounds to 
humans and animals still remains largely unknown. Certain modified forms of 
mycotoxins, such as ?-zearalenol (?-ZEL), a major phase I metabolite of ZEN in animals 
and plants, may be more hazardous than their precursors, whilst others are less 
hazardous, such as ?-zearalenol (?-ZEL) (Zinedine et al., 2007). On the other hand, phase 
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II metabolic reactions resulting in conjugation with polar metabolites such as 
carbohydrates or sulfate are generally viewed as detoxification processes. The limited 
existing toxicity studies, performed almost exclusively with DON3Glc, are principally in 
agreement that conjugated modified mycotoxins possess a significantly reduced direct 
toxicity compared to precursor forms (Gratz, 2017). Regardless of the suspected low 
intrinsic toxic potential of these mycotoxin derivatives, they may be manifesting 
toxicological implications via other mechanisms, for instance by releasing the toxic 
precursor during digestion or food manufacturing processes. 
Currently, there is no regulatory framework covering modified mycotoxins. In 
2011, the Joint Food and Agriculture Organization (FAO)/World Health Organization 
(WHO) Expert Committee on Food Additives (JECFA) decided to include the acetylated 
derivatives of DON, 3-acetyl-DON (3Ac-DON) and 15-acetyl-DON (15Ac-DON), in its 
existing provisional maximum tolerable daily intake (PMTDI) of 1 μg/kg body weight (bw) 
(JECFA, 2011). In the EU, the European Food Safety Authority (EFSA) has lately been 
actively engaged in assessing the risks associated with modified mycotoxins and 
establishing health-based guidance values for groups of individual Fusarium mycotoxins 
together with their modified forms. It is worth mentioning, that both scientific bodies 
have explicitly emphasised the urgent need for further work on the identification of as 
yet uncharacterised modified mycotoxins, the generation of more occurrence data in 
food and feed for known modified mycotoxins and investigations into their 
toxicokinetics and toxicity. 
The tremendous progress that has occurred during the past couple of decades 
in the area of analytical chemistry has provided scientists with an arsenal of modern high-
throughput instruments that can be utilised to address numerous analytical challenges 
related to most contaminants relevant to food and feed safety. Undoubtedly, research 
concerning mycotoxins and presently modified mycotoxins has taken advantage of 
these developments (Krska et al., 2017). Hyphenated analytical techniques and more 
specifically liquid chromatography–mass spectrometry (LC–MS)-based methods are now 
routinely used not only for the concurrent targeted determination of multiple mycotoxins 
in various sample matrices, but also in metabolomics studies for the identification of 
novel mycotoxins and metabolites thereof  (Malachová et al., 2017). In recent years, the 
use of high resolution mass spectrometry (HRMS) analysers has been pivotal in 
mycotoxin research, allowing the accurate, non-targeted identification of modified 
mycotoxins, even retrospectively (Righetti et al., 2016). In conjunction with 
advancements in the development of analytical instrumentation, bioinformatics software 
packages that can rapidly process large quantities of raw LC–HRMS data have emerged. 
These powerful tools are becoming indispensable in metabolic profiling, yielding 
insights into the interactions of complex biological systems such as plants and 
microorganisms. 
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Nevertheless, safety assessment on the relevance of modified mycotoxins to 
human and animal health constitutes a perplexing endeavour for a number of reasons. 
First, for each native mycotoxin present in food or feed, potentially dozens of 
modifications may co-exist. These mixtures of various mycotoxins and their modified 
forms can cause unpredictable combined toxic effects upon exposure (Nathanail et al., 
2016). Secondly, an unequivocal bottleneck in modified mycotoxin research is the 
absence of reference standards for all but a handful of these compounds, which are 
necessary to allow further investigations and quantification in commodities (Broekaert et 
al., 2015). Finally, only limited toxicokinetic and toxicity data are available to allow a 
better understanding of the toxicological behaviour of the few sufficiently characterised 
modified mycotoxins, which is likely to differ from that of their precursors (De Boevre et 
al., 2015). Hence, there is a wealth of information still to be generated in this area. 
The original contribution of this Ph.D. dissertation was in shedding some light on 
a number of the manifold unexplored areas related to modified mycotoxins. In particular, 
the main aims of the thesis were to present an extensive literature overview of key 
aspects related to modified Fusarium mycotoxins and study their formation, natural 
occurrence and metabolic fate. To achieve the research goals, reliable, sensitive and 
accurate analytical LC–MS-based techniques were developed and validated, which were 
capable of simultaneously determining several modified mycotoxins together with their 
precursors. Such state-of-the-art methodology was used to generate information on the 
natural occurrence of modified mycotoxins in Finnish cereal grains for the first time. 
Another highlight of this work was the identification of novel modified forms following 
exposure of barley and wheat to the Fusarium trichothecene mycotoxins HT-2 toxin 
(HT2) and T-2 toxin (T2), and to eventually provide new insights into plant–mycotoxin 
interactions and the detoxification pathways involved. Finally, investigations were 
conducted to assess the impact of high doses of the trichothecenes DON, HT2 and T2, 
as well as DON3Glc on brewing yeast and to examine the potential formation and/or 
release of conjugated moieties during fermentation. 
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2 LITERATURE REVIEW 
 
2.1 Fusarium fungi and mycotoxins 
 
Fungal inoculum can enter the food chain either while crops are growing in the field, via 
the colonisation of living plants by parasitic fungi, or by spoilage fungi after crops have 
been harvested. Fusarium, first described and defined by Link (1809) as Fusisporium, is 
a form genus of ascomycete fungi. Many Fusarium species are notorious plant 
pathogens and toxin producers, affecting agriculture and horticulture on a global scale. 
These moulds can also act as direct pathogens to humans and some domesticated 
animals, with members of Fusarium oxysporum and F. solani commonly being 
associated with keratitis (Bullock and Khamis, 2010) and skin and nail infections in 
immunocompromised individuals (Gupta et al., 2000). 
In Europe, the main host plants of fusaria are cereal grains and potatoes, on 
which they may cause seed, head and leaf blight, root, crown, head and cob rot, as well 
as storage rot in tubers and kernels (Nirenberg, 1989). Plant diseases such as Fusarium 
head blight (FHB) that are associated with Fusarium spp. can be devastating for small 
grain cereals (wheat, barley, oats, rye and triticale). Numerous publications have 
underlined the massive economic impact that Fusarium infections can have in cereal 
production and food security, deteriorating quality and reducing grain yields (Parry et 
al., 1995; Bottalico and Perrone, 2002; Chakraborty and Newton, 2011). Fusaria can also 
produce a variety of phytotoxic metabolites upon infestation of plant tissue that act as 
virulence or pathogenicity factors, interfering with plant defence responses and 
facilitating fungal colonisation on host plants. Some of these compounds may also be 
detrimental to human and animal health and thus classified as mycotoxins. 
As a consequence, contamination of food and feed with mycotoxins produced 
by Fusarium species, also known as fusariotoxins, may cause intoxications, especially in 
farm animals. More specifically, cereal grains used for human consumption and animal 
feed are subject to contamination with trichothecenes, ZEN and fumonisins, all of which 
are regarded as major classes of Fusarium mycotoxins (D’mello et al., 1999). All three 
major classes were discovered during the 30-year golden period of Fusarium 
mycotoxicology between 1961 and 1991 (Desjardins, 2006). By the end of this period, 
toxicologists had already unravelled their mechanisms of toxicity: trichothecenes, 
inhibition of protein synthesis; ZEN, binding to the oestrogen receptor (ER); and 
fumonisins, inhibition of sphingolipid biosynthesis. Other Fusarium mycotoxins, often 
referred to as “emerging” mycotoxins, such as fusaproliferin, beauvericin and 
moniliformin (reviewed in Jestoi, 2008), were also characterised at that time. It should 
 18 
be noted that the present work principally focused on the trichothecene mycotoxins 
HT2, T2, DON and nivalenol (NIV), as well as ZEN and many of their known derivatives. 
 
2.1.1 Trichothecenes 
 
The trichothecenes are large group of more than 200 chemically related mycotoxins 
(Grovey, 2007), produced by various species of Fusarium, Myrothecium, Spicellum, 
Stachybotrys, Cephalosporium, Trichoderma and Trichothecium (Cole et al., 2003). 
Fusarium spp. predominantly associated with trichothecene production in Europe are F. 
graminearum, F. culmorum, F. sporotrichioides and F. poae, among others (Bottalico, 
1998). The trichothecene biosynthetic pathway requires the expression of a transporter 
protein and a network of regulatory genes to form the tricyclic sesquiterpene backbone 
with an olefinic bond between carbons 9 (C-9) and 10, as well as an epoxide ring at C-
12,13 (Desjardins and Proctor, 2007). Trichothecenes are non-volatile, low-molecular 
weight, heat-stable compounds (Hazel and Patel, 2004) and are divided into four groups 
(types A–D), according to their chemical properties and producer fungi (Ueno et al., 
1973). 
 The main type A trichothecenes are HT2 (Chemical Abstracts Service; CAS No. 
26934-87-2; C22H32O8) and T2 (CAS No. 21259-20-1; C24H34O9) and do not contain a 
carbonyl group at the C-8 position, in contrast to type B, represented primarily by DON 
(CAS No. 51481-10-8; C15H20O6) and NIV (CAS No. 23282-20-4; C15H20O7), which do 
possess a carbonyl function at C-8 (Figure 1). Type C trichothecenes (e.g. crotocin and 
baccharin) are characterised by a second epoxide function at C-7,8 or C-9,10. Lastly, 
trichothecenes of type D (e.g. satratoxin and roridin) contain a macrocyclic ring between 
C-4 and C-15 (Ueno, 1980). 
Of all Fusarium mycotoxins known to date, trichothecenes have been most 
strongly linked with mycotoxicoses of humans and animals in Europe. The acute toxicity 
of trichothecenes varies somewhat, but type A trichothecenes generally tend to be more 
acutely toxic than type B, with a decreasing order of toxicity from isovaleryl > hydrogen 
> hydroxyl substitutions at the C-8 position (Rotter, 1996). Due to the low molecular 
weight and amphipathic nature of trichothecenes, integumentary and gastrointestinal 
absorption occur rapidly, resulting in systemic exposure and subsequent toxic effects 
especially on proliferating tissues (McCormick et al., 2011). From a toxicological 
perspective, trichothecenes are recognised as having multiple effects on eukaryote cells, 
including protein, deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) synthesis 
(Thompson and Wannemacher Jr, 1986; Shifrin and Anderson, 1999) and the disruption 
of mitochondrial metabolism (Minervini et al., 2004), as well as effects on cell division 
and membrane function (Bunner and Morris, 1988; Rocha et al., 2005). The underlying 
molecular mechanisms of action are now mostly well documented. 
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Trichothecene Molecular 
weight (g/mol) 
R1 R2 R3 R4 R5 
Type A HT2 424.48 −OH −OH −OCOCH3 −H −OCOCH2CH(CH3)2 
 T2 466.52 −OH −OCOCH3 −OCOCH3 −H −OCOCH2CH(CH3)2 
Type B DON 296.32 −OH −H −OH −OH =O 
 NIV 312.32 −OH −OH −OH −OH =O 
Figure 1. Chemical structures of HT2, T2, DON and NIV with carbon numbering of the tetracyclic 
trichothecene skeleton. 
A number of in vitro assays have concluded that although trichothecenes have a 
broad range of biological effects, their major mode of action is the inhibition of protein 
synthesis in a large number of mammalian cell lines tested (reviewed by Gutleb et al., 
2002). At the cellular level, the common chemical scaffold of trichothecene inhibitors 
moderates their binding to the A-site of the peptidyl transferase centre of the 60S 
subunit of eukaryotic ribosomes, interfering with protein translation (de Loubresse et al., 
2014). A ribotoxic stress response induced by exposure to trichothecenes, such as DON, 
is then typically induced, eliciting the activation of mitogen-activated protein kinases 
(MAPKs) and up-regulation of pro-inflammatory cytokines and chemokines (Pestka, 
2010; Cano et al., 2013; Zhang et al., 2016). These complex effects may evoke 
immunostimulation or immunosuppression, depending on the dosage, duration and 
frequency of exposure, or trigger cell signalling cascades ultimately mediating apoptosis 
(Pestka et al., 2004). In addition, DON and T2 have been found to inhibit protein 
synthesis in ribosomes from wheat and maize (Casale and Hart, 1988). These toxins are 
known to act as virulence factors in disease development by inducing reactive oxygen 
species, which in turn stimulate apoptosis and assist necrotrophic fungal growth 
(Nishiuchi et al., 2006; Desmond et al., 2008). There is sufficient scientific evidence 
suggesting the phytotoxicity of trichothecenes produced by Fusarium spp., causing 
necrosis, chlorosis and mortality and enabling them to mediate a variety of plant 
diseases such as stalk, root and leaf rot, as well as wilts (Ismaiel and Papenbrock, 2015). 
Among all the trichothecenes identified to date, only a few type A and B toxins 
are of relevance to food and feed safety because of their prevalence in crops. T2 is the 
most acutely toxic trichothecene to humans and animals and can trigger anorectic 
effects and emetic events upon single exposure, as can HT2 (EFSA, 2011a). In vivo tests 
have shown that T2 causes haemato- and myelotoxicity and is associated with an 
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increased infection rate, DNA damage and the induction of apoptosis, and has been 
found responsible for outbreaks of alimentary toxic aleukia (ATA) (Li et al., 2011). The 
characteristic symptoms of ATA are fever, haemorrhage, necrosis, leukopenia and 
exhaustion of bone marrow, resulting in up to 60% mortality for this endemic foodborne 
disease (Ueno, 1980). Probably one of the most hazardous food-associated mycotoxins, 
partly also due to its high prevalence, is DON, which is able to cross biological 
membranes and provoke intoxications characterised by vomiting, anorexia, abdominal 
pain, diarrhoea and headaches (Maresca, 2013). Fungal metabolites of DON such as 
3Ac-DON and 15Ac-DON can also be present in food- and feedstuffs. These modified 
forms of DON may be reverted to the parent toxin by gut microbiota during digestion 
or may exert intrinsic toxicity; for certain endpoints, 15Ac-DON can be more toxic than 
DON (Pinton et al., 2012). Comparably to the other trichothecenes, NIV toxicity is 
manifested by hepatotoxicity, myelotoxicity and immunotoxicity, as well as 
developmental toxicity (EFSA, 2013). A testament to their toxicity is epidemiological 
evidence and intelligence assessments supporting the contention that trichothecenes 
have been used as biological warfare agents in military operations in Southeast Asia and 
Afghanistan (Wannemacher Jr et al., 1997). 
Apart from the trichothecene mycotoxins being discussed in this thesis, other 
trichothecenes are also toxicologically important contaminants in cereals (e.g. 
diacetoxyscirpenol) and in indoor air (e.g. satratoxin H). However, currently unidentified 
mycotoxins may potentially be present in crops or start appearing as a consequence of 
selection pressure from resistant plants on fungal populations, with serious implications 
for food safety. Recently, several newly identified strains of F. graminearum were 
isolated in North American wheat that were capable of producing novel type A 
trichothecenes (Varga et al., 2015). These mycotoxins were labelled as NX-2 and NX-3. 
The extent to which the co-occurrence of several Fusarium mycotoxins and their 
modified forms, in cereal grains and animal feed, might enhance toxic effects has not 
hitherto been possible to quantify. Furthermore, information on chronic effects resulting 
from exposure to single or mixtures of mycotoxins is also very limited. 
 
2.1.2 Zearalenone 
 
ZEN (CAS No. 17924-92-4; C18H22O5), is a low-molecular-weight (318 g/mol), non-
steroidal oestrogenic mycotoxin. ZEN is heat stable, with its degradation occurring at 
temperatures higher than 150 ºC or under alkaline conditions (Ryu et al., 2003). It is 
biosynthesised via a polyketide pathway by a variety of Fusarium spp., including F. 
graminearum, F. culmorum, F. cerealis and F. equiseti. Chemically, ZEN is a resorcyclic 
acid lactone (Figure 2), containing an ester group (C-1), one ketonic group (C-7), one 
olefinic group (C-11,12) and two phenolic hydroxyls (C-14 and C-16) (Urry et al., 1966). 
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Figure 2. Chemical structure of ZEN with carbon numbering. 
ZEN is rapidly and extensively absorbed in the mammalian gastrointestinal tract 
(GIT). During metabolism of ZEN, the keto group at C-7 is reduced, a reaction mediated 
by 3?- and 3?-hydroxysteroid dehydrogenases, forming two stereoisomeric metabolites: 
?-ZEL and ?-ZEL (Minervini et al., 2008). These metabolites can also be formed by fungi 
and plants (Bottalico et al., 1985; Berthiller et al., 2006). ZENs are not acutely toxic and 
do not cause fatal mycotoxicoses in humans or animals, having oral median lethal doses 
(LD50) of > 2000–20,000 mg/kg bw in different animal models (JECFA, 2000). However, 
they have been associated with oestrogenic effects, manifesting as hyperoestrogenism. 
ZEN and some of its phase I metabolites constitute an important class of endocrine-
disrupting chemicals that have been shown, in several in vitro and in vivo test systems, 
to competitively bind to ER-? and ER-?, inducing oestrogenic-like effects by activating 
gene transcription via oestrogen-responsive elements (Zinedine et al., 2007). The 
highest binding affinity to oestrogen receptors and subsequent oestrogenic effects has 
been reported to be ?-ZEL > ZEN > ?-ZEL (Frizzell et al., 2011; Fitzpatrick et al., 1989). 
Swine is one of the most sensitive species to ZENs, where direct ingestion of 
contaminated feed causes enlargement of the mammary glands and organs of the 
genital tract, atrophy of ovaries, infertility and other reproductive effects in females, as 
well as enlargement of the mammary glands and atrophy of the testes in males 
(Desjardins, 2006). ZEN has also been found to be clastogenic in a variety of cell culture 
systems and capable of inducing micronuclei in bone marrow cells and chromosomal 
aberrations in vivo (EFSA, 2011b). The formation of ZEN/?-ZEL catechol metabolites that 
elicit oxidative DNA damage has been associated with the observed genotoxic effects 
of the mycotoxin (Fleck et al., 2012). 
Regarding plant effects, ZEN appears to be generally less phytotoxic compared 
to certain trichothecenes (Ismaiel and Papenbrock, 2015). Nevertheless, ZEN can affect 
plant growth and development, as well as the functioning of the photosynthetic 
apparatus (Kościelniak et al., 2009). Furthermore, ZEN and its ?- and ?-ZEL derivatives 
caused the leakage of electrolytes and root cell death in two maize (Zea mays L.) cultivars 
(Repka et al., 2014). In another study, when mature maize embryos were exposed to a 
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mixture of ZEN and DON, additive and possibly synergistic inhibition of root and shoot 
elongation was observed compared to DON alone (McLean, 1995). 
 
2.2 Modified Fusarium mycotoxins 
 
2.2.1 Nomenclature 
 
Mycotoxins alone do not epitomise the only health hazard for humans and animals as 
derivatives of them, originating from a number of different sources, can still be present 
in food and feed. Mycotoxins chemically altered via metabolic processes or, abiotically, 
via interactions with food matrix components may co-exist together with native forms at 
significant concentrations (Berthiller et al., 2013; Freire and Sant’Ana, 2017). These 
mycotoxin derivatives may exhibit a significantly different chemical and toxicological 
behaviour compared to the parent molecules and have been in the spotlight of 
mycotoxin research during the past decade or so. 
Following the formulation of a working hypothesis by Miller et al. (1983) 
regarding the formation of “unknown metabolites” by plants exposed to mycotoxins, 
the next key scientific discovery in the area was accomplished with the introduction of 
the term “masked mycotoxins” (Gareis et al. 1990). This term was originally intended to 
emphasise the presence of certain mycotoxin metabolites and the role they could play 
in cases of animal mycotoxicoses, where there was no correlation between toxicity 
symptoms in affected animals and the mycotoxin content detected in their feed. It also 
highlighted the fact that such mycotoxin derivatives were, at the time, undetectable by 
routine analytical techniques. However, as analytical methodology has rapidly evolved 
and simultaneously altered mycotoxins are constantly being characterised, previously 
unknown/masked mycotoxins are becoming unmasked/known. 
Since the introduction of the term “masked mycotoxins”, it has been 
ambiguously used in the literature to describe all types of mycotoxin structural 
alterations. Terminology including “hidden”, “conjugated” and “bound” mycotoxins 
has also been used for similar and often overlapping purposes (Berthiller et al., 2016). 
In order to address the issue of inconsistent nomenclature, Rychlik et al. (2014) published 
a systematic definition consisting of four hierarchic levels. According to that new 
definition, distinctions were made at the highest level between “free” (e.g. DON), 
“matrix-associated” (e.g. DON-oligosaccharides) and “modified” mycotoxins. In the 
next hierarchical levels, modified mycotoxins were further subdivided into two 
categories: those biologically conjugated by plants (e.g. DON3Glc; Figure 3), animals 
(e.g. DON-3-glucuronide) or fungi (e.g. zearalenone-14-sulfate, ZEN14Sulf) and those 
chemically modified thermally (e.g. norDON), non-thermally (e.g. DON-sulfonate) or 
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differently (e.g. de-epoxy-deoxynivalenol, DOM-1). As a side note, for mycotoxins 
biologically modified by plants, the term “masked” is still acceptable as a synonym. In 
an attempt to harmonise future references to altered mycotoxins, EFSA adopted the 
definition of “modified” mycotoxins and the above categorisation system (EFSA, 2014). 
Furthermore, EFSA recommended in the same opinion the utilisation of an unequivocal 
system of abbreviations and chemical structure numbering for both parent and modified 
mycotoxins, to resolve complications arising from inconsistent naming in the scientific 
literature. 
In this thesis, the term “modified mycotoxins” is used to refer to compounds 
resulting from biologically-induced alterations in mycotoxin structures regardless of their 
origin, whilst unaltered mycotoxins are referred to interchangeably as “native”, 
“precursor” or “parent”. Additionally, both the abbreviation and numbering system 
proposed by EFSA in 2014 have been implemented. 
 
 
 
Figure 3. In planta formation of modified mycotoxins, e.g. by conversion of DON into DON3Glc by 
glucosyltransferases. 
 
2.2.2 Formation by plants and fungi  
 
Mycotoxins can be structurally modified by plants, microorganisms, mammals and food 
manufacturing processes. Here, modified derivatives of mycotoxins arising from 
interactions with plants and moulds are mainly discussed. 
Plants are equipped with versatile detoxification systems to counteract the 
deleterious effects of natural and synthetic chemicals or xenobiotics. Xenobiotics that 
contain electrophilic sites are the ones that are particularly hazardous to all organisms. 
These molecules can exert toxic effects by covalent binding to nucleophilic sites (e.g. 
DNA and proteins). Many xenobiotics are lipophilic, readily absorbed and can 
accumulate to toxic levels within plant cells, unless effective detoxification takes place. 
The metabolic cascade employed by plants for protection from toxic compounds can 
be divided into three stages: i) phase I activation reactions (usually oxidation and 
hydrolysis), ii) phase II conjugation reactions with endogenous substances (e.g. glucose, 
glutathione (GSH), amino acids, etc.) and iii) phase III compartmentation processes 
(Coleman et al., 1997). 
Glucosyltransferase
DON3GlcDON
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During phase I metabolism, reactive or polar groups are introduced to the 
xenobiotic by enzymatic action. However, if a xenobiotic already has a reactive site 
suitable for conjugation, this stage may then be omitted. The cytochrome P450 
monooxygenases (P450s) play an important role in the phase I metabolism (oxidation) 
of xenobiotics and exist as integral membrane proteins in the endoplasmic reticulum of 
plant cells (Schuler, 1996). Esterases and amidases catalyse hydrolysis reactions. 
Because phase I reactions are in principal activating, the resulting metabolites may not 
always be less phytotoxic than the precursor molecules. 
Phase II biotransformation reactions involve the covalent linkage of xenobiotics 
to various endogenous molecules, giving rise to end-products with increased 
hydrophilicity and molecular weight, as well as with altered chemical and toxicological 
properties. Glucosylation (i.e. conjugation to a glucose moiety) is one of the primary 
mechanisms that plants utilise to maintain metabolic homeostasis and to detoxify 
xenobiotics (Jones and Vogt, 2001). Lipophilic small-molecule acceptors are 
glucosylated at –OH, –COOH, –NH2, –SH and C–C groups by glucosyltransferase (GT) 
enzymes, particularly of family 1 (Bowles et al., 2006); the activated sugar donor of plant 
GTs for xenobiotics is primarily uridine diphosphate glucose (UDP-G). Generally, 
glucosylation transforms toxins into stable non-reactive storage forms with increased 
water solubility and reduced toxicity for the plant. Historically, ZEN was the first 
mycotoxin for which conjugation to the ?-D-glucopyranoside was reported and 
characterised as ZEN14Glc in cereal cell cultures by Engelhardt et al. (1988). The other 
mono-glucosylated isomer of ZEN, zearalenone-16-glucoside (ZEN16Glc), was also 
much later described in the literature (Kovalsky Paris et al., 2014). In planta glucosylation 
of Fusarium mycotoxins are commonly ?-linked glucose conjugates (e.g. DON3Glc, 
nivalenol-3-glucoside (NIV3Glc) and ZEN14/16Glc), whereas both ?- and ?-glucoside 
conjugates have been reported for T2 (Gratz, 2017). 
Conjugation of xenobiotics with GSH, the tripeptide ?-glutamyl-cysteinyl-glycine, 
is another common detoxification pathway in plants, frequently targeting electrophilic, 
hydrophobic and toxic compounds. GSH is abundant in plants (> 1 mM in the 
cytoplasm), and the conjugation of endogenous phytochemicals and exogenous toxins 
with it is either spontaneous or mediated by glutathione S-transferases (GSTs) (Dixon et 
al., 1998). These conjugations are generally substitution-based reactions, and less often 
addition reactions, which have been found to play an important role in the selective 
tolerance of plants towards herbicides (Edwards et al., 2000). Other chemical 
modifications may occur in plants prior to compartmentation, involving the addition of 
moieties such as of malonic acid, sulfate, amino acids and more. 
Finally, for phase III, the major pathways known thus far to exist in plants are for 
the metabolites to be exported into cell vacuoles or into the extracellular space, or to 
be deposited into lignin and other cell wall components (Sandermann Jr, 1992). The 
addition of hydrophilic moieties onto lipophilic toxins prevents passive diffusion across 
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lipid bilayers between cellular compartments, thus making carrier systems necessary for 
the transport of metabolites, which are most likely to vary depending on the type of 
conjugated moiety (Berthiller et al., 2013). As a consequence of compartmentation, the 
conjugated toxic substances are prevented from interacting with cellular components 
and exerting their toxicity to the plant. 
Hence, modified mycotoxins can be formed by plant defence mechanisms as a 
physiological response to fungal infection. The majority of characterised modified 
mycotoxins are conjugated metabolites of parent fungal metabolites (mycotoxins) with 
polar compounds (EFSA, 2014). Glucosylation, sulfation, acetylation and GSH 
conjugation are the most frequently reported pathways involved in the formation of 
modified mycotoxins by plants and fungi (Berthiller et al., 2009). These pathways are not 
unique to mycotoxins, and as previously described, they are often succeeded by 
compartmentation processes in plants. Figure 4 illustrates two examples of in planta 
enzyme-catalysed detoxification reactions (GSH conjugation and glucosylation) of 
mycotoxins. 
 
 
 
Figure 4. The three-stage enzyme-catalysed detoxification process of mycotoxins in plants. The broken 
arrow indicates optional metabolic steps that may not be necessary for conjugation reactions to take place. 
Adapted from Coleman et al., 1997. 
Abbreviations: P450, cytochrome P450 monooxygenases; GST, glutathione S-transferase; GSH, glutathione; 
GT, glucosyltransferase; UDP-G, uridine diphosphate glucose; Glc, glucoside; Tr1, glutathione-conjugate 
transporter; Tr2, glucose-conjugate transporter; Cys, cysteine. 
 
Fungi can also contribute to the modified mycotoxin load of commodities, since 
they are capable of either directly excreting modified mycotoxins or metabolising 
existing mycotoxins (Broekaert et al., 2015). The acetylated DON derivatives, 3Ac-DON 
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and 15Ac-DON, can be directly excreted by fungi; both metabolites are biosynthetic 
precursors of DON and arise from a common precursor (3,15-diacetyl DON), and are 
also used as genetic markers to differentiate between 3Ac-DON and 15Ac-DON 
chemotypes in Fusarium (Alexander et al., 2011). Moreover, moulds can metabolise 
existing mycotoxins produced toxigenic species. Namely, ZEN14Sulf was first isolated 
from a rice culture of F. graminearum and reported by Plasencia and Mirocha (1991). 
Fungi of the genera Rhizopus and Aspergillus are also able to biotransform ZEN to 
ZEN14Sulf (El-Sharkaway et al., 1991; Brodehl et al., 2014). In addition, fungal 
glucosylations of the Fusarium mycotoxins ZEN, HT2, T2 and DON to ZEN14Glc, HT-2 
toxin-3-glucoside (HT2-3-Glc), T-2 toxin-glucoside (T2-Glc) and DON3Glc, respectively, 
have been described in the literature (Kamimura, 1986; Busman et al., 2011; Tian et al., 
2016). 
 
2.2.3 Transformations via food processing and brewing 
 
A large proportion of the harvested cereal grains are further processed into various 
products, including flour, bread, pasta, bread and beer. Food processing can impact on 
mycotoxins present in raw materials by physical removal, adsorption to solid surfaces, 
as well as chemical and enzymatic transformations. Furthermore, the transfer of heat 
during food manufacturing processes can cause either release of the precursor 
mycotoxins or reactions with food macromolecules such as sugars, proteins and lipids 
(Suman and Generotti, 2016). Large variations in the levels and chemical structures of 
mycotoxins and modified forms have been documented for cleaning, milling, brewing, 
baking, (alkaline) cooking, fermentation, roasting and extrusion (reviewed in Karlovsky 
et al., 2016). Hence, knowledge of the chemical fate of mycotoxins under various types 
of food processing operations is of utmost importance in ensuring the safety of 
foodstuffs. As regards food processing, this Ph.D. dissertation focused on investigating 
the fate of mycotoxins during beer fermentation and their impact on brewing yeast. 
Beer is the most consumed alcoholic beverage in the world and can be subjected 
to mycotoxin contamination, predominantly due to infected raw materials. Beer 
production involves a variety of procedures that might impact on the initial level of 
mycotoxins in a positive or negative way (Pascari et al., 2018). The two main processes 
in beer making are malting and brewing. During malting, which consists of three stages 
(steeping, germination and kilning), raw barley or another grain is steeped in water to 
obtain the correct moisture content and allowed to germinate under precise conditions 
to produce malt. The malt is then soaked into brewing liquor (mashing) and the 
temperature is raised to produce the liquid extract (wort), which is then separated from 
the insoluble material (spent grains). The other important step in brewing is 
fermentation, upon which the sugary wort is converted into beer by producing alcohol, 
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carbon dioxide, plus some amount of other flavouring metabolic by-products (Willaert, 
2007). Beer fermentation is a process initiated by yeast primarily of the Saccharomyces 
genus: ale or top fermentation using S. cerevisiae and lager or bottom fermentation 
using S. pastorianus (Pascari et al., 2018). A number of studies have investigated the 
transfer of mycotoxins, particularly trichothecenes and ZEN, from the starting cereal 
commodities (barley and malt) into the final beer-making chain. Generally, DON is a 
mycotoxin frequently found in different beers together with DON3Glc, whereas NIV, 
HT2, T2, ZEN and fumonisins have rather rarely been documented and/or at lower 
concentrations (Varga et al., 2013; Peters et al., 2017).  
Lancova and co-workers (2008) reported that the levels of Fusarium mycotoxins 
tended to significantly decrease during the steeping step. This is due to the treatment 
of grains with quite a high amount of water, which removes a proportion of water-soluble 
mycotoxins from the outer matrix surface (Schwarz et al., 1995). During the germination 
process, mycotoxins may undergo extensive structural transformations. For instance, the 
DON content was reduced by 50% with an almost equal amount of DON3Glc formation, 
because of the high enzymatic activity in germinating grains (Maul et al., 2012). 
Nevertheless, de novo Fusarium micromycete growth accompanied by mycotoxin 
production may occur in this stage of brewing, resulting in significantly increased 
mycotoxin levels (Lancova et al., 2008). According to the same paper, kilning appears 
to contribute minimally to mycotoxin levels. On the contrary, mashing is a very crucial 
step influencing the mycotoxin concentration dynamics in brewing. Under certain 
conditions, technological parameters such as temperature, the ratio of water to raw 
material and enzymatic activity can dramatically increase mycotoxin concentrations 
(levels as high as 600% of DON content in malt have been reported) (Niessen et al., 
1993). Nevertheless, the key factor concerning the mycotoxin content in the final beer 
product is the starting malt contamination (Kostelanska et al., 2011). 
Finally, yeast fermentation may also be affected by the fungal metabolites in the 
wort. Decreases in the rate of fermentation by S. cerevisiae have been recorded in 
fermentation broths containing 10–50 μg/g T2, 5–50 μg/g ZEN and 50 μg/g DON (Wolf-
Hall, 2007). However, there was no effect at 20 μg/g DON. NIV at levels below 50 μg/g 
was also found not to have an effect on ale or lager yeast strains (Boeira et al., 1999), 
and only at very high concentrations was a synergistic interaction between DON and 
ZEN observed (Boeira et al., 2000). Yeast fermentation can also affect mycotoxin 
concentrations by adsorption to the yeast cell wall and metabolism (Karlovsky et al., 
2016). To sum up, beer is undoubtedly affected by mycotoxin contamination and beer 
production processes can influence the mycotoxin load and accumulated forms to a 
great extent. Several parameters have been found to cause an inhibitory effect on 
mycotoxin levels, namely the starting raw material contamination, steeping, mashing 
and fermentation.  
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2.3 Toxicological ramifications of modified Fusarium 
mycotoxins 
 
Modified mycotoxins can substantially differ in toxicokinetic and toxicodynamic 
parameters compared to their precursors, due to often marked structural differences 
and the resulting physico-chemical properties (polarity, solubility, etc.). Humans are 
principally exposed to mycotoxins and derivatives thereof via contaminated foodstuffs, 
whereas the lungs and skin might only represent a possible route in certain occupational 
cases (e.g. farmers and bakers); animals are exposed via feed. Following the 
consumption of contaminated commodities, modified mycotoxins may either become 
metabolically formed within an organism or re-activated in the GIT, and potentially exert 
adverse effects on target organ(s)/system(s). Nevertheless, evaluation of any additional 
health burden arising from modified mycotoxins is hindered by the poor availability of 
exposure and toxicity data, even though the literature is rich in reports concerning the 
toxicological profiles of unmodified mycotoxins. Figure 5 outlines the theoretical fate of 
modified mycotoxins in monogastric species based on current knowledge. 
Pertaining to the toxicological significance of modified mycotoxins, current 
research has focused on i) understanding their chemical/metabolic fate during food 
processing or digestion and ii) investigating their intrinsic toxicity. Due to the complexity 
and high cost of animal studies, in addition to the limited availability of pure modified 
mycotoxins, the conducting of comprehensive in vivo investigations is not favoured. 
Currently, only a few in vivo studies on modified mycotoxins are available, which do 
provide, however, very useful information concerning the metabolic fate and systemic 
toxicity of these compounds. On the other hand, non-animal test methods (e.g. in silico 
and in vitro; reviewed in Nathanail et al., 2016) are powerful assays that can effectively 
assist in overcoming several of the drawbacks associated with in vivo experiments, and 
grant researchers the necessary flexibility and reliability to keep pace with the constantly 
rising number of identified (modified) mycotoxins. To date, the bulk of available toxicity 
data on plant and fungal modified Fusarium mycotoxins have essentially targeted the 3-
glucoside of DON and some acetylated DON derivatives, accompanied by a number of 
ZEN-modified forms (Broekaert et al., 2015). 
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Figure 5. Theoretical fate of modified mycotoxins in monogastric species.  
*Unconfirmed. 
Original source: Nathanail et al., 2016; © The Royal Society of Chemistry 2016. 
 
For DON, an in silico analysis was recently performed to investigate the impact of 
glucosylation on the manifestation of its toxicity (Pierron et al., 2016). It was demonstrated 
that DON3Glc is sterically unable to bind to the A-site of the ribosomal peptidyl 
transferase centre, in contrast to its parent. In a follow-up experiment by the same 
authors, the cell viability and barrier function of Caco-2 cells were unaffected by exposure 
to DON3Glc, and it did not activate JNK or P38 MAPKs, the activation of which mediates 
apoptosis and can cause up-regulation of pro-inflammatory cytokines and chemokines 
(Pestka, 2010). Similar findings from other in vitro studies verified the absence of adverse 
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toxic effects of DON3Glc, reporting no impairment of Caco-2 cell viability (up to 16.8 μM 
DON3Glc) (Alizadeh et al., 2016) and no cytotoxicity in IPEC-J2 porcine intestinal cells 
(Broekaert et al., 2016). Microarray analysis of 30,000 genes revealed that the treatment 
of intestinal explants with 10 μM DON3Glc did not change the expression or cause any 
histomorphological alterations. By contrast, 10 μM DON caused morphological lesions 
and up-regulation of genes of pro-inflammatory cytokines (Pierron et al., 2016). It thus 
appears that the size increase of DON3Glc in addition to the glucosylated hydroxyl group 
at C-3, essential for binding to the ribosome, renders this modified mycotoxin 
significantly less toxicologically active. DON3Glc has also been shown to have a strongly 
reduced ability to inhibit protein synthesis in wheat ribosomes compared to DON 
(Poppenberger et al., 2003). Other DON derivatives such as 3Ac-DON, 15Ac-DON and 
DOM-1 show wide variability in their toxicity profiles. Different studies have concurred 
that 3Ac-DON and DOM-1 are less toxicologically potent than DON, whilst 15Ac-DON 
is usually more potent, albeit depending on the endpoint of interest (Payros et al., 2016). 
Observations of reduced toxicological activity, similar to DON conjugates, have 
also been documented in in vitro assays for derivatives of ZEN. Both ZEN14Glc and 
ZEN16Glc were tested in Caco-2 cells for cytotoxicity and found to be negative (Cirlini 
et al., 2016). ZEN14Glc has been demonstrated to exhibit reduced ER binding capacity 
compared to ZEN (Poppenberger et al., 2006), a fact that was recently confirmed by a 
mixed in vitro/in silico approach confirming its inability to effectively bind and activate 
ERs (Dellafiora et al., 2017). In vitro and in silico modelling also showed that ZEN14Sulf 
did not activate ERs and ZEN14Sulf was non-oestrogenic in MCF-7 human breast cancer 
cells (Drzymala et al., 2015). Toxicity studies on other modified mycotoxins, apart from 
those previously discussed in Section 2.1, have been scarce. 
Although conjugations of mycotoxins with various moieties appear to mostly 
alleviate their toxicological activity, possible health effects can still be manifested from 
the liberation of toxic aglycones during mammalian digestion. Evidence from in vitro 
digestive systems strongly suggests that several important modified trichothecenes 
(DON3Glc, NIV3Glc, T2-Glc and HT2-3-Glc) and modified ZEN compounds such as 
ZEN14Glc, ZEN14Sulf,? ?-zearalenol-14-glucoside? ??-ZEL14Glc) and? ?-zearalenol-14-
glucoside???-ZEL14Glc) remain unaffected under conditions prevailing in the upper GIT 
(Gratz, 2017). Several modified trichothecenes, namely DON3Glc, NIV3Glc and T2-Glc, 
have been found to not be efficiently transported through intestinal epithelial cell 
monolayers, whilst their precursors were able to be transferred to various degrees (De 
Nijs et al., 2012; Gratz et al., 2017). For ZEN14Glc, findings are somewhat in 
disagreement, with one study reporting no transport across intestinal epithelium 
monolayers and no significant release of ZEN after 24 h of exposure to ZEN14Glc (2 μM), 
whereas another study reported uptake by Caco-2 cells, as well as de-glucosylation of 
approximately 20% of the applied 40 μM ZEN14Glc, being released as apical ZEN (Cirlini 
et al., 2016). Importantly, all these modified forms can be effectively de-conjugated by 
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human colonic microbiota with varying kinetics, and further metabolised to many 
currently unknown metabolites (Berthiller et al., 2011; Dall’Erta et al., 2013; Gratz et al., 
2017). 
Complementary to in vitro data, in vivo studies have also compared the digestive 
fate and toxic responses of modified mycotoxins with their native analogues. In an in vivo 
metabolism experiment, equimolar amounts of DON and DON3Glc were orally 
administered as single doses in six Sprague-Dawley male rats (Nagl et al., 2012). Most of 
the applied DON3Glc was recovered in faeces as DON or DOM-1, indicating extensive 
de-conjugation, presumably in the GIT of rats. Interestingly, intestinal absorption of 
DON3Glc was measured to be reduced by a factor of four compared to DON. The in 
vitro stability of DON3Glc in the stomach was verified in vivo by Veršilovskis et al. (2012), 
who administered by gavage 25 μg of DON3Glc to two male Wistar rats and was able to 
detect only ca 2% of DON in the stomach. However, the same study documented an 
extensive de-conjugation of DON3Glc in the small intestine attributable to the enzymatic 
activity of tissue ?-glucosidases. Nagl et al. (2014), also conducted a follow-up study in 
which equimolar amounts of DON and DON3Glc were orally administered to four male 
piglets on days 3 and 9 of the study, respectively, and DON3Glc intravenously on day 13. 
The largest proportion of DON3Glc was excreted in urine and only negligible amounts 
were found in faeces, revealing species-specific differences in the metabolism of this 
modified mycotoxin. Nonetheless, the fact that DON3Glc was almost completely absent 
from pig excreta is line with results obtained for rats. In vivo, DON3Glc was also found 
incapable of eliciting pro-inflammatory cytokine and chemokine messenger RNA (mRNA) 
responses in mice following oral exposure via gavage to 2.5 mg DON3Glc/kg bw (Wu et 
al., 2014a). At similar dose levels (2.5–10 mg/kg bw), DON3Glc rapidly elicited anorectic 
responses that mimicked DON in a nocturnal mouse food consumption study but was 
markedly less effective at inducing emesis in minks (Wu et al., 2014b). Taken together, 
available data on DON3Glc suggest that this modified mycotoxin is only absorbed in the 
GIT, and release of the aglycone only takes place in distal parts of the intestine, thus 
minimising the absorption of free DON. It is also significantly less toxicologically active 
compared to its precursor. 
However, the first investigation concerning the in vivo fate of a glucosylated 
mycotoxin, was conducted by Gareis et al. (1990). A diet artificially contaminated with 
synthesised ZEN14Glc (396 μg/kg) was fed to a female pig over a period of two weeks. 
Analysis of the excreta revealed considerable amounts of ZEN, ?-ZEL and??-ZEL, but no 
presence of the initially dosed modified mycotoxin. The authors thus posited complete 
de-conjugation of ZEN14Glc during digestion and release of the aglycone ZEN, which 
was then further metabolised. Notably, no clinical signs of hyperoestrogenism were 
observed in the animal. In a rat uterus bioenlargement bioassay, six Sprague-Dawley rats 
per group were administered intragastrically equimolar amounts (630 nmol) of either ZEN 
or ZEN14Sulf (Plasencia and Mirocha, 1991). The results indicated that ZEN14Sulf partially 
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retained the oestrogenic properties of ZEN. Hydrolysis of ZEN14Glc to free ZEN in the 
stomach of rats has been reported, in contrast to DON3Glc, which remained stable. After 
administration of 25 μg ZEN14Glc to two Wistar rats, considerable amounts of ZEN 
(approx. 18% of the administered dose) were found in the stomach, indicating hydrolysis 
of the modified mycotoxin in the upper digestive tract (Veršilovskis et al., 2012). In 
another in vivo experiment, ZEN (10 μg/kg bw) and equimolar amounts of ZEN14Glc, 
ZEN16Glc and ZEN14Sulf were orally administered to pigs as a single bolus using a 
repeated measures design (Binder et al., 2017). All modified forms were readily 
hydrolysed to ZEN and converted to other mostly unknown metabolites in the GIT of 
pigs. Of significance is that glucosylated metabolites of ZEN were recovered to a greater 
extent in faeces, denoting reduced bioavailability and slightly reduced toxicity. The most 
recent study exploring the metabolic fate of ZEN, ?-ZEL, ?-ZEL, ZEN14Glc and ZENSulf 
in pigs, reported age-dependent differences in the oral bioavailability of ZEN (ranging 
between 61–85%), complete absorption of ?-ZEL and ?-ZEL, complete hydrolysis of both 
ZEN14Glc and ZEN14Sulf to ZEN and extensive glucuronidation of all compounds 
(Catteuw et al., 2019). On the basis of their findings, the authors highlighted the 
importance of including modified ZEN forms in feed analysis and utilising glucuronide 
metabolites of ZEN derivatives in biomonitoring studies. 
To summarise, from the limited existing toxicity data on a handful of modified 
mycotoxins that have been reasonably toxicologically tested, two generalised 
conclusions can be drawn. Firstly, from in silico, in vitro and in vivo studies, the few 
currently known modified mycotoxins appear to possess (considerably) reduced intrinsic 
toxicity compared to their native analogues. However, the toxicological relevance of 
certain compounds ought not be underestimated, as they may act via different, as yet 
obscure mechanisms compared to their precursors. Secondly, the bioavailability and 
digestive fate of modified forms can significantly differ among them and from their 
precursors, leading to the assumption that these compounds cannot be viewed as a 
homogeneous group of compounds with identical toxicological characteristics. Finally, 
the toxicological implications associated with the release of an aglycone in the lower GIT 
warrants further investigations to better assess the impact on intestinal cells 
(histomorphology, barrier function and immune responses), potential colonic absorption 
and the impact on the gut microbial composition and eventual potential systemic 
manifestation in an organism. 
 
2.4 Analysis of mycotoxins and derivatives 
 
Whenever food/feed safety risk assessments of mycotoxins and their derivatives result 
in unfavourable outcomes, regulatory measures, e.g. in the form of maximum levels, 
may ensue. Devising appropriate risk management strategies often involves complex 
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processes, heavily dependent on the evaluation of occurrence, exposure and toxicity 
data for the contaminants under investigation (EFSA, 2012). To obtain ample qualitative 
and quantitative data on these toxins in a reliable manner, the development of fit-for-
purpose analytical methods is necessary. Additionally, routine surveillance of regulated 
mycotoxins requires robust, highly-sensitive detection methods, allowing for the 
determination of a multitude of target compounds, i.e. known analytes of interest in 
various sample matrices. Native mycotoxins in food- and feedstuffs are commonly 
analysed by chromatographic methods such as thin layer chromatography (TLC), gas 
chromatography (GC), LC, or rapid immunochemical methods e.g. enzyme-linked 
immunosorbent assay (ELISA).  
For the majority of analytical applications that require reliable and accurate 
quantification, LC–MS is nowadays recognised as the go-to method by both research 
and official control laboratories. Native and modified mycotoxin determination with 
hyphenated chromatographic methods is frequently a multistep process, including 
sampling, homogenisation, extraction, clean-up and, when needed, analyte enrichment 
prior to determination (Cirlini et al., 2012). The application of matrix-specific sample 
preparation techniques and optimisation of chromatographic and MS parameters are 
both essential for sensitive and accurate concurrent analysis of a wide range of 
chemically diverse mycotoxins. These subjects are in the focus of this section and 
especially as regards LC–MS methodologies. 
 
2.4.1 Sampling and sample preparation 
 
Analytical procedures for mycotoxin determination ordinarily commence with sampling 
and sample comminution to obtain a suitable size that would allow the extraction of 
analytes and subsequent measurements. The aim of sampling is to collect representative 
sample(s), e.g. from a lot of an agricultural product, of a workable size in the laboratory 
(Köppen et al., 2010). Due to the heterogeneous distribution of mycotoxins in 
agricultural commodities, adequate sampling is a very crucial step for reliable analytical 
determination. Generally, the most effective approaches to reduce the variability of 
mycotoxin test procedures are to increase the laboratory sample size, the degree of 
sample comminution and the number of aliquots quantified (Whitaker, 2006). The 
methods of sampling and analysis for official control of the levels of mycotoxins in 
foodstuffs are laid down in Commission Regulation (EC) No 401/2006 (EC, 2006a). 
Strategies applied for sampling of parent mycotoxins are also suitable for conjugated 
mycotoxins (EFSA, 2014). For research purposes, sampling approaches may have to be 
considerably adjusted in order to embrace the experimental hypothesis and conditions 
(sample amount, type, chemical stability of analytes, etc.). An additional complication in 
certain metabolomics studies is that during sampling, immediate quenching of all 
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metabolic processes should be performed without alteration of the metabolic state 
(Kluger et al., 2015b). Storage conditions must also not permit alterations of the 
metabolic state or cause changes to metabolite species and levels. 
Sample preparation is the next key step for a successful protocol in the chemical 
analysis of mycotoxins. The majority of LC–MS methods rely on the extraction of analytes 
from the biological matrices into a liquid phase and optional clean-up to remove 
undesirable matrix components (Turner et al., 2009). The extraction methods applied 
depend on the chemistry of the target analytes and on the type of matrix for which 
extraction is performed. Because of the wide range of physico-chemical properties of 
mycotoxins, particular consideration needs to be given to the extraction efficiency of the 
solvent mixture. Conjugated mycotoxin derivatives are usually more polar than their 
precursors. Therefore, extraction schemes should facilitate the removal of both forms 
from sample matrices with comparable recoveries. Several different extraction 
procedures are used, of which the oldest, but still frequently used, is solvent extraction 
(Kralj Cigić and Prosen, 2009). Typically, the extraction of polar analytes is favoured by 
the presence of water in the extraction solution mixture, whilst the extraction of 
hydrophobic mycotoxins is enhanced by organic solvents. The most widely used 
extraction solvents are mixtures of methanol:water and acetonitrile:water in varying 
ratios, regularly containing modifiers such as acids or bases. (Meneely et al., 2011). 
According to the literature, the extraction of DON, NIV, HT2, T2 and ZEN, as well as 
many of their derivatives, has been successfully achieved using various ratios of 
acetonitrile and water, acidified with formic or acetic acid (Zachariasova et al., 2010; De 
Boevre et al., 2012; Malachová et al., 2014). In a metabolomics study, Cajka et al. (2014) 
accomplished optimal extraction of polar/medium polar barley metabolites employing 
either acetonitrile:water (84:16, v/v) or a mixture of methanol:water (50:50, v/v). The 
authors eventually chose the latter solution due to its broadest representation of 
metabolites based on polarity. Other extraction techniques that have been successfully 
incorporated in mycotoxin analysis include accelerated solvent extraction, pressurised 
liquid extraction, microwave-assisted extraction and supercritical fluid extraction (Krska 
et al., 2008). 
For further purification and analyte enrichment, liquid extracts can be submitted 
to solid phase extraction (SPE), specifically tailored multifunctional columns (e.g. 
MycoSep® push-through clean-up columns), immunoaffinity columns or modifications of 
the “quick, easy, cheap, effective, rugged and safe” (QuEChERS) technique (Malachová 
et al., 2017). The purpose of sample clean-up is to enhance the signal-to-noise ratio and 
minimise interference by matrix components that may cause analyte signal suppression 
or enhancement (SSE; i.e. matrix effects) (Trufelli et al., 2011). The majority of sample 
preparation techniques used in mycotoxin analyses have been developed for the 
determination of parent mycotoxins, and more so the regulated ones (see Section 2.7). 
As a consequence, they may not be suitable for the determination of modified 
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mycotoxins. Vendl et al. (2009), evaluated the suitability of several clean-up strategies 
(C18-SPE, primary and secondary amines, MycoSep and immunoaffinity columns) for the 
determination of DON, ZEN and their major modified metabolites in cereals and cereal-
derived products by liquid chromatography–tandem mass spectrometry (LC–MS/MS). 
Overall, none of the tested clean-up methods proved suitable to accommodate a wide 
range of polarities and the final method thus used no sample clean-up. 
The limited availability of analytical standards for modified mycotoxins has led to 
the development of indirect methods as an attractive alternative to target analysis. Such 
approaches are based on chemical or enzymatic treatments that cleave the conjugated 
moieties and release the parent mycotoxin. The supposed advantage of these techniques 
is that measurements of all modified forms present within a sample can be performed 
without the need for analytical standards, because the modified mycotoxin concentration 
is estimated as the total precursor analyte content after subtracting the free precursor 
content. However, a critical assessment was conducted of three indirect methods for total 
DON determination, and none was found able to de-conjugate the parent mycotoxin 
(DON) from the modified forms DON3Glc, 3Ac-DON and 15Ac-DON (Malachová et al., 
2015). The authors concluded that use of acidic or alkaline hydrolytic process was not 
suitable for the indirect determination of DON and efforts should be directed towards 
methods relying on enzymatic hydrolysis. Ideally, accurate determination of modified 
forms should be based on analytical standards. 
 
2.4.2 Liquid chromatography–mass spectrometry 
 
LC coupled with ultraviolet, diode array or fluorescence detectors have been widely used 
techniques for reliable and robust detection of mycotoxins in food at reasonably low 
levels. Over the past two decades, however, LC–MS/MS based methods have been 
established as the “golden standard” for determination of low-molecular weight food 
contaminants, including mycotoxins, over a concentration range of several orders of 
magnitude (Righetti et al., 2016). Key features of LC–MS/MS methods are their ability for 
multi-analyte determination with high analytical selectivity, sensitivity, accuracy and 
robustness (Songsermsakul and Razzazi-Fazeli, 2008). These techniques also offer highly 
specific chemical information on the molecular mass and the isotopic fine structure of 
compounds, making them extremely useful in metabolomics studies for identification and 
characterisation of modified mycotoxins (De Boevre et al., 2015). 
LC is a versatile technique for the separation of analytes in a mixture, according 
to their physico-chemical properties, by chemical interactions of analytes between a 
liquid mobile phase and a solid stationary phase. Chromatographic separation in multi-
mycotoxin methods is achieved either with high performance liquid chromatography 
(HPLC) instruments or with the more modern technology, ultra high performance liquid 
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chromatography (UHPLC). In modern LC–MS/MS applications, chromatographic 
separation is mainly used to attenuate ion suppression effects, frequently occurring when 
multiple compounds reach the ion source simultaneously. Additionally, in metabolomics 
experiments in particular, chromatography can be used as retention-time identifier for 
the analyte of interest (Patti, 2011). Reversed phase which is considered as the most 
popular type of LC separation in mycotoxin analyses is relying on hydrophobic 
interactions between the analytes and the stationary phase for separation, ensuring 
retention for a wide range of substances. The eluents in reversed phase chromatography 
are polar (e.g. mixtures of water with acetonitrile or methanol), whilst the column materials 
are apolar (most often C18) (Snyder et al., 2010). Hydrophilic interaction chromatography 
(HILIC), which is a variant of normal phase LC, is ideal for separation of small polar 
compounds (Buszewski and Noga, 2012). 
Following chromatographic separation, analytes are transferred from the liquid 
phase to the gaseous phase and are ionised before they enter the mass spectrometer, 
which operates under high vacuum in order for the generated ions to reach the detector 
intact. Different MS interfaces have been utilised for analysis of mycotoxins in food and 
feed, as well as in biological matrices (e.g. organ tissues, urine, faeces, blood and other 
samples). Nowadays, modern LC–MS instruments utilise atmospheric pressure chemical 
ionisation (APCI), atmospheric pressure photo-ionisation (APPI) or electrospray ionisation 
(ESI) interfaces (Songsermsakul and Razzazi-Fazeli, 2008). ESI is the most widely utilised 
ionisation technique in LC–MS/MS applications and belongs to the so-called “soft” 
ionisation techniques in which ions are generated without decomposition of the analyte. 
In positive mode, ESI leads to the formation of protonated ions [M+H]+, or adducts such 
as [M+Na]+. In the negative mode, ESI deprotonated ions [M–H]– or adducts, e.g. 
[M+CH3COO]–. 
Mass spectrometers are then able to separate charged particles based on their 
mass-to-charge ratio (m/z) and measure relative abundances of ions (Boyd et al., 2011). 
Most quantitative methods used nowadays rely on LC–MS instrumentation and 
particularly triple quadrupole (TQ) mass spectrometers. These provide a high linear range 
and good sensitivity, but on the downside, they require tuning of the analytes during 
method development and can only be used for measurement of already known analytes. 
With this instrument, selected reaction monitoring (SRM) mode is possible, which is highly 
capable for sensitive quantitation (Holčapek et al., 2012). In the SRM mode, the first and 
the third quadrupoles act as mass filters, whilst the second one is the collision chamber, 
in which the target ion is fragmented. The ions are fragmented by collision-induced 
dissociation with a collision gas (usually nitrogen or argon) to form product ions that are 
further detected. The MS data are displayed in the total ion chromatogram (TIC), which 
is created by summing up intensities of all mass spectra belonging to the same scan. In 
the extracted ion chromatogram (EIC) each selected mass or mass transition is shown 
separately. Ion trap and time-of-flight (TOF) are two also commonly used in mycotoxin 
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analytics. QTOFs are hybrid HRMS instruments, combining a quadrupole with a TOF and 
are capable for measurements of high mass accuracy in both full and MS/MS modes 
(Holčapek et al., 2012). 
Hyphenated chromatographic techniques, and particularly LC–MS/MS, allow for 
rapid, sensitive and accurate quantification that fosters the strong tendency of recent 
years towards development of multi-(modified) mycotoxin determinations (Cirlini et al., 
2012). In 2006, a method was developed for the determination of 39 free and modified 
mycotoxins in two consecutive chromatographic runs (ESI– and ESI+) (Sulyok et al., 2006). 
A few years later, an LC–MS/MS method using both ESI– and APCI probed was published 
that could analyse simultaneously DON and ZEN, along with eight of their modified 
forms (Vendl et al., 2009). Multi-methods have been further expanded, fully exploiting 
the power offered by MS detection relying on simplified sample preparation processes 
that can be applied without necessitating dedicated sample clean-up. Nowadays LC–
MS/MS methods are able to accommodate accurate and rapid determination of 
hundreds of analytes in a single run and in different matrices (Malachová et al., 2014). 
In today’s world, however, with more and more toxic substances constantly 
receiving regulatory attention, the use of HRMS has unlocked additional capabilities in 
mycotoxin research, including concurrent identification of theoretically unlimited non-
target compounds, even at minute concentrations, as well as retrospective data analysis 
(Kluger et al., 2015a). The use of full scan acquisition mode with high sensitivity, 
combined with high resolving power (up to 100,000 full width at half maximum, FWHM; 
defined at m/z) and accurate mass measurement (< 5 ppm) are the main characteristics 
of the increased popularity of HRMS. The mass accuracy of a measurement is the relative 
difference between the measured mass and the exact mass (i.e. sum of the most 
abundant isotopes of the constituent atoms of this molecule; Murray et al., 2013), 
expressed in parts per million (ppm) (De Boevre et al., 2015). The accurate mass of a 
precursor ion, spectral information on elemental composition, together with the accurate 
mass of its fragment ions are valuable pieces of information in the identification of its 
chemical structure. Although such data are crucial in metabolite identification, and can 
relatively easily be obtained with HRMS apparatus, locating metabolites of interest can 
be a daunting task in reality. To address this issue, targeted and untargeted 
metabolomics approaches, as well as sophisticated data processing algorithms and 
software, which can detect and process metabolite-derived MS signals and 
chromatographic peaks within huge amounts of LC–HRMS raw data, have been 
developed (see Section 2.6). 
In LC–MS/MS analyses, however, SSE caused by matrix components is a major 
drawback, which can impair accuracy and sensitivity of a method. Especially in analytics 
where no sample clean-up is applied, detection of low-level analytes may severely be 
hampered by co-eluting components that alter the ionisation efficiency (Gosetti et al., 
2010). Consequently, matrix effects can directly influence the amount of analyte ions 
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reaching the detector, causing either lower (suppression) or higher (enhancement) analyte 
signal compared to that obtained from the same compounds in neat standard solution, 
which in turn will lead to underestimation or overestimation of target analyte 
concentrations. The exact mechanism behind matrix effects remains unknown, but it has 
been hypothesised that matrix components might be interfering with the process of 
analyte droplet formation and transition to the gaseous phase or creating competition 
with target compounds for the limited available charges inside the ionisation interface 
(Taylor, 2005). Matrix effects are substance-dependent, and the chemical nature of 
different mycotoxins has a significant effect on the extent of matrix effects (Malachová et 
al., 2017). The type of matrix analysed, the sample preparation, as well as the 
chromatographic and MS conditions can also greatly affect the degree of matrix effects 
(Gosetti et al., 2010). 
There are, however, strategies to overcome matrix effects and at least partially 
compensate for their negative influence in LC–MS/MS methods. But first, it is crucial to 
determine whether matrix effects are present and to what extent. Matrix induced SSE can 
be estimated by the equation proposed by Sulyok et al. (2006). For instance, sample 
dilution to minimise undesired matrix effects or clean-up techniques to remove interfering 
matrix components are probably the most widely used approaches in mycotoxin analysis 
(Krska et al., 2008). Although, dilution might not be appropriate if target analytes are 
expected to be present in trace amounts and sample clean-up techniques are frequently 
not applicable to a multitude of chemically distinct mycotoxins and are time-consuming, 
as previously discussed. If matrix effects cannot be eliminated with sample preparation, 
adjustments to the chromatographic conditions and/or alternate calibration methods 
should be considered (Trufelli et al., 2011). An attractive alternative to time-consuming 
manual sample preparation techniques that can minimise the effect of interfering matrix 
components, without the need for manual sample preparation is on-line sample clean-up 
coupled with LC–HRMS (Ates et al., 2014). Another possible approach to cope with matrix 
effects is the stable isotope dilution assay (SIDA). Several multi-mycotoxin methods have 
been developed based on this technique that use labelled isotopologue standards (Varga 
et al., 2012; Zhang et al., 2017), including also isotopologues of modified forms 
(DON3Glc, 3Ac-DON and 15Ac-DON) (Habler and Rychlik, 2016). 
 
2.4.3 Method validation and performance characteristics 
 
Method validation is a crucial process in the development of any new analytical method. 
Its purpose is to demonstrate that the method is suitable for the intended applications 
and it is capable of providing reliable results. However, of the multitude of methods that 
have been published over the years regarding the determination of mycotoxins in food 
and feed, only a limited number include performance characteristics and in-house 
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validation data (Krska et al., 2008). In the EU, the general guidelines on the performance 
of analytical methods and the interpretation of results are laid down in Commission 
Decision 2002/657/EC (EC, 2002a), which defines validation as: “the confirmation by 
examination and the provision of effective evidence that the particular requirements of 
a specific intended use are fulfilled.” Such evidence, or functional qualities attributed to 
an analytical method, are determined via several performance characteristics including 
specificity, linearity, accuracy, trueness, recovery, precision, repeatability, 
reproducibility, ruggedness and the detection limit. It should be noted that there is no 
existing regulatory framework for the proper validation of multi-mycotoxin methods or 
confirmatory methods used for the identification of unknown compounds. 
An overview of the typical performance characteristics evaluated during the 
validation of methods used in the analysis of mycotoxins is provided in Malachová et al. 
(2017). Briefly, method specificity describes the ability to distinguish between a target 
analyte and other components under the experimental conditions (e.g. isomers, 
impurities and matrix). The linearity of an analytical procedure is another important 
performance characteristic that denotes its ability to obtain test results (within a given 
working range) that are directly proportional to the concentration of the analyte in the 
sample. The accuracy of a quantitative method refers to the closeness of agreement 
between a test result and the accepted reference value and is determined through 
trueness and precision. The verification of trueness is accomplished by analysing 
certified reference materials or, if not available, by measuring the recovery (i.e. 
percentage of the true concentration of a substance) of additions of known analyte 
amounts to a “blank” matrix. The precision of a method is the degree of scatter between 
a series of measurements and is expressed as the relative standard deviation (RSD) of 
the repeated analysis of a reference or fortified material under the prescribed conditions. 
Hence, repeatability is the precision under the same operating conditions over a short 
interval of time (e.g. repeatability, RSDr). On the other hand, reproducibility can be 
defined either as within-laboratory precision by estimating the variation of 
measurements between different days, different analysts, etc. (e.g. precision, RSDR) or 
as precision between laboratories. Lastly, the limit of detection (LOD) is defined as the 
lowest concentration of analyte in a sample that can be discerned from a blank sample 
with a specific certainty, whereas the limit of quantification (LOQ) is the lowest 
concentration at which the analyte can be determined with a certain precision and 
accuracy. 
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2.5 Natural occurrence of modified Fusarium 
mycotoxins 
 
Unlike humans and animals, which are able to metabolise mycotoxins and eliminate 
water-soluble metabolites through urine and faeces, in planta-formed metabolites must 
be expected to remain in the infested plant and could reach consumers via the 
consumption of food items containing the contaminated plant material (EFSA, 2017a). 
Survey data concerning the mycotoxin content in different commodities are of 
considerable importance for establishing appropriate risk management measurers and 
devising mitigation strategies. To date, analytical methodologies have mainly focused on 
investigation of the natural presence of parent mycotoxins in foods and feeds, whilst 
limited data are available on the presence of modified forms. An overview of known 
modified DON, NIV, HT2, T2 and ZEN mycotoxins, generated in plants and/or fungi, 
together with the origin and source of initial documentation is given Table 1. 
Several survey studies have been conducted regarding the natural occurrence of 
DON3Glc in cereal crops and cereal-derived goods, including an in-depth review with 
extensive occurrence data that was recently published in the format of a scientific 
opinion by (EFSA, 2017b). Briefly, it was estimated that the ratios of concentrations of 
3Ac-DON to DON, 15Ac-DON to DON and DON3Glc to DON were 10%, 15% and 
20%, respectively. The highest mean concentrations of DON and the sum of DON, 3Ac-
DON, 15Ac-DON and DON3Glc were recorded for food in the category of “Products 
for special nutritional use” and for feed, in “Cereal straw”, with their co-occurrence 
varying considerably between different food, feed and grain categories. DON3Glc, in 
particular, has been reported in barley, oats, wheat and maize, as well as the cereal-
derived products malt, beer and bread (Crews and MacDonald, 2016). 3Ac-DON and 
15Ac-DON are also consistently abundant in a large proportion of cereal grains and 
commodities (breakfast cereals, fibre-enriched bread and oatmeal, among others) (De 
Boevre et al., 2013; Bryła et al., 2016). 
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Table 1. Overview of known modified forms of DON, NIV, HT2, T2 and ZEN in plants and/or fungi. 
Compounds identified in the course of this thesis have not been included. 
 
Origin Modified mycotoxin 
(precursor) 
Producing organism(s) Reference(s) 
Plants 
and fungi 
DON3Glc (DON) maize cell suspension cultures; 
Trichoderma strains 
Sewald et al., 1992;  
Tian et al., 2016 
 HT2-3-Glc (HT2, T2) wheat and oat kernels; 
Fusarium sporotrichioides 
(unconfirmed) 
Busman et al., 2011; 
Latanzzio et al., 2012 
 T2-Glc (T2) wheat and oat kernels;  
yeasts of the Trichomonascus 
clade 
Busman et al., 2011; 
McCormick et al., 2012 
 3Ac-T2 (T2) Fusarium graminearum, 
Fusarium nivale;  
oats (artificially inoculated) 
Yoshizawa et al., 1980; 
Meng-Reiterer et al., 
2016 
 ZEN14Glc (ZEN) Rhizopus spp.;  
maize cells 
Kamimura, 1986; 
Engelhardt et al., 1988 
 ZEN16Glc (ZEN) barley seedlings, wheat and 
Brachypodium distachyon cell 
suspension cultures; 
Aspergillus oryzae, Rhizopus 
spp. 
Kovalsky Paris et al., 
2014;  
Brodehl, 2014 
 ZEN14Sulf (ZEN) Fusarium graminearum; 
barley, maize, oats, wheat 
Plasencia and Mirocha, 
1991;  
De Boevre et al., 2012 
 ?-ZEL (ZEN)? Fusarium roseum;  
maize cells 
Hagler et al., 1979; 
Engelhardt et al., 1988 
 ?-ZEL (ZEN)? Fusarium roseum;  
maize cells 
Hagler et al., 1979; 
Engelhardt et al., 1988 
 ?-ZEL14Glc (ZEN) maize cells;  
Aspergillus oryzae, Rhizopus 
spp. 
Berthiller et al., 2009; 
Brodehl, 2014 
 ?-ZEL14Glc (ZEN) maize cells;  
Aspergillus oryzae, Rhizopus 
spp. 
Berthiller et al., 2009; 
Brodehl, 2014 
Fungi 3Ac-DON (DON) Fusarium roseum Yoshizawa and Morooka, 
1973 
 15Ac-DON (DON) Fusarium graminearum Miller et al., 1983 
 neosolaniol (HT2, T2) Fusarium (unidentified species) Torp and Langseth, 1999 
 T2-triol (HT2, T2) Fusarium (unidentified species) Torp and Langseth, 1999 
 T2-tetraol (HT2, T2) Fusarium (unidentified species) Torp and Langseth, 1999 
 zearalanone (ZEN) Saccharomyces cerevisiae El-Sharkawy and Abul-
Hajj, 1988 
 ?-zearalanone (ZEN) Fusarium (unidentified species) Erasmuson et al., 1994 
 ?-zearalanone (ZEN) Fusarium (unidentified species) Erasmuson et al., 1994 
Plants DON-di-glucoside (DON) barley, malt, commercially 
baked cereal goods 
Zachariasova et al., 2012 
 DON-tri-glucoside (DON) barley, malt, commercially 
baked cereal goods 
Zachariasova et al., 2012 
 DON-tetra-glucoside (DON) barley, malt, commercially 
baked cereal goods 
Zachariasova et al., 2012 
 DON-hexitol (DON) wheat (artificially inoculated) Kluger et al., 2015b 
 DON-S-cysteine (DON) wheat (artificially inoculated) Kluger et al., 2015b 
 DON-S-cysteinyl-glycine 
(DON) 
wheat (artificially inoculated) Kluger et al., 2015b 
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Table 1. Continued. 
 
Plants DON-glutathione (DON) wheat (artificially inoculated) Kluger et al., 2015b 
 DON-di-hexoside (DON) wheat (artificially inoculated) Kluger et al., 2015b 
 DON-anhydro-glutathione 
(DON) 
wheat (artificially inoculated) Kluger et al., 2015b 
 DON-malonyl-glucoside 
(DON) 
wheat (artificially inoculated) Kluger et al., 2015b 
 15-acetyl-DON-3-glucoside 
(DON) 
wheat (artificially inoculated) Kluger et al., 2015b 
 DON-3-sulfate (DON) wheat (artificially inoculated) Warth et al., 2015 
 DON-15-sulfate (DON) wheat (artificially inoculated) Warth et al., 2015 
 NIV3Glc (NIV) wheat (artificially inoculated) Nakagawa et al., 2011 
 HT2-di-glucoside (HT2, T2) barley Veprikova et. al., 2012 
 T2-di-glucoside (T2) corn Nakagawa et al., 2013 
 15-acetyl-T2-tetraol-glucoside 
(HT2, T2) 
oats (artificially inoculated) Meng-Reiterer et al., 2016 
 dehydro-15-acetyl-T2-tetraol-
glucoside (HT2, T2) 
oats (artificially inoculated) Meng-Reiterer et al., 2016 
 hydroxy-HT2-hexosyl-
glucoside (HT2, T2) 
oats (artificially inoculated) Meng-Reiterer et al., 2016 
 hydroxy-HT2-glucoside (HT2, 
T2) 
oats (artificially inoculated) Meng-Reiterer et al., 2016 
 hydroxy-HT2 (HT2, T2) oats (artificially inoculated) Meng-Reiterer et al., 2016 
 hydroxy-HT2-anhydro-hexosyl-
glucoside (HT2, T2) 
oats (artificially inoculated) Meng-Reiterer et al., 2016 
 T2-triol-glucoside (HT2, T2) oats (artificially inoculated) Meng-Reiterer et al., 2016 
 dehydro-HT2-glucoside (HT2, 
T2) 
oats (artificially inoculated) Meng-Reiterer et al., 2016 
 HT2-hexosyl-glucoside (HT2, 
T2) 
oats (artificially inoculated) Meng-Reiterer et al., 2016 
 HT2-malyl-glucoside (HT2, T2) oats (artificially inoculated) Meng-Reiterer et al., 2016 
 HT2-malonyl-glucoside (HT2, 
T2) 
oats (artificially inoculated) Meng-Reiterer et al., 2016 
 HT2-anhydro-hexosyl-
glucoside (HT2, T2) 
oats (artificially inoculated) Meng-Reiterer et al., 2016 
 feruloyl-T2 (T2) oats (artificially inoculated) Meng-Reiterer et al., 2016 
 ZEN-di-hexoside (ZEN) Arabidopsis thaliana Berthiller et al., 2006 
 ?-ZEL-di-hexoside (ZEN) Arabidopsis thaliana Berthiller et al., 2006 
 ?-ZEL-di-hexoside (ZEN) Arabidopsis thaliana Berthiller et al., 2006 
 ZEN-malonyl-hexoside (ZEN) Arabidopsis thaliana Berthiller et al., 2006 
 ?-ZEL-malonyl-hexoside (ZEN) Arabidopsis thaliana Berthiller et al., 2006 
 ?-ZEL-malonyl-hexoside (ZEN) Arabidopsis thaliana Berthiller et al., 2006 
 ZEN-pentosyl-hexoside (ZEN) Arabidopsis thaliana Berthiller et al., 2006 
 ?-ZEL-pentosyl-hexoside (ZEN) Arabidopsis thaliana Berthiller et al., 2006 
 ?-ZEL-pentosyl-hexoside (ZEN) Arabidopsis thaliana Berthiller et al., 2006 
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Various modified forms of HT2 and T2 have also been described in the literature, 
as a result of fungal and/or plant metabolism. In an early study, Baccharis spp. were 
found able to metabolise T2 into the phase I and II metabolites HT2, 3’-hydroxy-HT2 
and T2-tetraol (Mirocha et al., 1988). Similarly, yeasts have been reported capable of 
biotransforming HT2 and T2. For instance, yeasts of the Trichomonascus clade 
biotransformed T2 into 3Ac-T2, T2-Glc and neosolaniol (McCormick et al., 2012). In 
planta glucosylation was documented by Busman et al., (2011), who detected and 
tentatively identified HT2- and T2-3-glucosides in oat and wheat kernels inoculated with 
F. sporotrichioides. This finding was confirmed by the detection of these compounds in 
naturally contaminated oats and wheat (Lattanzio et al., 2012), as well as in commercially 
available maize powder reference material (Nakagawa et al., 2012). These developments 
were followed by the discovery of di-glucosylated forms in naturally contaminated cereal 
grains (Veprikova et al., 2012; Nakagawa et al., 2013). Notably, accurate mass 
measurements and the fragmentation pattern provided evidence, in both studies, for 
possible glucosylation of HT2 at the C-3 and C-4 positions. The ubiquitous prevalence 
of both HT2 and T2 mono-glucosides in more than 75% of 20 naturally contaminated 
samples of barley, oats and wheat was confirmed, and the presence of two HT2-di-
glucoside isomers in barley (Veprikova et al., 2012). As no reference standards for these 
modified forms were available at the time, the authors reported that the mean peak area 
ratios (%) between glucosylated to parent toxins were around 17%. During a 2015 study, 
HT2-3-Glc was quantified at levels of up to 163 μg/kg in 17 out of 18 field barley 
samples, whereas T2-Glc was detected in only a few samples and at low concentrations 
(Lattanzio et al., 2015). In a survey study, 30 samples from a variety of cereal-derived 
food and feed matrices were collected from the Belgian market and analysed, but HT2-
3-Glc and T2-Glc could not be detected, even though both parent forms were present 
in some of the samples (De Boevre et al., 2012). 
The only in planta conjugated metabolite of NIV that has been characterised to 
date is its 3-glucosylated form, which was first detected in wheat grains artificially 
inoculated with F. graminearum (Nakagawa et al., 2011) and then structurally identified 
as NIV3Glc by LC–MS/MS and nuclear magnetic resonance (NMR) measurements 
(Yoshinari et al., 2014). In the former study, more than 15% of NIV was estimated to have 
been converted into its glucoside, whereas in the latter study, NIV3Glc was quantified 
in naturally contaminated wheat, at concentrations up to 4000 μg/kg and accounting for 
up to 27% of the total parent toxin. In a very recent survey in Polish wheat grains (n = 
300), NIV3Glc was determined in approximately 15% of the samples collected in 2017 
and 2018, at concentrations ranging between 5–40 μg/kg (Bryła et al., 2019). The 
NIV3Glc/NIV molar ratio was between 15–20%. Even though NIV3Glc is the only 
currently known phase II metabolite of NIV, other conjugated metabolites are likely to 
be formed due to the presence of four –OH groups in its backbone. 
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Modified forms of ZEN have been described in mammals, plants and fungi 
following biotransformation of native ZEN, with a significant number of modified ZEN 
compounds being common among different species (EFSA, 2016). Hitherto, only a few 
studies have described the presence of ZEN modified forms in crop plants. Schneweis 
et al. (2002), reported that ZEN was present in 92% of the 24 field wheat samples from 
a 1999 harvest in Bavaria, with levels ranging between 11 to 860 μg/kg. ZEN14Glc was 
detected in 42% of the samples analysed at concentrations between 17–104 μg/kg, all 
of which were ZEN-positive and exhibited a linear concentration correlation between 
the two compounds. In a survey of ZEN and its derivatives in 84 cereal-based foods, 
ZEN14Sulf predominated in abundance, with the highest quantity being about 6 μg/kg; 
none of the analysed samples were found to contain any ZEN14Glc,??- and ?-ZEL or ?- 
and ?-ZEL14Glc (Vendl et al., 2010). The 2012 Belgian market survey reported the 
occurrence of ZEN and a number of its modified forms in cereal-based food products 
(De Boevre et al., 2012). The findings of that study revealed that ?- and ?-ZEL occurred 
in 53% and 63%, respectively, of the samples analysed (n = 30). A noteworthy result was 
that in one maize sample, the sum of ZEN14Glc, ZEN14Sulf and ?-ZEL14Glc, in 
comparison to the concentration of ZEN in the same sample, indicated that 
approximately 90% of the available precursor mycotoxin had been metabolised. Lastly, 
Brodehl et al. (2014) described the transformation of more than 50% ZEN into 
ZEN14Glc, ZEN16Glc,??-ZEL and the novel metabolite ?-zearalenol-sulfate by Rhizopus 
and Aspergillus species, both commonly used species in the biotechnological 
production of fermented food (e.g. soy products). In general, whole grain cereal 
products appear to be the source of ZEN14Glc, ?-ZEL14Glc, ?-ZEL14Glc and ZEN14Sulf 
in food and feed, and modified forms may account for a few per cent up to 100% relative 
to ZEN (EFSA, 2016). 
Natural occurrence data on modified Fusarium mycotoxins, both in grains and 
products thereof, are becoming more widely available. Currently, most prevalence data 
exist for DON3Glc, 3Ac-DON, 15Ac-DON and a few modified ZEN forms. The data 
clearly reflect the ubiquitous presence of modified mycotoxins in most cereal crops and 
cereal-derived products, thus justifying the research efforts in the field during the past 
decade. However, the lack of analytical standards, and especially the time required for 
them to become available for newly identified modified mycotoxins, remains an 
important bottleneck in the effort to expand our understanding over a broader 
assortment of these substances. Future investigations focusing on the presence of 
modified mycotoxins in animal-derived products (milk, meat, eggs, etc.) could be of 
value to assess the potential carry-over along the food chain.  
 
 
 45 
2.6 Metabolomics in mycotoxin research 
 
“Metabolomics” was defined in the 1990s as the comprehensive analysis of the whole 
metabolome of an organism, which represents the entire complement of its metabolites 
(Oliver et al., 1998), and is one of the three keystone functional genomics technologies 
alongside transcriptomics (i.e. gene expression changes at the RNA level) and 
proteomics (i.e. protein expression changes) (van der Werf and Mariët, 2005). The 
general application of metabolomics is to provide insight into complex biological 
processes and eventually understand the relationship between an organism’s genotype 
and phenotype. In essence, metabolomics experiments aim to generate a snapshot of 
the metabolic state of an organism and characterise the fluctuations in the abundances 
of measured metabolites arising from natural processes or external, experimental biotic 
or abiotic perturbations (Schuhmacher et al., 2013). It is important to note that there is 
a clear distinction between primary metabolism, which refers to all essential anabolic 
and catabolic processes required for cell maintenance and proliferation, from secondary 
metabolism, which is not essential for the survival of cells and was described as early as 
1891 by Kössel (Kliebenstein, 2004). Secondary metabolites are a very diverse group of 
compounds and their production is highly inducible, meaning that their abundance is 
associated with complex environmental, developmental and physiological factors. 
The utilisation of metabolomics in the study of plants, diseases and the 
environment is steadily increasing. The field has markedly advanced during the previous 
couple of decades owing to important developments in analytical methodologies and 
data processing software and has found a prominent role in mycotoxin research. From 
an analytical perspective, metabolomics constitutes a huge challenge, as it deals with 
the determination of largely chemically heterogeneous mixtures of metabolites with 
concentrations that can range from pico- to milli-molar levels. One of the strategies 
applied in mycotoxin metabolomics studies is metabolite profiling, which is defined as 
the (semi)quantitative analysis of a set of metabolites of a sample (Kluger et al., 2015a). 
Most such experiments rely on LC–HRMS and NMR spectroscopy for metabolite 
profiling and fingerprinting; the two analytical techniques can also be regarded as 
complimentary to each other. NMR methods can deal with complex sample matrices 
without the need for sample preparation and produce signals that corelate directly and 
linearly with compound abundance, although lacking high sensitivity (Lu et al., 2008). 
On the other hand, LC–HRMS offers high selectivity and sensitivity and is becoming an 
integral part to most metabolomics approaches. 
Analytical methods have primarily been developed and utilised for routine 
measurements of the 400 or so currently known mycotoxins. However, extreme weather 
conditions that cause rapid changes in fungal biodiversity may affect mycotoxins in food 
and feed (Paterson and Lima, 2010). Moreover, living organisms (plants, mammals and 
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microorganisms), as well as food manufacturing processes can chemically alter the 
structure of mycotoxins and as a result tremendously expand the body of compounds 
potentially relevant to safety (Berthiller et al., 2013). In contrast to the plethora of 
chemical knowledge that is available for parent mycotoxins, very little is currently known 
about the chemistry of modified mycotoxins. In this context, metabolomics approaches 
have been increasingly gaining momentum over the past decade in mycotoxin-related 
studies and becoming the cornerstone in metabolite profiling for understanding plant 
resistance mechanisms and plant–pathogen interactions (Righetti et al., 2016). 
 
2.6.1 Targeted and untargeted metabolomics 
 
The two fundamental concepts in metabolomics are targeted and untargeted 
methodologies. Targeted approaches are generally hypothesis-driven and aim at the 
detection of chemically defined metabolites, focusing on one or more metabolic 
pathways (Patti et al., 2012). In targeted approaches, analytical procedures are 
commonly tailored to accommodate the physicochemical properties of the specified set 
of analytes of interest, for which chemical identification and absolute quantification are 
usually possible. Targeted analyses are mostly performed with TQ–MS with SRM, 
allowing for highly sensitive, robust and relatively high-throughput measurements of a 
wide range of small molecules. There is a wealth of published literature describing 
optimal protocols for sample preparation and targeted analysis of mycotoxins and 
derivatives in a variety of biological matrices (Berthiller et al., 2017; Berthiller et al., 2018; 
Tittlemier et al., 2019).  
On the other hand, untargeted metabolomics are global in scope and strive to 
simultaneously measure as many metabolites as possible, including those currently 
unknown at the time of measurement. In a broad sense, untargeted metabolomics could 
also be described as screening against a large database of compounds or a 
retrospective analysis of compounds not specifically anticipated (Righetti et al., 2016). 
LC–HRMS (e.g. QTOF, Orbitrap) is the most commonly utilised analytical tool in 
untargeted metabolomics research. However, as no reference standards are available 
for most newly detected metabolites, only relative concentrations can be determined 
and not exact levels.  
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2.6.2 Stable isotopic labelling-assisted untargeted 
metabolomics 
 
Analysis of biological samples with LC–HRMS instrumentation can result in the detection 
of several hundreds to thousands of peaks from a single analysis. Each of these peaks is 
referred to as a “feature” and corresponds to a detected ion signal with a unique m/z 
and retention time that is constant throughout a set of biological samples, whereas the 
intensity may significantly vary between samples (Kuhl et al., 2011). It is worth noting 
that eluting metabolites may give rise to numerous ion species and thus produce more 
than one feature, including multiply charged ions, several adduct ions (e.g. sodium, 
ammonium, potassium), in-source fragments and isotopologues carrying a varying 
number of heavier isotopes (e.g. 13C, 15N) (Bueschl et al., 2014). All features belonging 
to the same metabolite are termed a “feature group” and share the same 
chromatographic retention time and peak shape. For automated data processing of LC–
HRMS-derived metabolomics datasets, several software packages and algorithms, such 
as MetAlign, Maven and XCMS, to name a few, have been developed and are frequently 
used in the field of metabolomics (Kluger et al., 2015a). 
In untargeted metabolomics, effective data processing, reliable 
annotation/identification and accurate quantification of metabolites constitute major 
challenges (Scalbert et al., 2009; Patti et al., 2012; Dunn et al., 2013). However, 
metabolomic profiling using stable isotopic labelling (SIL)-assisted approaches offers 
great potential to tackle these challenges and allow in-depth investigations of the 
metabolic fate of certain tracer compounds. SIL metabolomic profiling is an innovative 
strategy to monitor and interpret the resulting metabolome, following the interactions 
of biological systems with artificially labelled molecules, employing stable isotopes of 
elements (e.g. 13C- or 15N-labelling). Compared to non-labelled pendants (compounds 
with a natural isotopic distribution), labelled molecules have a higher molecular weight 
due to their enrichment with low abundance naturally occurring stable isotopes. As 
native and labelled compounds possess identical physico-chemical properties, they 
perfectly co-elute with very similar chromatographic peak shapes and can be easily 
separated by their m/z and show distinct isotope patterns in HRMS data (Bueschl et al., 
2014). By monitoring pairs of non-labelled and labelled precursor molecules, a holistic 
view of the metabolism of any given tracer can be achieved. MetExtract, the data 
processing software utilised in Studies III and IV, is a computational tool aiming at the 
untargeted automated global detection of LC–HRMS signals originating from 
metabolites generated within a biological system (Bueschl et al., 2012). Thus far, only a 
handful of publications in the literature have employed SIL-assisted untargeted 
metabolomics for mycotoxin research. In the first ever application of this workflow in 
mycotoxin research, (Kluger et al., 2015b) investigated the metabolism of DON in wheat 
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and reported a total of nine DON biotransformation products. A very similar 
experimental setup was used by Meng-Reiterer et al. (2016), to unravel the metabolism 
of HT2 and T2 in oats. The authors annotated 16 HT2 and 17 T2 metabolites, including 
novel glucosylated and hydroxylated forms. The SIL-assisted untargeted approach was 
also very recently used to study the fate of DON and identify its degradation products 
during the baking of crackers, biscuits and bread (Stadler et al., 2019). 
It worth mentioning that to unequivocally identify a metabolite, its retention time 
and MS/MS spectrum need to be compared to an authentic reference standard. For the 
majority of compounds detected in untargeted metabolomics, however, no reference 
standards are available and only putative annotation can be achieved, even with the 
most advanced MS instrumentation. LC–HRMS analysis does not provide information on 
the exact structure and stereochemistry of the analytes, and the reported structures can 
consequently only be regarded as putative until characterised by NMR spectroscopy. 
 
2.7 Risk assessments and regulations 
 
The knowledge that mycotoxins can have serious health effects on consumers and 
livestock has led more than 100 countries to establish regulations and specific limits for 
a number of these compounds in food and feed (FAO, 2004). Current regulations are 
based on scientific opinions issued by international organisations such as JECFA and 
EFSA, the latter having undertaken the responsibilities previously handled by the 
Scientific Committee on Food (SCF) in the EU. The establishment of legislative limits (i.e. 
maximum/indicative levels or guidance values) of acceptability of certain mycotoxins in 
food- and feedstuffs, as well as law-making are enabled by surveillance projects on 
worldwide mycotoxin contamination, risk assessments and consideration of socio-
economic factors (van Egmond et al., 2007). Risks associated with mycotoxins are 
dependent on the intrinsic hazardous properties of the toxin and expected exposure. 
JECFA, SCF and EFSA have published scientific opinions and/or established 
guidance values for all the precursor mycotoxins examined in this work. Between the 
years 2000 and 2001, JECFA conducted safety evaluations of several mycotoxins and 
established PMTDI values for ZEN (0.5 μg/kg bw), DON (1 μg/kg bw) and the sum of HT2 
and T2 (0.06 μg/kg bw). Around the same period, SCF published a series of opinions for 
DON, NIV and the sum of HT2 and T2 (summarised in SCF, 2002), as well as for ZEN 
(SCF, 2000). In these opinions, the following tolerable daily intake (TDI) values were 
established: a TDI of 1 μg/kg bw for DON; a temporary TDI of 0.2 μg/kg bw for ZEN; a 
temporary TDI of 0.7 μg/kg bw for NIV; and a combined temporary TDI for HT2 and T2 
of 0.06 μg/kg bw. 
Following the work of SCF, EFSA maintained the TDI value for human exposure 
of 1 μg/kg bw for DON without considering, at the time, specific measures for the 
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metabolites 3Ac- and 15Ac-DON. On the other hand, the TDI of ZEN was lowered to 
0.25 μg/kg bw, after applying the necessary uncertainty factors, based on a no observed 
effect level (NOEL) of 10 μg/kg bw per day for oestrogenic effects in piglets (EFSA, 
2011). In the same year, EFSA adopted a scientific opinion with respect to the risks 
incurred by the presence of HT2 and T2, concluding with a combined TDI of 0.1 μg/kg 
bw due to immunological effects in pigs. In the opinion, it was argued that both 
mycotoxins would be included under a common TDI because of the rapid metabolism 
of T2 to HT2 (EFSA, 2011). The CONTAM Panel also derived a TDI for NIV (1.2 μg/kg 
bw), from a 90-day rat study in which reduced white blood cell counts were observed 
(EFSA, 2013). 
In the EU, risk assessments of mycotoxins have resulted in regulations that aim 
to protect consumers and livestock from the harmful effects of certain mycotoxins. 
Specifically, Commission Regulation (EC) No 1881/2006 (EC, 2006b) and its 
amendments have established maximum levels (MLs) for aflatoxin B1, aflatoxin M1, the 
sum of aflatoxins B1, B2, G1 and G2, ochratoxin A, patulin, DON, ZEN and the sum of 
fumonisins B1 and B2 in relevant food categories. Consequently, foodstuffs listed therein 
that contain any of these mycotoxins, at a concentration exceeding the MLs set out in 
the regulation, must not be placed on the EU market. For the type A trichothecenes HT2 
and T2, Commission Recommendation 2013/165/EU (EC, 2013) has been published, 
providing indicative values for the sum of the two toxins in cereals, cereal-derived 
products and (compound) feed. For the presence of other mycotoxins in feed, MLs have 
only been set for aflatoxin B1 and rye ergot (Claviceps purpurea) in Directive 2002/32/EC 
(EC, 2002b); guidance values have been set for the presence of DON, ZEN, ochratoxin 
A and the sum of fumonisins B1 and B2 in products intended for animal feeding 
(Commission Recommendation 2006/576/EC; EC, 2006c). Currently, no legal MLs exist 
in the EU for NIV in food or feed products (EFSA, 2013). At the time of writing, no 
legislative limits for modified forms of Fusarium mycotoxins exist, either. Table 2 
presents the MLs, indicative levels and guidance values of the native Fusarium 
mycotoxins studied in this thesis, in different types of commodities derived from small 
grain cereal grains.  
Regulators are nowadays reassessing the risk of Fusarium mycotoxins by taking 
into account the presence of modified mycotoxins in food and feed. At first, JECFA 
proposed to include to the existing PMTDI of 1 μg/kg bw for DON, its acetylated 
congeners 3Ac-DON and 15Ac-DON (JECFA 2011). In this regard, the Committee 
considered the toxicities of 3Ac-DON and 15Ac-DON as equal to that of DON and thus 
as contributing factors to the total DON-induced toxicity. However, at that time, 
DON3Glc was not included in the group PMTDI due to insufficient toxicological 
information. JECFA experts also noted that absorption, distribution, metabolism and 
excretion (ADME) studies and occurrence survey reports were needed for this compound. 
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Table 2. Maximum levels, indicative levels and guidance values for the Fusarium mycotoxins DON, HT2, T2 
and ZEN in food and feed, according to Commission Regulation (EC) No 1881/2006 with amendments, 
Commission Recommendation 2006/576/EC and Commission Recommendation 2013/165/EU. 
 
Food/feed matrices Mycotoxin(s) 
 DON Sum of HT2 and T2 ZEN 
Feed and compound feed ? 900–12,000 μg/kg 250–2000 μg/kg 100–3000 μg/kg 
Unprocessed cereals ? 1250–1750 μg/kg 100–1000 μg/kg 100–350 μg/kg 
Milling fractions and products ? 750–1250 μg/kg 50 μg/kg 200–300 μg/kg 
Cereals intended for direct 
human consumption, flour, pasta, 
bread, snacks, etc. ? 
500–750 μg/kg 25–200 μg/kg 50–400 μg/kg 
Processed cereal-based foods 
and baby foods ? 
200 μg/kg  15 μg/kg 20 μg/kg 
? Guidance values relative to a feedstuff with a moisture content of 12%, except for HT2 and T2, which 
are indicative values. 
? Maximum levels, except for HT2 and T2, which are indicative values. 
 
Recently, a succession of scientific opinions published by the CONTAM Panel of 
EFSA have highlighted the risks of modified mycotoxins for human and animal health and 
provided updated guidance values; the opinions are presented here in chronological 
order. In the case of ZEN, the panel decided to set a group-TDI of 0.25 μg/kg bw 
expressed as ZEN equivalents for ZEN and its modified phase I and II metabolites (EFSA, 
2016). Later, in 2016, another EFSA opinion was published establishing guidance values 
for HT2, T2 and their modified forms. A group-TDI of 0.02 μg/kg bw and a group-acute 
reference dose (ARfD) of 0.3 μg/kg bw were derived for the sum of HT2, T2 and their 
phase I and II metabolites. Relative potency factors were assigned to conjugated 
metabolites, which are not toxic per se, but could, given suitable conditions, release their 
toxic aglycones. For NIV, no new relevant data have become available since the 
publication of the previous opinion, and the TDI of 1.2 μg/kg bw and the ARfD of 14 
μg/kg bw thus remained unchanged in EFSA’s latest evaluation of NIV (EFSA, 2017c). 
However, NIV3Glc was included in these values because of its presumed potential to 
hydrolyse back to its precursor mycotoxin. Lastly, for DON, EFSA maintained the same 
value of 1 μg/kg bw but transformed it into a group-TDI to include the modified 
derivatives 3Ac-DON, 15Ac-DON and DON3Glc (EFSA, 2017); a group-ARfD of 8 μg/kg 
bw per eating occasion was also calculated. 
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3 AIMS 
 
The rationale behind this Ph.D. thesis was to study the formation and natural occurrence 
of modified Fusarium mycotoxins in cereals, as well as their metabolic fate in beer 
fermentation. More specifically, the aims of the thesis were: 
 
•? To develop rapid, accurate and reliable analytical methods based on LC–MS/MS 
for the simultaneous determination of certain Fusarium mycotoxins and their 
modified forms in cereal grains (I and II); 
 
•? To conduct a nationwide survey in Finnish cereal grains for the natural occurrence 
of Fusarium mycotoxins and their modified forms (II); 
 
•? To unravel the metabolism and identify potential biotransformation products of 
the Fusarium type A trichothecenes HT2 and T2 in barley and wheat, via the 
utilisation of state-of-the-art analytical methodology and SIL-assisted untargeted 
metabolomics (III and IV); 
 
•? To investigate the metabolic fate of DON, DON3Glc, HT2 and T2 during beer 
fermentation and their potential to cause adverse effects in brewing yeast (V). 
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4 MATERIALS AND METHODS 
 
4.1 Experimental overview 
 
The experimental work of this Ph.D. dissertation consists of five research studies (I–V). 
Study I was carried out in the Chemistry Unit of the Finnish Food Authority 
(Ruokavirasto), Helsinki, Finland (previously: Chemistry and Toxicology Unit, Finnish 
Food Safety Authority, Evira) and in the Special Solutions Center of Thermo Fisher 
Scientific (Dreieich, Germany). The experimental work of Study II was conducted in the 
laboratory facilities of the Finnish Food Authority in collaboration with the University of 
Natural Resources and Life Sciences, Vienna (BOKU), Austria. The in planta 
metabolomics Studies III and IV were performed in the Institute of Bioanalytics and Agro-
Metabolomics and the Institute for Biotechnology in Plant Production of the Department 
of Agrobiotechnology, IFA-Tulln (BOKU). For Study V, the brewery fermentation and the 
analysis of yeast and spent medium were carried out in the VTT Technical Research 
Centre of Finland (Espoo, Finland). For the same study, mycotoxin determination and 
identification of resulting metabolic products in wort and yeast samples were performed 
in the Finnish Food Authority, with additional measurements taking place at the 
Department of Food and Environmental Sciences of the University of Helsinki (Helsinki, 
Finland). 
In Study I, the performance of on-line clean-up in comparison to conventional 
mycotoxin sample preparation techniques for LC–MS/MS determination of DON and its 
modified form, DON3Glc, in barley and wheat was assessed. Study II describes the 
development of a multi-analyte LC–MS/MS method for the simultaneous determination 
of Fusarium mycotoxins and several of their currently known modified metabolites. The 
method was in-house validated and utilised for the analysis of naturally contaminated 
Finnish cereal grains. In Studies III and IV, untargeted metabolic profiling approaches 
based on SIL and LC–HRMS/MS were applied in order to investigate the metabolism of 
HT2 and T2 in both barley and wheat. Finally, Study V was performed to examine the 
metabolic fate of DON, DON3Glc, HT2 and T2, as well as their potential adverse effects 
on lager yeast during brewery fermentation.  
 
4.2 Chemicals and reagents 
 
Acetic acid, acetonitrile, ammonium acetate, ammonium formate, ammonium hydroxide 
(25%), formic acid, hexane and methanol, all of HPLC grade or higher, were purchased 
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from one or more of the following vendors: Agilent Technologies (Waldbronn, 
Germany), J.T. Baker (Deventer, the Netherlands), Sigma-Aldrich (Steinheim, Germany 
and Vienna, Austria), Thermo Fisher Scientific (Langenselbold, Germany) and VWR 
(Leuven, Belgium and Vienna, Austria). Tween 20 was obtained from Sigma-Aldrich 
(Vienna, Austria) and Celite 545 from Merck (Billerica, MA, USA). Water was purified by 
reverse osmosis with a Millipore Milli-Q Plus system (Espoo, Finland) in Studies I, II and 
V, and with an ELGA Purelab Ultra-AN-MK2 system from Veolia (Vienna, Austria) in 
Studies III and IV. 
Analytical standards of HT2, T2, 3Ac-DON, DON, NIV, ZEN, ?-ZEL, ?-ZEL in solid 
form and DON3Glc (50 μg/mL in acetonitrile) were purchased from Sigma-Aldrich 
(Steinheim, German). Additional HT2 and T2 standards that were used in Study V were 
obtained from Romer Labs (Tulln, Austria). Crystalline non-labelled HT2 (purity 92%) and 
T2 (purity 85%), as well as uniformly labelled U-[13C22] HT2 (purity 86%; degree of 
enrichment 99.3 atom % 13C) and U-[13C24] T2 (purity 98%; degree of enrichment 99.6 
atom % 13C) of Studies III and IV were purchased from Romer Labs GmbH (Tulln, Austria). 
The modified mycotoxins DON3Glc (Berthiller et al., 2005), ZEN14Glc, ?-ZEL14Glc, ?-
ZEL14Glc (Berthiller et al., 2009), ZEN16Glc (Kovalsky Paris et al., 2014), ZEN14Sulf 
(Mikula et al., 2013), HT2-3-Glc and NIV3Glc (Michlmayr et al., 2018), used in Studies II–
IV, were enzymatically produced or chemically synthesised by BOKU. Finally, 3-acetyl-
T2 toxin (3Ac-T2) was synthesised from T2 using acetic anhydride in 
dichloromethane/pyridine with 4-dimethylaminopyridine as catalyst. The chemical 
structures and purities (≥ 95%) of all resulting modified mycotoxins were verified by NMR 
and LC-UV measurements. The standard T-2 toxin-?-glucoside (T2-?-Glc) was prepared 
as described in McCormick et al. (2015). 
 
4.3 Samples and spiking experiments 
 
4.3.1 Finnish cereal grains  
 
Cereal grains analysed for Fusarium mycotoxins and their modified forms in the survey 
study (II) were randomly obtained from the quality monitoring programme of the Finnish 
grain harvest. The quality monitoring programme is based on samples sent in by farmers. 
Each sample weighed 2 kg and consisted of several subsamples collected from arbitrary 
points of a particular field. In total, 95 samples were analysed, consisting of 34 barley 
(50% malting varieties, 38% feed varieties and 12% for other purposes), 31 oat (16% 
food varieties, 84% feed, farm trade and seed varieties) and 30 spring wheat (77% food 
varieties, 13% feed varieties and 10% seed varieties), all samples from the 2013 harvest 
(n = 1117). These samples represented commonly cultivated small grain cereal varieties 
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in Finland from different geographic areas (Figure 6). The 2013 Finnish grain harvest 
quality monitoring programme targeted mainly high-risk areas regarding mycotoxin 
contamination.  
 
Area Cereal grains (n = 95) 
Barley Oats Wheat 
1 4 3 6 
2 10 1 5 
3 2 1 5 
4 5 3 3 
5 2 1 3 
6 0 2 4 
7 2 2 0 
8 0 3 1 
9 1 2 0 
10 0 3 0 
11 5 6 2 
12 3 1 0 
13 0 3 1 
14 0 0 0
15 0 0 0 
Total: 34 31 30 
 
 
Figure 6. Origin and number of the Finnish cereal grains analysed in Study II. 
4.3.2 Plant materials and mycotoxin treatment 
 
Barley (Hordeum vulgare L. sensu lato) of the variety “Calcule” was selected for the 
qualitative screening and time-course experiment in Study III. For the metabolomics 
profiling experiment (IV), the awn-free spring wheat (Triticum aestivum L.) variety 
“Remus” (“Sappo”/“Mex”/“Famos”) was used, which is highly susceptible to FHB. The 
time-course experiment of Study IV was conducted on both Remus and the FHB-
resistant variety “CM-82036-1TP-10Y-OST-10Y-OM-OFC” (abbreviated to “CM-
82036”), which possess awns and originates from the cross of the varieties “Sumai-3” 
and “Thornbird”. 
Initially, barley and wheat seeds were germinated and planted into pots. The 
pots (23 cm diameter) were filled with seven-litre portions of a substrate, prepared from 
of a mixture of 500 L heat-sterilised compost, 250 L peat, 10 kg sand and 250 g rock 
flour. Five seedings of each plant variety were planted in each pot. During the 
experiments, pots were watered typically three times per week. Plants used for 
qualitative screening were grown in the greenhouse and after tillering were transferred 
to a growth chamber with computer-controlled settings for light, temperature and 
relative humidity. Light intensity was 560 μmol/sm2 for barley and 360 μmol/sm2 for 
wheat at 1 m above the soil. Relative air humidity was set between 60% and 70% during 
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plant growth. Temperature (day/night) and duration of illumination (hours) varied 
according to the developmental stage of the plants: after planting until the end of 
tillering, 12 °C/10 °C/12 h; end of tillering to mid-stem extension when the ear starts to 
swell, 14 °C/10 °C/14 h; mid-stem extension to start of heading, 16 °C/14 °C/14 h; from 
the start of heading until the start of flowering, 18 °C/14 °C/14 h; and from the start of 
flowering until the end of the experiments, including application of the test solutions 
and sampling, 20 °C/18 °C/16 h. 
The treatment of barley and wheat plants commenced at the flowering stage 
with three biological replicates per treatment group (HT2, T2 and mock). Toxin/mock 
solutions were applied to only one ear of each plant to prevent potential systemic effects 
related to previously treated ears. For the qualitative screening experiments, injection 
of the respective test solutions (5 μL per spikelet in barley and 10 μL per spikelet in 
wheat) was performed with an electronic pipette into each outer floret of a spikelet. In 
the metabolic profiling experiments, a 50:50 (v/v) mixture of 13C-labelled and non-
labelled test solutions of HT2 or T2 were applied; mock ears were treated only the with 
spiking solution. In total, 180 and 200 μg of the 12C/13C toxin mixtures were applied in 
adjacent barley and wheat spikelets, respectively, at time points 0, 48, 96, 120 and 144 
h. Sampling was performed 24 h after the last spiking. 
For the time-course experiments, ears were treated similarly except that a single 
dose of 200 μg non-labelled toxin was injected in 10 pairs of neighbouring spikelets on 
one ear. Samples were collected at 0, (6), (12), 24, (48) and 72 h (time points in 
parenthesis collected only from wheat treated samples), as well as after one week and 
at full ripening. Barley and wheat ears were weighed, flash-frozen in liquid nitrogen and 
stored at −80 °C until analysis. Only the middle (treated) parts of ears were analysed. 
 
4.3.3 Brewing fermentation experiments 
 
The fermentation experiments of Study V were performed at the 100-mL scale with the 
lager yeast S. pastorianus VTT A-63015 (abbreviated as A15), which was obtained from 
the VTT Culture Collection (http://culturecollection.vtt.fi). Erlenmeyer flasks contained 
97.5 g of 11.5° Plato unhopped wort and 2.5 g of yeast suspension, giving a pitching 
rate of 5 g/L. Wort contained DON, HT2 and T2 individually at either low (100 μg/L) or 
high (10,000 μg/L) concentrations. Another batch was prepared with 400 μg/L DON3Glc 
or a mixture of T2 and HT2 (5000 μg/L each). Control wort contained 200 μL acetonitrile 
and all dose groups were prepared in triplicate. Cultivations lasted for four days and 
were carried out at 15 °C under aerobic conditions and with shaking (120 rpm). A 5-mL 
sample was taken directly before and directly after inoculation. Two samples of 5 mL 
were taken daily in the first two days and once daily thereafter, resulting in the following 
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time points: 0, 4, 24, 28, 48, 72 and 96 h. Samples were centrifuged and the supernatant 
was flash-frozen in liquid nitrogen and stored at −80 °C until analysis. 
 
4.3.4 Method validation samples  
 
In Study I, commercially available finely ground barley and wheat flours (Myllyn Paras 
Oy, Hyvinkää, Finland) were used as blank material, after ensuring no/minimal 
contamination of target analytes. These barley and wheat flours (20 ± 0.01 g) were 
spiked with either 200 μg/kg DON and 50 μg/kg DON3Glc (low concentration level) or 
750 DON μg/kg and 160 μg/kg DON3Glc (high concentration level), with six replicates 
for each level. For Study II, the same types of barley and wheat flours were used for 
validation. For oat matrix validation, oat kernels from the Finnish grain quality monitoring 
programme were used that were finely ground and analysed for the absence of target 
analytes prior to spiking. Three spiking levels, with six replicates, were prepared for each 
matrix with varying concentrations of the 16 target analytes included in the method: 
3Ac-DON, DON, DON3Glc, HT2, HT2-3-Glc, NIV, NIV3Glc, T2, ZEN, ZEN14Glc, 
ZEN14Sulf, ZEN16Glc, ?-ZEL, ?-ZEL14Glc, ?-ZEL and ?-ZEL14Glc. Concentration levels 
ranging between 5 and 800 μg/kg were added into 0.500 ± 0.005 g of cereal flour and 
were allowed to soak overnight in the dark at room temperature. The process was 
repeated on three days. Barley (variety Calcule) and wheat (variety Remus) samples of 
the mock groups were used for method validation in Studies III–IV. An acetonitrile 
solution containing HT2, T2, HT2-3-Glc and 3Ac-T2 (and T2-?-Glc only for barley) was 
spiked into 100 ± 2 mg of blank sample at one concentration of 1500 μg/kg in biological 
triplicate and stored overnight at room temperature. Lastly, for the in-house validation 
of Study V, blank wort was spiked with either 80 or 8000 μg/L DON, HT2 and T2 or a 
single concentration of 250 μg/kg DON3Glc, all in three replicates. Non-spiked blank 
samples were also analysed in all studies as part of method validation. 
 
4.4 Sample preparation 
 
The samples prepared in Study I were first extracted with 80 mL acetonitrile:water (84:16, 
v/v) by mixing in a horizontal shaker for 2 h, and afterwards 8 mL was used for each of 
the following sample preparation techniques: i) extract and shoot, ii) purification with 
MycoSep 227 clean-up columns (Romer Labs Inc., Union, MO, USA), iii) MycoSep 227 
with an additional 8 mL acetonitrile elution step, iv) centrifugal filtration with Amicon® 
Ultra-15 filter devices (Millipore, Schwalbach, Germany) and v) automated on-line 
sample clean-up with the TLX–1 system (Thermo Fisher Scientific, Franklin, MA, USA) 
utilising TurboFlow™ chromatography. It is worth noting that the selection of 
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conventional sample preparation approaches was by no means exhaustive, as 
immunoaffinity columns, QuEChERS and several other commercially available 
techniques were not assessed in this study. 
Barley, oat and wheat samples analysed during the survey study (II) were finely 
ground and extracted using 2 mL of acetonitrile:water:acetic acid (79:20:1, v/v/v) per 
0.500 ± 0.005 g sample. After the 90-min extraction, 350 μL of the supernatant was 
transferred into HPLC vials and diluted with an equal amount of acetonitrile:water:acetic 
acid (20:79:1, v/v/v) before analysis with LC–MS/MS. For oats, an additional step to 
remove fat with the addition of 1 mL hexane to the extract (ca. 1.2 mL) was implemented 
after extraction. The mixture was shaken for 10 min and centrifuged at 2700 × g for 5 
min. The hexane layer was then removed, and 350 μL of the extract layer was diluted 
with an equal amount of acetonitrile:water:acetic acid (20:79:1, v/v/v) and transferred 
into HPLC vials for analysis. 
The same extract and shoot based sample preparation process was used in both 
Studies III and IV. Frozen barley and wheat ears were ground into a fine powder with a 
ball mill for 30 s at 30 Hz under cooled conditions (liquid nitrogen). After 
homogenisation, 100 ± 2 mg of sample was extracted with 500 μL of 
acetonitrile:water:formic acid (79:20.9:0.1, v/v/v) for 90 min. After centrifugation at 
22,750 × g, supernatants (ca. 200 μL) were transferred into HPLC vials and diluted 
depending on whether the samples were prepared for quantification or metabolite 
annotation/identification with analytical instrumentation outlined in Table 3. 
In Study V, 2 mL of wort was transferred into test tubes with 7.9 mL acetonitrile, 
0.1 mL acetic acid and 0.25 g Celite. After 1 h of shaking at 200 rpm, the extracts were 
filtered through folded paper filters. Aliquots of 3.5 mL were taken in duplicate from 
each sample and evaporated to dryness at 40 °C. Samples were reconstituted with 500 
μL of acetonitrile:water (50:50, v/v) and transferred into HPLC vials for analysis. For yeast 
analysis, a 20% (w/v) yeast suspension was prepared by adding 4 mL water for each 1 g 
of fresh yeast mass. A 50-μL sample was added to 250 μL of extraction solvent consisting 
of acetonitrile:methanol (2:1, v/v) and homogenised in a ball mill. After homogenisation, 
the samples were centrifuged to remove solid particles and stored at −80 °C until 
analysis. 
 
4.5 Analytical methods 
 
Chromatographic and MS parameters of all methods developed and used for the 
purposes of the experiments of this thesis are described in detail in papers I–V. Table 3 
presents an overview of these methods. 
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4.6 Method validation 
 
All analytical methods used in Studies I–V were in-house validated by spiking 
experiments in cereal matrices, according to legislative criteria laid down in Commission 
Regulation (EC) No 401/2006 (EC, 2006) and Commission Decision 2002/657/EC (EC, 
2002). Validation was performed in order to assess method performance by ensuring 
absolute quantification of target analytes, for which analytical standards were readily 
available for given matrices. Method validation parameters included specificity, linearity, 
apparent recovery (RA), RSDr, RSDR, LOD and LOQ. Detailed information concerning the 
calculation of validation parameters is presented in the Materials and Methods section 
of each paper. In Studies II–V, matrix effects were also estimated and expressed as SSE, 
according to (Sulyok et al., 2006). Finally, extraction recovery (RE) was determined as the 
ratio of RA to SSE in Studies III and IV. 
 
4.7 Data processing 
 
4.7.1 Statistical data analysis 
 
Validation data from Studies I–V were processed with Microsoft Excel® 2010 (Microsoft 
Co., Redmond, WA, USA). Statistical analysis in Study V was performed by one-way 
analysis of variance (ANOVA) and Tukey’s HSD post hoc test (p = 0.05), using IBM SPSS 
software v. 22 (SPSS Inc., Chicago, IL, USA). 
 
4.7.2 Untargeted metabolite screening 
 
Acquired profile data from Studies III and IV were first centroided and converted to the 
mzXML data format (Pedrioli et al., 2004) with MSConvert from the ProteoWizard 
package (Kessner et al., 2008) version 3.0.3959 (http://proteowizard.sourceforge.net), 
before being processed with MetExtract software (Bueschl et al., 2012). This 
bioinformatics tool searches for characteristic isotope patterns of native (12C or M and 
M+1) and partially 13C-labelled (13C or M’ and M’–1) ion pairs. 
The calculated ? m/z difference between 12C and 13C ion pairs corresponds to n-
labelled C-atoms, originating from the uniformly 13C-labelled tracer: HT2 or T2 in these 
experiments. In samples treated with HT2, a mass difference of 22.0738 Da between the 
12C and 13C ion pairs indicated the presence of the HT2 skeleton within a metabolite’s 
molecular structure. Likewise, for metabolites containing an intact T2 backbone in their 
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structure, a difference of 24.0805 Da was measured between the 12C and 13C ion pairs. 
A lower 13C count value from 22 and 24 for HT2 and T2, respectively, denoted 
metabolites that had undergone cleavage of one or more moieties originally present in 
their carbon skeleton. Figure 7 provides a schematic representation of the principle 
behind feature detection by MetExtract. 
 
Figure 7. Schematic representation of feature detection using MetExtract software. Corresponding 12C/13C 
features are identified by a mass shift between monoisotopic and 13C-labelled peaks of 22.0738 Da for HT2 
and 24.0805 Da for T2, typical isotopic distribution patterns and a similar peak shape.  
The thresholds set for a positive hit were that Δ m/z should have ≤ 4 ppm 
deviation from the theoretical value and that the observed 12C/13C abundance ratio 
between native and 13C-labelled ion forms had to be 1.0 ± 0.5. EICs generated for M 
and M’ ions were recognised as chromatographic peaks with the algorithm of (Du et al., 
2006) and had to show a minimum Pearson correlation of 0.75. Such extracted ion pairs 
that were present in both EICs and had the same retention time (± 10 scans) were 
convoluted into feature groups (i.e. metabolites) using a minimum Pearson correlation 
of 0.85. Feature groups may have included quasi molecular ions, various adducts, in-
source fragments and/or multiply charged ions; all derived from the same eluting 
metabolite. 
4.7.3 Targeted metabolite screening 
MetaboLynx™ XS software (Waters Co. Milford, MA, USA) was used for targeted 
metabolite screening of raw full scan LC–QTOF–MS data in Study V. MetaboLynx XS is 
a post-acquisition tool that compares MS data between control and treated samples and 
reveals peaks that could be attributed to biotransformation products by identifying 
variances in chromatographic retention times and signal intensities. After removing false 
positives, MS/MS experiments were conducted on those putative metabolites denoted 
by MetaboLynx XS and were characterised by manual spectral interpretation. 
MetExtract 
m/z 
A
b
un
d
an
ce
 Δ m/z 
Mass Spectrometry 
A
b
un
d
an
ce
 
m/z 
12C 
13C 
Chromatography 
Retention Time 
A
b
un
d
an
ce
 
A
b
un
d
an
ce
A
b
un
d
an
ce
A
b
un
d
an
ce
Data Processing
 62 
5 RESULTS 
 
5.1 Conventional sample preparation versus on-line 
clean-up (I) 
 
In Study I, an inter-laboratory method comparison was conducted to assess the 
performance of four conventional sample preparation techniques used in mycotoxin 
determination against automated on-line clean-up. Samples prepared with the 
conventional techniques, i)–iv), were analysed with a newly developed LC–ESI–TQ–
MS/MS method, while samples processed with on-line clean-up, v), were analysed with 
an existing TLX–LC–HRMS method (Ates et al., 2013) after some necessary optimisation. 
Initially, the suitability of different columns was examined for both methods in terms of 
chromatographic separation and the retention of target analytes. For the LC–ESI–TQ–
MS/MS method, a HILIC ACQUITY column (Waters) and an ACQUITY UPLC BEH amide 
column (Waters) were tested; for the TLX–LC–HRMS method, a reversed phase C 18, a 
polymeric Cyclone-P and an MCX 2 column were tested (all by Thermo Scientific). 
Sufficient retention, optimal peak shape and chromatographic separation of the target 
analytes DON and DON3Glc were achieved with the UPLC amide column using the 
former method and with the MCX 2 using the latter. 
 The methods were then in-house validated. Ion detection was performed in SRM 
mode with the TQ instrument, in which the parent ion of each analyte and two product 
ions were detected. For HRMS, identification of DON and DON3Glc was based on the 
presence of accurate mass ions of one parent ion and one fragment ion formed by higher-
energy collision dissociation (HCD) fragmentation. Analyte retention times for both 
methods were in the range of ± 2.5%. The five-point calibration curves were linear over 
the working range of 100–1600 μg/kg and 20–320 μg/kg for DON and DON3Glc, 
respectively, with the coefficient of determination (R2) values not being less than 0.985. 
Mean recoveries (%) ± %RSD of the spiking experiments are presented in Table 4. With 
the extract and shoot method, mean recoveries for DON and DON3Glc were between 
94–99% (3–8%) in barley and 87–99% (1–10%) in wheat. MycoSep 227, ii) and iii), yielded 
acceptable recoveries for DON in barley, 74–94% (3–11%), and in wheat, 87–105% (4–
8%), but not for DON3Glc, even with the additional acetonitrile elution step (recoveries 
< 30%). Application of centrifugal filtration resulted in recoveries within the acceptable 
range of 70–120%, but with slightly higher %RSD values than extract and shoot. Lastly, 
average recoveries (%RSD) with TurboFlow ranged between 73% and 96% (8–10%) in 
barley and 72% and 102% (5–12%) in wheat. 
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Table 4. Mean recoveries (%) of DON (200 and 750 μg/kg) and DON3Glc (50 and 160 μg/kg) from spiked 
barley and wheat samples with the following five sample preparation techniques: i) extract and shoot, ii) 
MycoSep® 227 clean-up column, iii) MycoSep 227 clean-up column with an additional acetonitrile elution 
step (8 mL), iv) centrifugal filtration and v) TurboFlow™ on-line clean-up. 
  
Matrices Analyte Concentration 
(μg/kg) 
Recovery (%) α 
  i) ii) iii) iv) v) 
Barley DON 200 96.9 ± 8.4 78.1 ± 7.7 94.2 ± 3.4 96.6 ± 9.8 83.0 ± 7.6 
  750  98.6 ± 3.0 73.7 ± 9.4 91.1 ± 10.9 81.9 ± 12.5 72.9 ± 10.1 
 DON3Glc 50  97.1 ± 4.3 < 10 28.1 ± 5.3 78.2 ± 7.9 83.0 ± 7.6 
  160  93.9 ± 2.5 < 10 20.0 ± 15.6 93.5 ± 12.3 95.8 ± 8.0 
Wheat DON 200  99.3 ± 5.1 98.0 ± 3.5 103.2 ± 7.8 98.4 ± 5.5 101.7 ± 12.4 
  750  89.8 ± 9.8 87.1 ± 6.5 104.7 ± 3.9 93.1 ± 12.5 93.1 ± 12.5 
 DON3Glc 50  86.6 ± 3.3 < 10 14.6 ± 9.7 85.4 ± 8.9 80.7 ± 9.1 
  160 98.3 ± 1.2 < 10 28.8 ± 12.2 90.6 ± 7.6 71.8 ± 5.0 
? Mean ± RSD of six replicates. 
 
LOD (LOQ = 2.5 x LOD) values for DON ranged between 0.5–1.3 (1.3–3.3) μg/kg 
and 0.4–1.1 (1.0–2.8) μg/kg in barley and wheat, respectively. For DON3Glc, LODs 
(LOQs) were 0.3–1.1 (0.8–2.8) μg/kg in barley and 0.1–0.8 (0.3–2.0) μg/kg in wheat. In all 
cases, the lowest LOD and LOQ values were obtained with TurboFlow chromatography, 
because analytes were effectively isolated from the bulk of interfering matrix 
components. Purification of the cereal extracts with MycoSep 227 clean-up columns 
yielded somewhat comparable LODs/LOQs to those of TurboFlow. However, the 
additional acetonitrile elution step probably released or pushed through more matrix 
components from the packing material, resulting in slightly increased LOD and LOQ 
values for both sample types. 
 
5.2 Multi-mycotoxin determination by LC–MS/MS (II) 
 
5.2.1 Method development and validation 
 
An LC–ESI–TQ–MS/MS method was developed and validated for simultaneous 
quantification in barley, oats and wheat of five Fusarium mycotoxins, HT2, T2, DON, NIV 
and ZEN, as well as a number of their modified forms: 3Ac-DON, DON3Glc, HT2-3-Glc, 
NIV3Glc, ZEN14Glc, ZEN14Sulf, ZEN16Glc, ?-ZEL, ?-ZEL14Glc, ?-ZEL and ?-ZEL14Glc 
(Study II). Following method development, in-house validation was performed according 
to the performance characteristics presented in Commission Regulation (EC) No 
401/2006 and Commission Decision 657/2002/EC. Validation was carried out for all three 
matrices (barley, oats and wheat), which were spiked with low, medium or high analyte 
mixtures (analyte concentrations in Table 1 of Study II). 
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Due to the presence of isomeric structures among the target analytes (e.g. ?-
ZEL/?-ZEL and ZEN14Glc/ZEN16Glc), proper chromatographic separation was essential 
for accurate quantification. After some necessary adjustments in the chromatographic 
parameters and the gradient elution programme, satisfactory retention and separation of 
all analytes were achieved using a Waters Atlantis column. Elution of analytes started at 
6.62 min with NIV3Glc and concluded at 14.58 min with ZEN (Figure 8). 
 
 
Figure 8. Overlaid quantifier extracted ion chromatograms of a wheat sample spiked with target analytes 
and analysed with LC–ESI–TQ–MS/MS. 
Optimisation was also performed in terms of extraction and more specifically the 
composition of the extraction solution. Four extraction mixtures were tested, including i) 
acetonitrile:water:acetic acid (79:20:1, v/v/v), ii) acetonitrile:water:formic acid 
(79:20.9:0.1, v/v/v), iii) acetonitrile:water (84:16, v/v) and iv) methanol:water (84:16, v/v). 
Barley (n = 3) and wheat (n = 3) were spiked with 500 μg/kg of each of the native 
mycotoxins and 3Ac-DON, DON3Glc, ?-ZEL and ?-ZEL. Mixture i) was demonstrated to 
be the most efficient in extracting these analytes from cereal matrices, with recoveries of 
≥ 90% for native mycotoxins and ≥ 80% for modified mycotoxins. 
The five-point calibration curves were linear (R2 = 0.982–1.000) for all analytes in 
their respective working ranges. In those samples for which analyte concentrations 
exceeded the upper spiking level of the calibration curve, appropriate dilutions with blank 
extracts were prepared and samples were re-analysed. LODs ranged from 0.1 to 4.1 
μg/kg in barley, 0.1 to 5.3 μg/kg in oats and 0.1 to 4.3 μg/kg in wheat. In general, DON, 
T2 and the derivatives of ZEN had the lowest LOD values in all matrices. On the other 
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hand, 3Ac-DON, HT2-3-Glc and NIV3Glc gave the highest LODs (more detailed 
information in Study II and its electronic supplementary material). 
 The RA varied between 90–116%, 84–115% and 93–112% in barley, oats and 
wheat, respectively. For the analytes that had legislative performance criteria available, 
the RA values were within the typically acceptable 70–120% range. For the remaining 
analytes with no such criteria, acceptable RA values were also achieved. RSDr and RSDR 
were also calculated for the three concentration levels. The RSDr values were relatively 
high for NIV3Glc and HT2-3-Glc, but never exceeded the 40% limit set in Commission 
Regulation (EC) No 401/2006 for the native HT2 at the low concentration level (100–200 
μg/kg). The RSDR values for all analytes were also below the 40–60% limit required by the 
same regulation for the analysis of native DON, HT2, T2 and ZEN. Finally, matrix effects 
(expressed as SSE) ranged between 59% and 121% for barley, 53% and 122% for oats 
and 67% and 123% for wheat. The highest signal suppression was observed for ZEN14Glc 
(SSE = 53% in oats) and the highest signal enhancement for 3Ac-DON (SSE = 123% in 
wheat). 
 
5.2.2 Survey data of Fusarium (modified) mycotoxins 
 
The results of this survey indicated that the most prevalent native mycotoxin was DON 
(incidence 93% of the samples analysed), followed by NIV (63%) and HT2 (57%). Detailed 
survey results, including the percentage of samples with mycotoxin or modified 
mycotoxin concentrations > LOD, as well as average, 95th percentile and maximum 
concentrations for all target analytes determined in barley, oats and wheat can be found 
in Table 4 of Study II. Figure 9 presents an overview of the number of samples found 
contaminated with target analytes concentrations > LOD during this survey. 
All of the oat samples and 97% of the wheat samples contained DON above the 
LOD values, with the mean DON concentrations generally being high in oats (2690 μg/kg) 
and in wheat (866 μg/kg), whilst in barley the mean values were lower (234 μg/kg). 
Increased DON concentrations were mostly recorded in oats, but also in a few barley and 
wheat samples that were cultivated in areas 4 and 7–11 (Figure 6). The legislative MLs for 
DON for unprocessed oats (1750 μg/kg) and wheat (1250 μg/kg) placed on the market 
for first-stage processing (Commission Regulation (EC) No 1881/2006) were exceeded in 
32% and 23% of the samples, respectively; no barley sample exceeded the 
corresponding ML for DON. For oats, according to the information provided by the 
farmers, only three of the samples exceeding the ML were intended for food, and in 
those, DON levels were between 2440–7280 μg/kg. Two samples that were intended for 
use as feed were above the guidance value of 8000 μg/kg for products intended for 
animal feed (Commission Recommendation 2006/576/EC), with considerably elevated 
DON levels of 16,400 and 23,800 μg/kg. 
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Figure 9. Overview of the number of cereal grains (n = 95), harvested in Finland during 2013, contaminated 
(> LOD) with Fusarium mycotoxins and modified mycotoxins. 
In oats, the incidence of 3Ac-DON (up to 2720 μg/kg) was 77.4% and there was a 
clear correlation between its presence and high DON concentrations. The mean 
concentration of NIV in oats was 635 μg/kg, with four samples being highly contaminated 
(> 1400 μg/kg), whereas the average concentrations in barley and wheat were 96.6 and 
48.9 μg/kg, respectively. HT2 and T2 were present in higher concentrations in oats 
(maximum concentrations 1830 μg/kg for HT2 and 548 μg/kg for T2), especially in 
samples from the southern parts of the country, whereas only relatively low amounts of 
these mycotoxins were detected in the other two cereal grains. Only one oat sample 
exceeded the indicative level for the sum of HT2 and T2 (2000 μg/kg; Commission 
Recommendation 2006/576/EC) for cereal products intended for feed and compound 
feed, as specified in Recommendation 2013/165/EU, and no cereal samples were above 
their respective indicative values for unprocessed cereals (100–1000 μg/kg). Only one 
wheat sample exceeded the ML set for ZEN (100 μg/kg) for cereal grains intended for 
food, which was also quite heavily contaminated with DON (1660 μg/kg). One oat sample 
(intended for feed) was found to contain the highest ZEN concentration (675 μg/kg) but 
was below the guidance value of 2000 μg/kg for animal feed. 
All modified mycotoxins analysed with this method were present in at least one 
sample. The most frequently detected modified mycotoxin by a considerable margin was 
DON3Glc, which was found in 81% of the barley, oat and wheat samples. It was quantified 
in concentrations up to 6600 μg/kg in a highly DON-contaminated oat sample. HT2-3-
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Glc (incidence 52% of the samples analysed), NIV3Glc (31%), ZEN14Sulf (29%) and 
ZEN16Glc (25%) were the other modified mycotoxins present in a high proportion of 
samples. Of these, the highest maximum concentrations were found for ZEN14Sulf, with 
220 μg/kg in oats, followed by NIV3Glc, with 65.3 μg/kg in barley. It is worth mentioning 
that the recently reported ZEN16Glc was detected in more samples than ZEN14Glc, 
which until a few years ago was the only glucosylated form of ZEN that had been 
characterised. The other ZEN derivatives (ZEN14Glc, ?-ZEL, ?-ZEL14Glc, ?-ZEL and ?-
ZEL14Glc) were found in less than 15% of the samples and at low levels. The relative 
proportions of modified/native mycotoxins, expressed as a molar ratio, were generally 
between 15–40% for DON3Glc/DON and somewhat higher for HT2-3-Glc/HT2 (30–55%). 
However, barley samples overall contained higher relative proportions of the modified 
mycotoxins DON3Glc and HT2-3-Glc, in comparison to the other types of cereal grains. 
Notably, the DON3Glc/DON ratio reached levels of up to 90%.  
 
5.3 Metabolism of HT2 and T2 in barley and wheat (III & 
IV) 
 
5.3.1 Metabolite annotation and identification 
 
The qualitative screening of in planta HT2 and T2 metabolites was performed by treating 
of flowering barley and wheat ears with 1:1 mixtures of non-labelled and uniformly 13C-
labelled toxins, followed by LC–HRMS/MS analysis and processing with MetExtract. 
Processing of LC–Orbitrap and LC–QTOF–MS full scan data by MetExtract revealed 
several individual features that were automatically grouped into distinct chromatographic 
peaks according to retention time and peak shape similarity. Each feature group 
represented a distinct metabolite, either including the intact parent toxin or a fragment 
of it. Figure 10 presents the TIC and the EICs of a barley sample treated with a 1:1 mixture 
of non-labelled and U-[13C22] HT2. The sample was analysed, as part of Study III, with LC–
Orbitrap in fast polarity switching mode and processed by MetExtract. 
Annotation of in planta formed metabolites was primarily based on accurate m/z 
values and LC–HRMS/MS spectral interpretation, but additional information such as 
assumed ion species and the 13C count were also taken into account. Wherever analytical 
standards were available (e.g. HT2-3-Glc and 3Ac-T2), their retention time, accurate mass 
and LC–HRMS/MS spectra were compared with the detected biotransformation products 
for identification. The majority of biotransformation products could be detected in both 
polarities, with [M+Na]+, [M+NH4]+ and [M+HCOO]− being the most frequently observed 
ion species in full scan mass spectra. Furthermore, for each metabolite recorded by 
MetExtract, the number of C atoms was determined, originating from the chemical 
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backbone of the inoculated precursors HT2 or T2. Structure identification of the putative 
metabolites designated by MetExtract was performed with targeted LC–HRMS/MS 
measurements. It is noted that for a small number of metabolites that had been previously 
reported in the literature and were not picked up by MetExtract, mainly due to low 
abundance in some samples, they were manually extracted by searching for their EICs of 
the corresponding 12C and 13C mass signals. 
 
Figure 10. Illustration of (a) fast polarity switching measurement using an Exactive™ Plus Orbitrap 
instrument and (b) EICs based on MetExtract data processing output. One representative barley sample 
treated with a 1:1 mixture of non-labelled and uniformly 13C-labelled HT2 (5 time points per flowering ear) 
was used to depict the positive (orange colour) and negative (blue colour) TIC of LC–Orbitrap measurement 
and EICs of non-labelled (up) and labelled (down) HT2 and its feature groups (metabolites) obtained by 
MetExtract software. Numbers above EICs refer to HT2 metabolites listed in Table 6; some EICs were scaled 
down for better visibility of the low abundant metabolites. 
Spectral interpretation was conducted by identifying the characteristic fragments 
of precursor mycotoxins, calculating molecular formulas and investigating the presence 
of typical plant conjugates. Mass deviations of precursor ions did not exceed ± 5 ppm in 
any of the measurements performed by LC–Orbitrap or LC–QTOF–MS. Table 5 provides 
the main characteristic fragments of the precursor ion of T2 that were used for structure 
annotation. MS fragments belonging to moieties such as glucose, malonic acid and ferulic 
acid did not contain a 13C skeleton, thus making it easier to calculate the masses of native 
plant conjugates; typical fragments of these moieties were also used for metabolite 
annotation. 
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Table 5. Characteristic LC–HRMS/MS fragment ions of T2 that were used for structure annotation. 
  
m/z Ion Molecular formula 
365.1595 [T2 – isovaleric acid + H]+ C19H24O7 
305.1383 [T2 – isovaleric acid – acetic acid + H]+ C17H20O5 
245.1172 [T2 – isovaleric acid – 2 acetic acid +H ]+ C15H16O3 
215.1067 [T2 – isovaleric acid – 2 acetic acid – CH2O +H ]+ C14H14O2 
185.0961 [C13H12O + H]+ C13H12O 
One of the novel metabolites found only in T2-treated ears of both cereals was 
putatively annotated as feruloyl-T2. Two distinct EIC peaks with the same accurate mass 
but with a slightly different retention time were detected, indicating the presence of cis- 
and trans-ferulic acid conjugates. An alternative explanation would be conjugation of T2 
to trans-ferulic acid and iso-ferulic acid. Figure 11 depicts the fragmentation pattern of 
one of the isomers of feruloyl-T2. In addition to typical T2 fragments, mass signals of m/z 
177.0549, m/z 145.0279 and m/z 117.0330 corresponding to [ferulic acid – H2O + H]+, 
[ferulic acid – H2O – CH3OH + H]+ and [ferulic acid – H2O – acetic acid + H]+ were detected. 
From the SIL data obtained, the T2 structure was reported as fully preserved, and it thus 
became clear that the ferulic acid was conjugated to the C-3 position of T2. LC–HRMS/MS 
spectra for the other in planta formed metabolites of HT2 and T2 are provided in papers 
III and IV, or in their electronic supplementary materials, and are not presented here.  
 
 
Figure 11. LC–HRMS/MS spectrum (with proposed structure) of feruloyl-T2, an in planta metabolite of T2. 
The ammonium adduct was chosen as the precursor (marked with a diamond). Characteristic T2 fragments 
(Table 5) are marked with an asterisk (*). 
Identified and annotated metabolites in barley are summarised in Tables 6 (for 
HT2; n = 9) and 7 (for T2; n = 13). All nine modified mycotoxins detected in HT2-treated 
barley ears were also identified in the T2-treated samples, due to the fast conversion of 
HT2 to T2, in addition to HT2, T2-?-Glc, 3Ac-T2 and two isomers of feruloyl-T2. The 
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accurate mass and ion species of the chosen precursor were used for targeted LC–
HRMS/MS analysis, except for metabolites in very low abundances (marked with ***), for 
which it was not possible to obtain a clear spectrum. 
Identically to the barley metabolomics experiments, raw LC–QTOF–MS data 
derived from the analysis of wheat samples inoculated with either HT2 or T2 were 
processed by MetExtract and inspected for in planta formed metabolites. For paper IV, 
only data from LC–QTOF–MS instrumentation and without fast polarity switching were 
obtained. In total, 31 feature groups were identified in wheat, out of which 12 in the HT2-
treated samples and 13 in the T2-treated samples were of sufficient intensity to enable 
further structural characterisation by LC–HRMS/MS measurements; no ion pairs were 
detected in the mock samples. The LC–HRMS/MS spectra of the detected metabolites of 
HT2 and T2 in wheat were compared with those observed in barley and were found to 
be identical. 
 
Table 6. Overview of putative HT2 metabolites detected in barley ears of the variety Calcule. Samples were 
collected after treatment with a mixture of 200 μg/ear 12C/13C HT2 (1:1) during days 1, 2, 3, 5, and 7 on the 
same ear. Identification and annotation were performed with accurate mass measurements and LC–
HRMS/MS spectra. 
 
Peak No. RT  
(min) 
Molecular 
formula α 
Ion species β m/z β Mass accuracy 
(ppm) 
13C 
count 
Putative metabolite 
1 6.7 C23H34O12 [M+NH4]+ 520.2380 −1.6 17 15-acetyl-T2-tetraol-
glucoside** 
2 8.3 C26H36O15 [M+NH4]+ 606.2381 −1.9 17 15-acetyl-T2-tetraol-
malonyl-glucoside** 
3 9.2 C23H32O12 [M+HCOO]− 545.1867 −1.6 17 15-acetyl-T2-tetraol-
glucoside[−2H]*** 
4 12.1 C28H42O14 [M+NH4]+ 620.2900 −2.1 22 hydroxy-HT2-glucoside** 
5 12.6 C31H44O17 [M+NH4]+ 706.2906 −1.5 22 hydroxy-HT2-malonyl-
glucoside** 
6 15.0 C26H40O12 [M+Na]+ 567.2402 −1.8 20 T2-triol-glucoside** 
7a 15.2 C34H52O18 [M+HCOO]− 793.3124 −1.5 22 HT2-di-glucoside** 
7b 15.8 C34H52O18 [M+HCOO]− 793.3124 −1.5 22 HT2-di-glucoside** 
8 16.1 C28H42O13 [M+NH4]+ 604.2950 −2.3 22 HT2-3-Glc* 
9 16.1 C31H44O16 [M+NH4]+ 690.2950 −2.6 22 HT2-malonyl-glucoside** 
HT2 16.8 C22H32O8 [M+NH4]+ 442.2428 −1.7 22 HT2* 
? Molecular formula of neutral compound. 
? Ion species and accurate mass of the most abundant ion. 
* Confirmation with standard by comparison of retention time, accurate mass and LC–HRMS/MS spectra. 
** Annotation with accurate mass and LC–HRMS/MS spectra. 
*** Annotation with accurate mass. 
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Table 7. Overview of putative T2 metabolites detected in barley ears of the variety Calcule. Samples were 
collected after treatment with a mixture of 200 μg/ear 12C/13C T2 (1:1) during days 1, 2, 3, 5, and 7 on the 
same ear. Identification and annotation were performed with accurate mass measurements and LC–
HRMS/MS spectra. Peaks i–iv and T2 are not shown in Figure 10. 
 
Peak
No. 
RT 
(min) 
Molecular 
formula α 
Ion species β m/z β Mass accuracy 
(ppm) 
13C 
count 
Putative metabolite 
1 6.7 C23H34O12 [M+NH4]+ 520.2384 −0.9 17 15-acetyl-T2-tetraol-
glucoside** 
2 8.3 C26H36O15 [M+NH4]+ 606.2382 −1.7 17 15-acetyl-T2-tetraol-
malonyl-glucoside** 
3 9.3 C23H32O12 [M+HCOO]− 545.1872 −0.7 17 15-acetyl-T2-tetraol-
glucoside[−2H]*** 
4 12.1 C28H42O14 [M+NH4]+ 620.2902 −1.7 22 hydroxy-HT2-glucoside** 
5 12.6 C31H44O17 [M+NH4]+ 706.2912 −0.7 22 hydroxy-HT2-malonyl-
glucoside** 
6 14.9 C26H40O12 [M+HCOO]− 589.2500 −0.3 20 T2-triol-glucoside** 
7a 15.2 C34H52O18 [M+HCOO]− 793.3139 +0.4 22 HT2-di-glucoside** 
7b 15.8 C34H52O18 [M+HCOO]− 793.3139 +0.4 22 HT2-di-glucoside** 
8 16.1 C28H42O13 [M+NH4]+ 604.2953 −1.8 22 HT2-3-Glc* 
9 16.1 C31H44O16 [M+NH4]+ 690.2952 −2.3 22 HT2-malonyl-glucoside** 
HT2 16.8 C22H32O8 [M+NH4]+ 442.2428 −1.7 22 HT2* 
i 17.0 C30H44O14 [M+Na]+ 651.2617 −1.0 24 T2-Glc*** 
T2 17.9 C24H34O9 [M+NH4]+ 484.2532 −1.9 24 T2* 
ii 19.1 C26H36O10 [M+NH4]+ 526.2640 −1.3 24 3Ac-T2* 
iii 20.0 C34H42O12 [M+Na]+ 665.2557 −1.7 24 feruloyl-T2** 
iv 20.2 C34H42O12 [M+Na]+ 665.2551 −2.6 24 feruloyl-T2** 
? Molecular formula of neutral compound. 
? Ion species and accurate mass of the most abundant ion. 
* Confirmation with standard by comparison of retention time, accurate mass and LC–HRMS/MS spectra. 
** Annotation with accurate mass and LC–HRMS/MS spectra. 
*** Annotation with accurate mass. 
 
All putative biotransformation products detected in wheat after treatment of 
wheat ears with either HT2 or T2 are illustrated as EICs in Figure 12. In general, the in 
planta metabolism of HT2 and T2 was closely related between barley and wheat. There 
were several common metabolites, with the exception of 15-acetyl-T2-tetraol-malonyl-
glucoside and 15-acetyl-T2-tetraol-glucoside[–2H], which were only annotated in barley, 
and dehydro-HT2-glucoside, which was only found in wheat. However, probably the most 
striking difference was the formation of two metabolites following exposure to HT2, which 
were only found in wheat and were putatively annotated as 3-acetyl-HT2 and T2. It should 
be noted, however, that the peak corresponding to the latter structure could have 
originated from the second isotopologue of 13C-T2, which could have been present as an 
impurity of the 13C-HT2 used for the treatment of the ears. Thus, the formation of T2 by 
wheat cannot be confirmed with certainty based on the available data. A summary of the 
identified and annotated metabolites of HT2 and T2 in the wheat variety Remus is 
presented in Table 8. 
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Figure 12. Overlaid EICs based on MetExtract data processing output showing the biotransformation 
products of one wheat sample treated with a mixture of 12C/13C HT2 (red colour) and one treated with a 
mixture of 12C/13C T2 (blue colour). EICs of non-labelled metabolites are displayed with positive intensity 
values, and those of the corresponding labelled metabolites as negative intensities. Numbers above EICs 
refer to HT2 and T2 metabolites listed in Table 8. 
Table 8. Overview of putative HT2 and T2 metabolites detected in wheat ears of the variety Remus 
(susceptible to FHB). Samples were collected after treatment with a mixture of either 200 μg/ear 12C/13C HT2 
(1:1) or 200 μg/ear 12C/13C T2 (1:1) during days 1, 2, 3, 5 and 7 on the same ear. Identification and annotation 
were performed with accurate mass measurements and LC–HRMS/MS spectra. Metabolites 11–13 were only 
detected in samples treated with T2. 
Peak 
No. 
RT  
(min) 
Molecular 
formula α 
Ion species β m/z β Mass accuracy 
(ppm) 
13C 
count 
Putative metabolite 
1 5.2 C23H34O12 [M+Na]+ 525.1940 −0.41 17 15-acetyl-T2-tetraol-
glucoside*** 
2 10.2 C28H42O14 [M+Na]+ 625.2461 −0.92 22 hydroxy-HT2-glucoside** 
3 10.9 C31H44O17 [M+Na]+ 711.2447 −3.33 22 hydroxy-HT2-malonyl-
glucoside** 
4 13.0 C26H40O12 [M+HCOO]− 589.2498 −0.64 20 T2-triol-glucoside** 
5 13.2 C28H40O13 [M+HCOO]− 629.2446 −0.78 22 dehydro-HT2-glucoside**
6 13.3 C34H52O18 [M+HCOO]− 793.3135 −0.08 22 HT2-di-glucoside** 
7 14.0 C34H52O18 [M+HCOO]− 793.3135 −0.08 22 HT2-di-glucoside** 
8 14.1 C28H42O13 [M+Na]+ 609.2518 +0.00 22 HT2-3-Glc* 
9 14.3 C31H44O16 [M+Na]+ 695.2505 −2.39 22 HT2-malonyl-glucoside** 
HT2 14.9 C22H32O8 [M+Na]+ 447.1992 +0.59 22 HT2* 
T2 16.0 C24H34O9 [M+Na]+ 489.2098 +0.68 22 T2* 
10 16.2 C24H34O9 [M+Na]+ 489.2083 −2.46 22 3-acetyl-HT2** 
11 17.3 C26H36O10 [M+Na]+ 531.2187 −2.57 24 3Ac-T2* 
12 18.1 C34H42O12 [M+Na]+ 665.2561 −1.12 24 feruloyl-T2** 
13 18.4 C34H42O12 [M+Na]+ 665.2561 −1.12 24 feruloyl-T2** 
? Molecular formula of neutral compound. 
? Ion species and accurate mass of the most abundant ion. 
* Confirmation with standard by comparison of retention time, accurate mass and LC–HRMS/MS spectra. 
** Annotation with accurate mass and LC–HRMS/MS spectra. 
*** Annotation with accurate mass. 
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5.3.2 Time course kinetics 
 
The kinetic profiles of T2 and HT2 and their formed metabolites were studied in the barley 
variety Calcule and in the wheat lines Remus (susceptible to FHB) and CM-82036 
(resistant to FHB). Treated ears of the plants did not show any premature bleaching after 
a single exposure of the mycotoxins. The absolute concentration values of HT2, HT2-3-
Glc and T2 were quantified with analytical standards, corrected for the observed SSE at 
the respective dilution, corrected for the ear weight and are presented here in 
μmol/treated ear. For quantification, the theoretically added mycotoxin amounts at Day 
0 of 200 μg HT2 (equal to 0.471 μmol) and 200 μg T2 (0.429 μmol) were used instead of 
the measured concentration. This adjustment was necessary due to the poor diffusion 
into the plant cells of the toxins immediately after treatment. 
Figure 13 illustrates the quantified time courses of HT2, T2 and their major 
modified form, HT2-3-Glc, in barley and the two wheat varieties. For all other metabolites, 
data obtained from EIC integrated peak areas were corrected for the individual ear 
weight and correlated with the highest observed area; their kinetic graphs are presented 
in papers III and IV as relative abundances. 
In barley, only about 25% of the inoculated HT2 remained unmodified within the 
first 24 h following treatment, with more than half of it being transformed into HT2-3-Glc. 
A steady decrease of HT2 and HT2-3-Glc was observed until the end of the experiment 
(Ripen), resulting in a final content of 7% and 34%, respectively, relative to the originally 
inoculated toxin. A similarly rapid decrease of HT2 occurred during the first day in both 
Remus and CM-82036 wheat varieties. However, HT2-3-Glc reached its peak 
concentration at a later time point, between days 3 and 7 after treatment. HT2-3-Glc 
concentrations were in all cases lower at ripening compared to the maximal amounts, a 
fact that implied further metabolism of this metabolite into additional biotransformation 
products such as HT2-di-glucoside, HT2-malonyl-glucoside, hydroxy-HT2-glucoside, 
hydroxy-HT2-malonyl-glucoside and 15-acetyl-T2-tetraol-glucoside, which reached 
maximal abundance at the ripening stage. In the wheat kinetics experiments, no 
significant differences in the amounts of HT2 and T2 metabolites in the two wheat 
varieties were determined. 
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Figure 13. Quantified time course kinetics of HT2 (blue colour), T2 (green colour) and HT2-3-Glc (red colour) 
in the barley variety Calcule and in the wheat lines Remus (susceptible to FHB) and CM-82036 (resistant to 
FHB). Ears were treated with either 200 μg HT2 or 200 μg T2 and harvested immediately, 1, 3 and 7 days 
after treatment and at the full-ripening stage (Ripen). 
In T2-treated ears, de-acetylation of T2 to HT2 progressed rapidly, and after one 
day, only 26%, 25% and 20% of the initially added toxins could be determined in barley, 
and the Remus and CM-82036 wheat varieties, respectively. At the same time HT2 was 
rapidly glucosylated to HT2-3-Glc and other metabolic products, as was shown in the 
HT2-treated samples. For instance, barley had already biotransformed 52% of the initially 
inoculated T2 into HT2 and HT2-3-Glc within one day. Besides glucosylation, C-3 
acetylation and (iso)ferulic acid conjugation were the immediate responses of plant 
detoxification mechanisms against T2. However, these compounds were further 
metabolised or became covalently bound to plant matrix, as their relative concentrations 
decreased over time. Conjugations with an additional glucose moiety or malonic acid to 
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HT2 mono-glucosides occurred later. Finally, hydrolysis of the acetyl group of HT2-3-Glc 
in C-15, leading to the formation of T2-triol-glucoside, presumably constitutes a 
consecutive reaction, because the compound was only observed in the ripened samples. 
Figure 14 depicts the integrated proposed metabolic fate of HT2 and T2 in barley and 
wheat based on the findings presented in Studies III and IV. 
 
 
Figure 14. Proposed integrated metabolic pathways of HT2 and T2 in barley and wheat. 
In summary, the in planta metabolism of HT2 and T2 in barley and wheat was 
unravelled by SIL-assisted metabolomics experiments and time course kinetic studies. 
Exposure to HT2 and T2 primarily activated metabolic reactions involving hydroxylation, 
(de)acetylation and various conjugations with glucose, malonic acid and ferulic acid. 
Kinetic data revealed that HT2 was the main metabolite of T2, whilst HT2-3-Glc was 
rapidly formed in high amounts, regardless of whether plants are exposed to HT2 or T2. 
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5.4 Yeast–mycotoxin interactions during beer 
fermentation (V) 
 
In Study V, two 96-h brewing fermentation experiments were performed using A15 yeast 
exposed to DON or DON3Glc, as well as HT2 and/or T2. In the first experiment, A15 
yeast was treated with either 100 μg/L (low dose groups) or 10,000 μg/L (high dose 
groups) DON, HT2 or T2. For Experiment 2, 400 μg/L DON3Glc or a mixture of 5000 
μg/L HT2 and 5000 μg/L T2 was used. The influence of these toxins on viability, fresh 
yeast mass, Plato, pH and alcohol production in comparison to the control groups is 
presented in Table 9. 
 
Table 9. Influence of DON, HT2 and T2 at low (100 μg/L, n = 3) and high (10,000 μg/L, n = 3) concentrations 
(Experiment 1), as well as DON3Glc (400 μg/L, n = 3) and a mixture of HT2 and T2 (5000 μg/L each, n = 3) 
(Experiment 2) on the growth, viability and fermentation of sugars after four-day brewing fermentations by 
the lager yeast strain A15 in 11.5° Plato wort. 
 
 
 
Experiment 1 
Toxin Concentration 
(μg/L) 
Viability 
(%) 
Fresh yeast 
mass (g/L) 
Plato pH Alcohol (v/v) 
Control 0 99.5 ± 0.1 41.4 ± 0.2 3.39 ± 0.01 3.87 ± 0.01 3.21 ± 0.04 
DON 100 99.6 ± 0.1 38.9 ± 1.6 3.38 ± 0.08 3.86 ± 0.01 3.23 ± 0.11 
 10,000 99.6 ± 0.1 36.7 ± 1.7 3.40 ± 0.03 3.88 ± 0.02 3.16 ± 0.04 
HT2 100 99.5 ± 0.1 38.1 ± 1.1 3.39 ± 0.06 3.86 ± 0.01 3.19 ± 0.08 
 10,000 99.5 ± 0.1 41.8 ± 0.8 3.39 ± 0.06 3.85 ± 0.01 3.14 ± 0.09 
T2 100 98.3 ± 1.4 41.4 ± 0.3 3.37 ± 0.05 3.85 ± 0.02 3.22 ± 0.08 
 10,000 95.8* ± 2.2 40.8 ± 1.4 3.25* ± 0.05 3.84 ± 0.01 3.37* ± 0.07 
Experiment 2 Control 0 99.4 ± 0.1 35.1 ± 0.2 2.15 ± 0.06 4.15 ± 0.02 3.59 ± 0.08  
DON3Glc 400 99.3 ± 0.1 36.1 ± 0.3 2.28 ± 0.04 4.14 ± 0.01 3.46 ± 0.04 
HT2 + T2 5000 each 98.3* ± 0.1 37.5 ± 1.6 2.32* ± 0.02 4.08* ± 0.01 3.53 ± 0.02 
* Statistically significant difference (p < 0.05) compared to the control group.  
 
In general, A15 yeast was tolerant even in the dose groups treated with 10,000 
μg/L DON, HT2 or T2. The only exposure group showing any statistically significant 
difference (p < 0.05) in comparison to the controls was the one treated with 10,000 μg/L 
T2. Even in that group, viability (%) was only slightly reduced to 95.8%, compared to 
approximately 99.5% observed in all other groups. These small deviations in the high T2 
group were also reflected in lower values for wort concentrations, 3.25° Plato compared 
to 3.39° Plato in the control, and in a minor increase in alcohol production, 3.37% versus 
3.21% in the control. For all other measured parameters, no deviations occurred between 
treated and control groups. Exposure to 400 μg/L DON3Glc or a mixture of HT2 and T2 
(5000 μg/L per toxin) in the second experiment did not result in any substantial adverse 
effects on the viability of cells or fermentation performance. 
The kinetic profiles of the four toxins were also investigated by relating the 
absolute quantified mean concentrations at time points 4, 24, 28, 48, 72 and 96 h to each 
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analyte’s mean concentration determined at 0 h. In the low exposure groups (100 μg/L), 
a rapid reduction in the dosed toxins of between 5% and 13% was already observed from 
the first sampling (time point: 4 h). A statistically significant overall decrease after 96 h 
fermentation was observed for the type A trichothecenes HT2 (66%) and T2 (69%) 
compared to DON (85%). Another difference was that for DON, no further reduction 
occurred after the first 24 h in the low exposure group, whereas for HT2 and T2, the 
decrease was constant throughout the 96 h of Experiment 1. In the high exposure groups, 
residual concentrations were consistently higher than in the low exposure groups for all 
three mycotoxins, resulting in residual relative concentrations between 85% and 91%. 
Data from Experiment 2 revealed that when HT2 and T2 were inoculated together, in 
concentrations of 5000 μg/L each, 80% and 78% were retrieved at the end of 
fermentation, respectively. Wort samples treated with DON3Glc were analysed at the 
end of the experiment for the presence of its precursor. However, no DON was found, 
even though the concentration of DON3Glc was reduced by 17% after 96 h fermentation. 
Therefore, no de-conjugation of the glucose moiety of DON3Glc occurred during yeast 
fermentation. On the contrary, yeast was found able to glucosylate DON, resulting in the 
formation of DON3Glc, which was verified by standard measurements (Table 10). 
 
Table 10. Overview of putative metabolites, as provided by MetaboLynx™ XS, that were detected during a 
96-h brewing fermentation by the lager yeast strain A15 in an 11.5° Plato wort treated with 10,000 μg/L of 
DON, HT2 or T2. 
 
Exposure group, 
detection time 
RT  
(min) 
Molecular 
formula α 
Ion species β m/z β Mass accuracy 
(mDa) 
Putative metabolite 
DON, 72 h 6.1 C21H30O11 [M+CH3COO]− 517.1934 +1.4 DON3Glc* 
DON, 24 h 7.2 C17H22O7 [M−H]− 337.1245 −4.3 3*/15Ac-DON** 
HT2, 72 h 10.4 C22H32O11S [M+Na]+ 527.1536 −2.1 HT2-sulfate** 
T2, 28 h 10.8 C22H32O8 [M+NH4]+ 442.2426 −0.3 HT2* 
HT2, 28 h 12.9 C24H34O9 [M+NH4]+ 484.2535 −0.1 T2*/3-acetyl-HT2** 
T2, 4 h 14.6 C26H36O10 [M+NH4]+ 526.2639 −0.2 3Ac-T2** 
? Molecular formula of neutral compound. 
? Accurate mass and ion species of the most abundant ion. 
* Confirmation with standard by comparison of retention time, accurate mass and HRMS/MS-spectra. 
** Annotation with accurate mass and HRMS/MS-spectra. 
  
A molar mass balance of the inoculated toxins was calculated after analysis with 
LC–TQ–MS/MS of wort and yeast biomass, which was collected at the end of the 
fermentation experiments. To compensate for matrix effects, matrix-assisted calibration 
with yeast biomass from the control groups was used. In the low-dose groups, target 
analytes were below LOD values. In the high-dose groups, minor toxin amounts, between 
0.3 and 0.8 μg, were determined in yeast biomass. The absolute mycotoxin amounts that 
were inoculated to wort in the high dose groups were measured to be at the beginning 
of fermentation: 1120 μg for DON, 1029 μg for HT2 and 893 μg for T2. Following the 
four-day fermentation, the remaining amounts were 921, 934 and 756 μg for DON, HT2 
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and T2, respectively. These differences between initial and final concentrations can be 
attributed to the physical binding and metabolism of the toxins by A15 yeast. 
Wort was also analysed for the presence of metabolites formed as a result of DON, 
DON3Glc, HT2 and T2 biotransformation by yeast during fermentation. Raw full scan LC–
QTOF–MS data were processed with MetaboLynx XS software and putative metabolites 
were annotated or identified by additional LC–QTOF–MS/MS measurements. All 
putatively identified metabolites are presented in Table 10 and relevant MS/MS spectra 
are provided in paper V. DON3Glc, 3Ac-DON, HT2 and T2 were detected in samples not 
inoculated with these toxins and were verified with available analytical standards. For the 
remaining putative metabolites, which were annotated as 15Ac-DON, HT2-sulfate, 3-
acetyl-HT2 and 3Ac-T2 and for which analytical standards were not available, spectral 
analysis revealed the presence of characteristic fragments belonging to their respective 
parent toxins. Based on these findings, trichothecenes are primarily metabolised via 
(de)acetylation, glucosylation and sulfation. 
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6 DISCUSSION 
 
6.1 Method development  
 
6.1.1 Sample preparation 
 
The choice and optimisation of sample preparation is paramount to the success of any 
analytical method, from the simplest to the most complex mycotoxin determinations. For 
the majority of LC–MS/MS analyses, extraction is necessary in order to efficiently isolate 
compounds of interest from any given matrix. Sample clean-up, however, can be 
considered as a double-edged sword, because on the one hand it may alleviate the 
severity of matrix effects, but on the other it may remove analytes of interest (Köppen et 
al., 2010). In Studies I–V, various extraction procedures were utilised according to the 
chemical nature of target mycotoxins and derivatives. 
Selection of the most appropriate extraction mixture and extraction conditions 
for a multitude of analytes with largely varying physico-chemical properties is generally 
challenging. Extraction solutions with a large proportion of methanol or acetonitrile (> 
75%), with or without the addition of acid (acetic or formic acid), have been routinely 
used in most mycotoxin analyses (Capriotti et al., 2012). In the course of this thesis, short 
extraction trials were conducted whenever necessary to evaluate the efficiency of 
extraction solutions. Since a number of the analytes that were included in the multi-
(modified) mycotoxin method, developed as part of Study II, had never before been 
quantitatively determined (e.g. NIV3Glc, ZEN16Glc), four different extraction mixtures 
were assessed for their efficiency in extracting the target analytes. The applicability of 
the solution acetonitrile:water:acetic acid (79:20:1, v/v/v), which has been employed in 
other methods based on the dilute and extract approach for analysis of type A/B 
trichothecenes, ZEN and modified forms thereof in cereal matrices (Vendl et al., 2009; 
De Boevre et al., 2012; Soleimany et al., 2012), was confirmed. This was primarily due 
to the improved extraction efficiency that was accomplished. For those methods in 
which multiple and/or unknown compounds were included, the versatile extraction 
mixtures of acetonitrile:water:acetic acid (79:20:1, v/v/v) or acetonitrile:water:formic or 
acetic acid (79:20.9:0.1, v/v/v) were also used. Minor adaptations on a case-by-case basis 
were implemented to achieve optimal extraction of target analytes and alleviate matrix 
effects by, for instance, incorporating a de-lipidation step (Study II) or the addition of 
Celite (Study V). 
In the inter-laboratory sample preparation comparison study (I), the extract and 
shoot approach and TurboFlow chromatography were the only sample preparation 
techniques that were deemed suitable for the concurrent determination of DON and 
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DON3Glc and performed in accordance with the performance characteristics set by 
current legislation. MycoSep 227 and centrifugal filtration required additional steps, 
frequent system maintenance (e.g. cleaning parts of the ESI interface from matrix 
components) or were found unsuitable for the simultaneous determination of DON and 
DON3Glc compounds, which possess different polarities. Whilst MycoSep cartridges 
have been extensively used since the 1990s for sample purification, especially in 
trichothecene analysis, they may not always be appropriate for the clean-up of samples 
containing mycotoxins and derivatives with largely varying polarities. It appears that the 
more hydrophilic DON3Glc was retained within the column packing material, together 
with matrix co-extracts, and did not pass through to the supernatant with DON. Even 
though the 227 cartridge is specifically designed for type A and B trichothecenes, the 
226 model or any other purification cartridge from the same manufacturer that is 
designed to accommodate a broader range of polarities may have been more suitable 
for DON3Glc. 
However, an extensive assessment of eight commercially available clean-up 
cartridges was performed by Vendl et al., (2009), including SPE, immunoaffinity columns 
and MycoSep (226 and 230), as well as using primary and secondary amines for clean-up. 
None of the tested clean-up methods yielded satisfactory results for the analysis of DON, 
ZEN or eight modified forms, with the authors stating that a group of compounds having 
such a wide polarity range is unlikely to benefit in its entirety from a single clean-up 
approach. De Boevre et al. (2012), also tested four clean-up columns (Florisil® Bond Elut, 
MultiSep® 225, MycoSep 229 and Oasis® HLB), but did not achieve acceptable recoveries 
for modified mycotoxins, and ended up using the extract/dilute and shoot approach. 
Nonetheless, in the case of the type A trichothecenes HT2 and T2, Lattanzio et al. (2012) 
applied the MycoSep 227 column in the clean-up of oat and wheat samples and 
accomplished the identification of the polar HT2 and T2 glucosides. It should be 
mentioned, however, that ideally appropriate clean-up would be very beneficial to LC–
MS/MS determinations, as alongside the extraction of a wide range of analytes, the co-
extraction of bulk matrix constituents is undesirable, because it may reduce the lifetime 
of the chromatographic column, result in frequent maintenance of the mass spectrometer 
and interfere with the ionisation process causing analyte SSE effects. 
Aside from Study I, which aimed at assessing different sample preparation and 
clean-up techniques, pre-treatment and purification were in all other studies kept to a 
minimum. With every clean-up procedure to reduce or eliminate unwanted co-extracted 
matrix components and minimise matrix effects, certain analyte classes may not be 
amenable to it and consequently become lost during the process and remain 
undetectable (Krska et al., 2008). Thus, clean-up was generally omitted in Studies II–V, as 
certain compounds could have potentially been lost during the process. Moreover, the 
high selectivity guaranteed by modern mass spectrometers allows the concurrent 
determination of multiple target analytes with minimal need for clean-up (Sulyok et al., 
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2010). As a result, multi-mycotoxin quantitative LC–MS/MS methods and LC–HRMS 
methods used for metabolomics applications tend to bypass perplexing clean-up 
procedures and rely on extract/dilute and shoot-type approaches, in which raw extracts 
are directly injected into the MS.  
 
6.1.2 Method validation and performance characteristics 
 
In principle, validation aims to demonstrate that a method is fit for the intended purpose 
and can produce selective, sensitive, accurate and reproducible results for a given 
property. Method validation is a sub-process of the quality assurance scheme of an 
analytical method (Brera and Miraglia, 1996). All methods developed for the 
quantification of mycotoxins or modified mycotoxins were in-house validated according 
to performance criteria and recommendations established in Commission Regulation (EC) 
No 401/2006 and Commission Decision 2002/657/EC. The degree of validation was 
dictated by the intended application and the fact that the methods were developed for 
research purposes and not for official control of mycotoxins and derivatives thereof. 
Complete validation of all analytes included in the methods was hindered by the 
unavailability or the very limited amounts of analytical standards for certain modified 
mycotoxins. 
The multi-(modified) mycotoxin method developed in Study II was successfully 
validated in three matrices (barley, oats and wheat). Calibration curves were linear over 
the respective working range of each analyte and the RA values were in agreement with 
the recommended legislative values (typically 70–120%). The LODs varied considerably, 
as expected, among different analytes and matrices, but generally allowed for the 
determination of all analytes at low μg/kg levels. As a general remark, the lowest LODs 
were achieved for DON, T2 and the derivatives of ZEN in all three matrices. The highest 
LODs were observed for 3Ac-DON, HT2-3-Glc and NIV3Glc. Since no performance 
criteria are available for modified forms, RSDr and RSDR values were calculated and 
compared to acceptable limits from their respective precursors DON, HT2, T2 and ZEN, 
as laid down in Commission Regulation (EC) No 401/2006. 
In the same method, minor to moderate matrix effects were documented, with 
63% of the target analytes in barley and wheat and half of them in oats being within the 
80–120% “acceptable” range. From the same results, oats appear to have caused slightly 
more pronounced matrix effects in comparison to barley and wheat, and these effects 
persisted even after de-lipidation. The methods in papers III–V were only validated on 
the basis of the quantification of target analytes for which analytical standards were 
available, and not on parameters related to metabolite identification. For these methods, 
appropriate dilutions of the sample extracts were performed, and absolute 
concentrations were only corrected for matrix effects if the SSE values were below 85% 
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or above 115%. Notably, there is no legislatively acceptable range for matrix effects and 
different authors have applied different ranges, usually between 90–110% (Malachová et 
al., 2014) or 80–120% (Varga et al., 2013). 
Despite the considerable progress of metabolomics and continuous expansion to 
new applications, major challenges still remain. In addition to fundamental aspects such 
as the reliable annotation of true sample metabolites, their putative identification and 
accurate (semi)-quantitation, proper workflow validation should also be addressed 
(Kluger et al., 2015a). Validation of untargeted methodologies is equally important to that 
of purely quantitative methods, in order to ensure that reliable and reproducible 
measurements are obtained. However, the analytical challenges and criteria are very 
different from quantitative methods. Untargeted metabolomics is intended for 
metabolite identification within biological samples, and based on this purpose, validation 
parameters ought to be established (Naz et al., 2014). Regarding the workflow 
implemented in the untargeted metabolomic Studies III and IV, it would have been very 
complex and cost-intensive to conduct a comprehensive validation. In 2007, the 
Metabolomics Standards Initiative (MSI) published the minimum metadata related to 
chemical analysis aspects of metabolomics as a means to communicate the confidence 
in identification (Sumner et al., 2007). This concept relies on four levels of identification 
that have been revised over the years and refined to cover broader applications, although 
it still lacks the ability to consider all strategies for the identification of metabolites, with 
new approaches continuously being introduced in this dynamic research field. 
 
6.1.3 Qualitative screening 
 
In Studies III and IV, the formation of T2 and HT2 metabolites in barley and wheat was 
examined via SIL-assisted untargeted metabolomics, LC–HRMS measurements and data 
processing with MetExtract software. The formed metabolites consisted of pairs of their 
native and partly labelled isomers. Most metabolites that were detected, contained, 
contingent on treatment, the intact chemical backbone of either HT2 or T2. This could 
be clearly verified by a measurable mass difference of 22.0738 Da, which corresponded 
to the mass difference between the 22 12C in the native and the 22 13C in the fully labelled 
HT2 tracers. Likewise, a mass difference of 24.0805 Da between the labelled and non-
labelled ion pairs of T2 was always recorded in metabolites containing its intact 24-carbon 
structure. Fragmentation patterns of HT2 and T2 backbones in all reported metabolites 
were in line with the previous reports (Busman et al., 2011; Lattanzio et al., 2012; 
Nakagawa et al., 2013). As the majority of conjugates contained glucoside and/or malonyl 
moieties, typical fragmentation patterns of these molecules were also considered in the 
metabolite characterisation exercise. When standards were available, the retention time, 
accurate mass and MS/MS spectra were used to identify the metabolite. For metabolites 
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with no available standards, apart from MS/MS fragmentation patterns that were used for 
structural elucidation, MetExtract could recognise the ? m/z difference between the 
monoisotopic [e.g. M+H]+ and non-labelled and fully 13C-labelled metabolite. The 
difference corresponded to the exact number of C-atoms of the uniformly labelled tracer 
remaining in the parent chemical backbone. A lower 13C count value from 22 and 24 for 
HT2 and T2, respectively, denoted metabolites that had undergone cleavage of one or 
more moieties originally present in their carbon skeleton. This additional information 
proved very useful in facilitating metabolite annotation. 
Another powerful technique was fast polarity switching, only utilised in Study III. 
While some metabolites preferentially ionise in just one of the two modes, many show 
different ion species in negative mode from the positive, yielding different adducts and 
in-source fragments. Most HT2 and T2 metabolites were detected in both polarities, 
except from T2-?-Glc, 3Ac-T2 and ferulyol-T2, which were only detected in the positive 
ionisation mode, and T2-triol-glucoside, only recognised in the negative mode. Hence, 
fast polarity switching enabled the detection of those compounds that may not have been 
“visible” in either negative or positive mode and it facilitated the annotation of ion 
species by providing complementary information from each mode. It also assisted in 
significantly minimising the analysis times, as each sample was only run once. Kluger et 
al. (2014), also applied fast polarity switching to examine the metabolism of 13C9-
phenylalanine in wheat cell suspension cultures in the presence of DON, during which 
the Exactive Plus Orbitrap MS was configured, similarly to Study III, to switch the 
ionisation polarity after each MS scan, which lasted approximately half a second. 
Importantly, MetExtract was capable of automatically processing fast polarity switching 
data, by performing feature pair detection separately for each mode and then 
convoluting the different pairs of the same metabolite conjointly for the positive and 
negative ionisation mode results. 
Altogether, LC–HRMS raw data processing with MetExtract software proved to be 
very effective in recognising distinct mirror symmetric isotopologue patterns of native 
and partially labelled modified mycotoxins, filtering out irrelevant biological signals and 
background noise, and thus enabling the holistic detection of truly relevant 
biotransformation products that were descendants of the tracer substances under 
investigation. This analytical workflow has also been successfully utilised to study DON 
metabolism in wheat (Kluger et al., 2015b) and HT2/T2 in oats (Meng-Reiterer et al., 
2016), and has led to the identification of several novel modified mycotoxins. 
Nevertheless, apart from its numerous benefits, there are also some drawbacks 
associated with this workflow. The workflow in its entirety is very complex to perform and 
expensive, as it requires modern LC–HRMS instruments, pure tracer substances with high 
isotopic enrichment, which are also very costly to produce, and experienced 
multidisciplinary personnel. In view of these limitations, as fragmentation data are 
essential for structural elucidation, metabolomics libraries have already been created with 
 84 
data acquired from commercially available or synthesised standards (Schrimpe-Rutledge 
et al., 2016). In the future, easy accessibility of researchers to comprehensive 
fragmentation pattern spectral databases of precursor mycotoxins and common 
conjugated moieties could substantially support the annotation of novel modified 
mycotoxins and mapping of metabolic pathways. 
On the other hand, a simpler and more pragmatic approach for most mycotoxin 
research laboratories in the world today, is the application of targeted metabolomics that 
aim to identify, and quantify when standards are readily available, unpredicted 
metabolites or expected metabolites such as those typically encountered in 
toxicokinetics/metabolism studies. Hence, the utilisation of software packages such as 
MetaboLynx XS, which was used in Study V to investigate the metabolism of 
trichothecenes in brewing yeast, can be advantageous. MetaboLynx XS is a post-
acquisition raw data processing tool that compares LC–HRMS full scan data between 
control and treatment samples and detects compounds that could be attributed to 
metabolic transformations. MetaboLynx XS data processing of wort samples spiked with 
10,000 μg/L DON, HT2 or T2 during a four-day fermentation by A15 lager yeast, resulted 
in the putative identification of six metabolites (DON3Glc, 3/15Ac-DON, HT2-sulfate, 
T2/3-acetyl-HT2 and 3Ac-T2). The proposed metabolites were analysed by LC–QTOF–
MS/MS measurements for further confirmation. MetaboLynx XS has been recently 
applied to study the metabolism of Fusarium mycotoxins and modified forms, e.g., the in 
vivo and in vitro metabolism of T2 (Yang et al., 2013) and ZEN (Yang et al., 2017), or the 
de-glucosylation of ZEN14Glc in vivo and in human liver microsomes (Yang et al., 2018). 
Finally, in addition to the importance of MS analysis and data processing, 
chromatographic separation also played an important role in uncovering isomeric 
modified mycotoxins. In order to recognise potential additional isomers of the HT2 and 
T2 metabolites present, a longer gradient method was employed to achieve 
chromatographic separation. As a result, with the longer gradient, the EICs of 15-acetyl-
T2-tetraol-malonyl-glucoside and HT2-malonyl-glucoside revealed two peaks, one major 
and one smaller, that were attributed to isomers resulting from the conjugation of malonic 
acid to different hydroxyl groups of glucose. Likewise, hydroxy-HT2-glucoside and 
hydroxy-HT2-malonyl-glucoside were detected in the form of three isomers, one major 
and two smaller peaks, suggesting that either the additional –OH was introduced to 
different positions of the HT2 backbone or that, again, the malonic acid was attached to 
different –OH groups of the glucose moiety. In the case of feruloyl-T2 and di-glucosylated 
HT2 isomers, two peaks were detected with the original chromatographic gradient having 
slightly different retention times, as was reported for the latter in Lattanzio et al. (2012). 
Interestingly, the long gradient method revealed that the retention time of the 
glucosylated T2 metabolite (22.2 min), only detected in barley (Study III), differed from 
that of the analytical standard T2-?-Glc (21.4 min). The difference in retention times 
indicates that T2 is probably converted into T2-3-O-?-glucoside in barley. These findings 
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contradict McCormick et al. (2015), who reported the occurrence of T2-?-Glc in oats and 
barley. 
 
6.1.4 Quantitative determination 
 
In this work, the simultaneous quantification of a group of Fusarium mycotoxins and 
modified forms thereof was exclusively performed with LC–MS/MS-based methods in 
either SRM or full scan modes. Absolute quantitation was achieved using standard 
calibrants if present, whereas for the novel modified mycotoxins of Studies III and IV, 
relative quantification was performed. It is worth mentioning that indirect modified 
mycotoxin determination was not applied in any of the methods used herein, but they 
were always directly quantified or semi-quantified. 
In Study I, the LC–MS conditions in the TLX–LC–HRMS technique were based on 
a previously developed and validated method for the determination in cereals and feed 
matrices of the Fusarium mycotoxins DON, ZEN, fumonisins (B1 and B2), HT2 and T2 (Ates 
et al., 2013), which was later extended for the analysis of plant metabolites (Ates et al., 
2014). Thus, method development primarily emphasised the appropriate selection of the 
chromatographic column between a reversed phase C18, a polymeric Cyclone-P and an 
MCX 2 column. The MCX 2 column was eventually chosen, as it offered sufficient 
retention and optimal peak shapes for the analytes DON and DON3Glc; the total analysis 
run time was also shortened to 14.1 min. For the LC–ESI–TQ–MS/MS method, a similar 
column assessment took place between a HILIC and an amide UPLC column. The latter 
provided optimal analyte separation, which was found not possible with the former, and 
it was thus chosen for the inter-laboratory method comparison study. Instruments 
operating in SRM mode, such as the one utilised here, are capable of yielding some of 
the lowest analyte LOD values, but it is crucial to undergo proper precursor and product 
ion selection, as well as vigorous optimisation of MS/MS parameters to achieve the best 
signal intensities. Therefore, thorough optimisation was carried out during the LC–ESI–
TQ–MS/MS method development for the selection of the optimal ionisation mode 
(ESI+/ESI−) per analyte, the selection of quantifier/qualifier ions and for the fine-tuning of 
the MS/MS conditions. The selected mass transitions and quantifier/qualifier ion ratios for 
all target analytes were confirmed to be identical in neat standard solution and in matrix. 
Quantification of DON and DON3Glc was achieved by comparing the peak areas of the 
samples with those from the external matrix-assisted calibration of barley and wheat. 
The same LC–ESI–TQ–MS/MS instrument was also used in Study II, with an 
Atlantis T3 UPLC column and a matching Atlantis T3 pre-column this time around. As in 
the previous study, method development was initiated by infusing individual analyte 
solutions into the MS, operating in both positive and negative ESI modes, for proper 
precursor and product ion selection. ZEN and most of its derivatives, with the exception 
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of ZEN14Glc and ZEN16Glc, as well as most of the type B trichothecene derivatives, were 
more easily ionised in the negative mode, whereas type A trichothecenes showed higher 
intensities in the ESI positive mode. Following instrument tuning with the target analytes, 
the chromatographic parameters were developed, focusing on adjustments of the 
gradient elution programme to accomplish sufficient retention, baseline separation of 
isomeric pairs and optimal peak shapes for all analytes. One characteristic example of the 
importance of chromatographic parameters and, in this case, gradient elution 
optimisation occurred between the modified mycotoxins ZEN14Glc, ZEN16Glc and ?-
ZEL14Glc which all shared a common precursor ion m/z 498.4. The three analytes also 
produced the same quantifier product ion 498.4>319.1, but ?-ZEL14Glc had a different 
qualifier ion (m/z 275.1), which allowed its unique identification among the three 
compounds. However, the isomeric compounds ZEN14Glc and ZEN16Glc, not only 
produced the same precursor/product ion (quantifier, qualifier) pairs (m/z 498.4>319.1, 
283.2) but also chromatographically co-eluted, making them indistinguishable. Hence, a 
short isocratic elution phase between the 7–9 min of the analytical run was introduced, 
into the linear gradient programme, which resolved the issue by allowing the 
identification of these compounds according to their retention times. For quantification, 
and to compensate for the observed SSE phenomena, matrix-assisted calibration of 
analyte-free representative sample material was necessary to reduce these effects to 
some degree and improve the accuracy and sensitivity of the method. 
Analyte quantification and relative quantification in Studies III and IV relied on LC–
HRMS instrumentation (LC–QTOF–MS and LC–Orbitrap). Absolute quantification was 
only possible for a handful of HT2 and T2 derived metabolites for which analytical 
standards were available at the time of the experiments (HT2, HT2-3-Glc, T2, 3Ac-T2 and 
T2-?-Glc). For all other metabolites, relative quantification was performed to establish 
their kinetic profiles from EIC integrated peak areas, corrected for the individual ear 
weight. Lastly, in Study V, an LC–ESI–TQ–MS/MS-based method was used to measure 
the analyte concentrations in wort and yeast biomass. Again, due to severe matrix effects 
being observed for DON (SSE = 78% in wort) and DON3Glc (SSE = 53% in wort), matrix-
assisted calibration curves were used for quantification. However, multi-mycotoxin 
methods are nowadays increasingly being developed using stable isotope dilution 
approaches to address the issue of matrix effects and allow for uncompromised 
determination of multiple analytes in a variety of matrices (Varga et al., 2012; Zhang et 
al., 2017; Habler and Rychlik, 2016). Although the utilisation of 13C-internal standards is 
the best way to dynamically account for matrix effects, matrix-assisted calibration has 
proven a viable alternative whenever isotopologic standards are not available (Li et al., 
2019). 
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6.2 Natural occurrence of (modified) Fusarium 
mycotoxins in Finnish cereals 
 
The results of the survey revealed that DON was the most abundant analyte and present 
at the highest concentrations. In the central and eastern areas of Finland, where maximal 
DON contamination was detected, frequent rainfall occurred between the end of June 
and beginning of July, according to the Finnish Meteorological Institute 
(http://www.fmi.fi), a period when the flowering of oats generally takes place. The rainy 
period was succeeded by warm climatic conditions, often in excess of 25 °C, which are 
optimal for DON-producing fungal species (Ramirez et al., 2006; Kokkonen et al., 2010; 
Wegulo, 2012). Until recently, the dominant species in Finland was F. culmorum in barley 
and wheat. However, in the past years, it has gradually been replaced by F. graminearum, 
which is a more prolific DON producer (Yli-Mattila, 2010). Similar fungal population shifts 
have been documented during the past couple of decades in other northern European 
countries, including the Netherlands (Waalwijk et al., 2003), the UK (Nicholson et al., 
2003), Sweden (Fredlund et al., 2008) and Denmark (Nielsen et al., 2011), to name a few. 
The DON levels in Study II were unusually high, reaching levels of up to 23,800 
μg/kg in oats and 5510 μg/kg in wheat, compared to survey data collected by the annual 
Finnish grain quality monitoring programme for several years before and after the 2013 
harvest. Importantly, the majority of samples contaminated with the highest DON levels 
were not intended for human consumption, but for feed (see Subsection 5.2.2). Analytical 
data generated with a reference method and presented in the grain quality annual report 
verified these unusually high DON concentrations from samples originating from the 
same areas (Hietaniemi et al., 2014). According to that report, only 73% of the analysed 
grains in 2013 fulfilled the requirements for use as food, whereas in the previous year, 
92% did. It is noteworthy that sampling of grains in 2013 was mainly targeted at high-risk 
areas. On rare occasions, similarly elevated DON concentrations have been documented 
in the literature during the past decade. For instance, about 40% of durum wheat samples 
collected in northern Italy in 2010 were found to exceed the respective ML for 
unprocessed cereals destined for human consumption, and the year after, two durum 
wheat samples were found to be contaminated with more than 25,000 μg/kg DON 
(Bertuzzi et al., 2014). 
 From the other native mycotoxins, NIV (incidence 63%) was the second most 
abundant following DON. It is mainly produced by F. poae and in smaller amounts by F. 
culmorum and F. graminearum in northern areas (Bottalico and Perrone, 2002) and in 
Finland (Yli-Mattila et al., 2008). The principally low levels of NIV in samples with high 
DON and 3Ac-DON presence suggest that F. culmorum and F. graminearum were 
predominantly of the 3Ac-DON-producing chemotype IA (Yli-Mattila, 2010). The highest 
levels of HT2 and T2 were detected in samples from the southern parts of the country 
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that had a drier and warmer climate than in the rest of the country. Such climatic 
conditions typically enhance the proliferation of F. sporotrichioides and F. langsethiae 
(Kokkonen et al., 2010; Medina and Magan, 2011), the major HT2/T2 producers in Nordic 
oats (Parikka et al., 2012). Interestingly, a larger proportion of all three types of cereals 
analysed in Study II were contaminated with HT2 in comparison to T2, and at a greater 
average concentration. Kokkonen et al. (2010), demonstrated that higher temperatures 
(25 °C) resulted in increased HT2 production compared to T2 for both F. sporotrichioides 
and F. langsethiae, whereas the opposite occurred at lower temperatures (15 °C). 
Moreover, plants are able to rapidly biotransform T2 into HT2, as shown in Studies III and 
IV, a fact that could also explain the higher incidence and mean HT2 levels observed in 
the survey samples. Lastly, ZEN, which is known to be produced at the end of the growing 
period before harvesting, was measured at low to medium levels of contamination. This 
was presumably due to the weather being warm and dry at that time in Finland, 
conditions not favourable for its production (Matthäus et al., 2004). 
 The availability of analytical standards for all the modified mycotoxins included in 
the LC–MS/MS method of Study II allowed for the collection of accurate quantitative data 
that would not otherwise have been possible. The entirety of modified mycotoxins 
analysed, namely, DON3Glc, HT2-3-Glc, NIV3Glc, ZEN14Glc, ZEN14Sulf, ZEN16Glc, ?-
ZEL, ?-ZEL14Glc, ?-ZEL and ?-ZEL14Glc, were detected in at least one sample and at 
concentrations higher than their respective LOQ value. Notably, the natural presence of 
modified forms such as ZEN16Glc and NIV3Glc in certain types of grains was reported in 
Study II for the first time ever. 
Quantitative measurements with LC–MS/MS revealed that DON3Glc was not only 
the most prevalent modified mycotoxin, with a staggering 81% incidence in total, but the 
second most detected analyte overall. The maximum concentration of DON3Glc was 
6600 μg/kg in a highly DON-contaminated oat sample intended for feed, but levels of 
up to 19,000 DON3Glc μg/kg have been documented in barley malt (Habler and Rychlik, 
2016). The relative proportion of modified to native mycotoxin (DON3Glc/DON), 
expressed as a molar ratio, was determined to be between 15–40%, and in a few barley 
samples reached 65–90%. In EFSA’s scientific opinion concerning the risks related to 
DON and its modified forms, it was stated that from data on a wide variety of cereals, 
3Ac-DON, 15Ac-DON and DON3Glc are currently the most relevant modified forms of 
the mycotoxin in Europe, and their concentration ratios relative to DON were 10%, 15% 
and 20% to DON, respectively (EFSA, 2017). In the same opinion, it was mentioned that 
in the category of malt and beer, maximum concentrations for DON3Glc approached 
those of DON, a fact that might be explained by the formation of DON3Glc during 
germination and brewing. The highest concentration of NIV3Glc was found in barley (65.3 
μg/kg), where this modified mycotoxin was detected in 62% of the samples, in contrast 
to only 16% in oats (max. 58.3 μg/kg) and 10% in wheat (max. 33.6 μg/kg). Interestingly, 
the incidence of the precursor NIV among barley and oats was around 70%, but the 
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former had a significantly lower average concentration (96.6 μg/kg) compared to the 
latter (635 μg/kg). These figures suggest that barley glucosylated NIV much more 
efficiently than the other cereal grains. In total, NIV3Glc was present in 31% of the 
samples and accounted for approximately 5–25% of the total NIV. This modified/native 
relative proportion range is in agreement with an earlier study reporting that more than 
15% of NIV was converted into NIV3Glc in wheat grain artificially infected with Fusarium 
fungi (Nakagawa et al., 2011). Another paper from Japan estimated that the percentage 
of NIV3Glc relative to NIV was between 12–27% in naturally contaminated wheat 
(Yoshinari et al., 2014). 
The existence of mono- and di-glucosides of HT2 and T2 had been reported a 
number of times in the literature prior to this work in barley, wheat, oats, corn and various 
cereal-based products (e.g. Busman et al., 2011; Veprikova et al., 2012; Lattanzio et al., 
2012). The molar ratio between HT2-3-Glc to HT2 was in the range of 15–40% and the 
maximum HT2-3-Glc concentration was measured at 300 μg/kg in an oat sample. 
Lattanzio et al. (2015) analysed barley samples from Northern Italy and estimated the 
relative proportion of modified/native HT2-3-Glc/HT2 to be roughly 37% and measured 
a maximum HT2-3-Glc concentration of 163 μg/kg. The mono-glucosyl congener of T2 
was detected in only a few samples and at low levels of not more than 14.5 μg/kg. 
Remarkably, in the same survey, the sum of HT2 and T2 glucosides ranged between 2% 
and 280% in relation to the summed concentrations of their precursors. These broad 
variations can be ascribed to differences in sampling time, cultivars, growing conditions 
and harvest season, among other factors. Finally, both phase I and II ZEN metabolites 
were determined in all three types of cereal grains. ZEN producers can also form ?- and 
?-ZEL, which may be further biotransformed by plants and fungi (e.g. species of Rhizopus 
and Aspergillus; Brodehl et al., 2014) into conjugated phase II metabolites. It is thus 
crucial to investigate whether similar biotransformation may occur during the 
biotechnological production of fermented foods using microorganisms capable of 
forming ?-ZEL and its conjugates. According to the survey findings, ZEN, ?- and ?-ZEL, 
along with one or more glucosylated forms and the sulfate conjugate, were found to co-
exist. ZEN14Sulf was generally the modified ZEN mycotoxin with the highest abundance 
with concentrations up to 220 μg/kg. Remarkably, the recently characterised ZEN16Glc 
was detected in more samples than the well-known ZEN14Glc. A survey study of cereals 
and cereal-derived food from the Belgian market also reported wide co-occurrence of 
ZEN with several of its derivatives (De Boevre et al., 2013). More specifically, ?- and ?-
ZEL accounted for 58% and 21% of ZEN, respectively, whereas ZEN14Glc represented 
an additional 42% and ?- and ?-ZEL14Glc accounted for 20%; ZEN14Sulf only amounted 
to about 5% of ZEN. Conducting survey studies to monitor the quality of the raw grains 
is crucial for economic and food safety reasons. To achieve this goal, analytical standards 
are urgently needed, as well as more data on the occurrence of modified mycotoxins in 
food and feed to better characterise the risks associated with these compounds.  
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6.3 Metabolic fate of trichothecenes 
 
6.3.1 Metabolism by plants 
 
Plants are equipped with an arsenal of natural mechanisms to counteract Fusarium 
infections and reduce mycotoxin accumulation (reviewed in Boutigny et al., 2008). 
Biotransformation and successional compartmentation are among the most effective 
plant defences against toxic xenobiotics. The complete inventory of metabolites 
tentatively identified in Studies III and IV is presented in Tables 6–8. All metabolites 
detected in the HT2-treated samples were found in the cereal ears inoculated with T2 
due to the rapid conversion of T2 into HT2 and subsequent common metabolism. Hence, 
HT2 is a major metabolite of T2 in barley and wheat, as is for many other organisms (Li et 
al., 2011). 
There is ample scientific evidence that the most common type of in planta phase 
II biotransformation of Fusarium mycotoxins is glucosylation. Conjugation of fusariotoxins 
to glucose molecule(s) by plants has been already described numerous times in the 
literature for DON, NIV and ZEN, as well as for HT2 and T2. Here, glucosylation was also 
confirmed to be the principal metabolic reaction. As a matter of fact, all of the HT2 
metabolites detected in barley had glucoside moieties incorporated to their structures, 
and all except two acetylated congeners of HT2 in wheat. Unsurprisingly, glucosylated 
metabolites also formed the bulk of annotated structures in the T2-treated cereals. Most 
trichothecenes, however, possess multiple functional groups that could seemingly 
undergo direct conjugation without necessitating phase I metabolism. In the first ever 
report describing the existence of HT2 and T2 glucosides, it was suggested that although 
T2 has only one likely site at C-3 for glucoside attachment, HT2 has an additional location 
for glucoside conjugation with its free hydroxyl functionality at C-4 (Busman et al., 2011). 
Lattanzio et al. (2012) also hypothesised that HT2 could be glucosylated at C-3 or C-4 
positions, after observing two distinct peaks in naturally contaminated oat and wheat 
samples that were characterised as mono-glucosylations. A few years later, two HT2 
mono-glucoside isomers were measured in barley from Northern Italy, tentatively 
identified as products of C-3 and C-4 glucose conjugations (Lattanzio et al., 2015). 
Nevertheless, in Studies III and IV, only a single peak was detected and identified as HT2-
3-Glc by HRMS/MS fragmentation and analytical standard measurements in both barley 
and wheat. The fact that no two peaks were found in Studies III and IV, may be potentially 
explained by differences in cultivation/experimental conditions or by differences in 
chromatographic parameters, including column temperature, mobile phase composition 
and gradient programme. T2-?-Glc was only detected in barley and not in any of the 
wheat varieties. 
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From a recent study by Li et al. (2015), it was demonstrated that transgenic wheat, 
expressing a barley UDP-GT with the ability to rapidly metabolise DON to the less toxic 
DON3Glc, was significantly more resistant to the spread of FHB compared to the non-
transformed controls. Although at present there is a lack of data to confirm or refute an 
analogous conjecture for HT2 and T2 glucosides, a reduction in their phytotoxic potential 
is not unreasonable to assume. Furthermore, two isomers tentatively annotated as HT2-
di-glucoside were found in both cereals. As the mono-glucosylation of HT2 occurred 
exclusively at C-3, the two sugar molecules are presumably conjugated at the same 
position in tandem but by a different enzyme, leading to ?-1,4 or ?-1,6 di-glucosides. No 
di-glucosylated metabolites were detected for T2. Despite the absence of such T2 
derivatives in these experiments, di-glucosylated T2 has previously been reported in corn 
(Nakagawa et al., 2013). It is worth mentioning that Zachariasova et al. (2012) described 
the occurrence of not only di-glucoside, but also tri- and tetra-glucosides of DON in 
cereal-based products. 
The toxicity of trichothecenes, as extensively documented in the literature, is 
considerably abated if the acetyl group at C-4 is transformed to a hydroxyl group and 
even more so when both acetoxy moieties from C-4 and C-15 are cleaved (Wu et al., 
2013). In the 12C/13C experiments, it was revealed that wheat was not only able to de-
acetylate T2 into HT2, but also to acetylate it. As previously described, HT2 has two 
hydroxyl groups at C-3 and C-4 positions, readily susceptible to acetylation, which could 
potentially result in the formation of either 3-acetyl-HT2 or T2. A feature pair recognised 
by MetExtract with m/z 489.2083 (12C)/511.2833 (13C) indicated the presence of 22 tracer-
derived carbon atoms and fitted the sum formula of the 13C-HT2 backbone having a non-
labelled acetyl group attached to it. Chromatographically, the retention time of the 
metabolite was close to but did not precisely match that of T2 (16.2 vs. 16.0 min; Study 
IV), and it is thus assumed that acetylation most likely occurred at C-3, forming 3-acetyl-
HT2. The concentration of this metabolite accounted for less than 0.4% of the applied 
HT2. In any event, acetylated HT2 was demonstrated to have been formed by wheat, and 
whether T2 might also have co-existed remains unclear on the basis of available data. 
Meng-Reiterer et al. (2016), however, confirmed that C-4 acetylation of HT2 to T2 
undoubtedly occurred in oats. Nonetheless, de-acetylation of T2 in both barley and 
wheat was seemingly far faster and more extensive compared to reverse acetylation of 
HT2, so the potential formation of 3-acetyl-HT2 or T2 after metabolisation of HT2 in wheat 
was only marginal. 
The majority of the other metabolites were derived from HT2-3-Glc by further 
modifications to its chemical backbone (Figure 14). For instance, malonyl-glucoside 
congeners are expected to have been formed by conjugation of malonic acid to the 
glucose moiety, as has been previously shown for ZEN in Arabidopsis thaliana (Berthiller 
et al., 2006) and DON in wheat (Kluger et al., 2015b). Malonyl-glucoside metabolites of 
alternariol and alternariol-9-O-monomethyl ether were also found in suspension cultures 
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of tobacco BY-2 cells (Hildebrand et al., 2015). In that study, it was shown by NMR data 
that linkage of the malonyl group can either happen at the C-6 position of the glucose, 
forming 6-O-malonyl-?-D-glucopyranosyl, or at the glucose C-4 position, forming 4-O-
malonyl-?-D-glucopyranosyl. Thus, NMR analysis of the detected malonyl-glucosides in 
Studies III and IV would be necessary for exact structure elucidation. Other glucoside-
based metabolites putatively identified were the following: 15-acetyl-T2-tetraol-
glucoside (loss of isovaleryl moiety at C-8), 15-acetyl-T2-tetraol-malonyl-glucoside 
(malonyl conjugation and loss of isovaleryl moiety at C-8), 15-acetyl-T2-tetraol-
glucoside[–2H] (loss of isovaleryl moiety and keto group formation at C-8; no MS/MS 
spectrum obtained), hydroxy-HT2-glucoside (hydroxylation at C-3’), hydroxy-HT2-
malonyl-glucoside (malonyl conjugation and hydroxylation at C-3’), T2-triol-glucoside 
(loss of acetyl group at C-15) and dehydro-HT2-glucoside (loss of water from the isovaleryl 
moiety of hydroxy-HT2-glucoside). The fact that no un-conjugated 15-acetyl-T2-tetraol, 
T2-triol, hydroxy-HT2 or dehydro-HT2 were detected in the samples indicates that the 
phase I metabolic reactions hydrolysis, de-acetylation and oxidation eventuated after the 
conjugation of glucose and malonyl moieties to active functional groups on the HT2 
backbone. As the glucosylation of DON has been confirmed to be an important 
detoxification process in plants (Poppenberger et al., 2003), it is suggested that 
glucosylated HT2 and T2 are potentially also less phytotoxic than their precursors. In 
contrast to other organisms, the toxicity of HT2 and T2 is equivalent to plants, but removal 
of the isovaleryl group of C-8 considerably alleviates their phytotoxic effects (Nishiuchi et 
al., 2006). Therefore, a single mycotoxin may undergo several detoxification processes in 
planta prior to vacuole compartmentation. 
3Ac-T2 and two isomeric derivatives of ferulyol-T2 (tentatively identified as trans-
feruloyl-T2 and trans-isoferuloyl-T2) were the only T2-specific modified forms in barley 
and wheat bearing the intact skeleton of the toxin. Notably, the conjugation of acetic and 
ferulic acids occurred directly to T2 without previous hydrolysis of the C-4 acetyl group 
and formation of HT2. Since ferulic acid naturally exists in plants as trans-ferulic acid 
(Sosulski et al., 1982), the second isomer is more likely trans-isoferuloyl-T2. However, the 
presence of cis-feruloyl-T2 should not be entirely excluded, because cis ferulic acid can 
derived from the trans form after light-induced non-enzymatic isomerisation (Katase, 
1981). Feruloyl conjugates have never previously been reported in the literature, not only 
for HT2 and T2 but for any other mycotoxin. This constitutes a major finding involving a 
novel pathway in the detoxification of type A trichothecenes. The study conducted for 
HT2 and T2 in oats, based on the same 13C-assisted approach, also reported acetic acid 
and ferulic acid conjugates of T2, together with many glycosylated and hydroxylated 
metabolites in common with those reported here, and other novel ones such as HT2-
malyl-glucoside (Meng-Reiterer et al., 2016). Hardly any malonic acid conjugations for 
HT2 and T2 were detected in oats, apart from HT2-malonyl-glucoside, which was present 
at minute concentrations approaching the LOD. Hence, it appears that 
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malonyltransferases of barley and wheat are either more efficiently expressed compared 
to oats or they are more active under the tested conditions. 
Trichothecene de-epoxidation of the C-12,13 epoxide ring, which confers toxicity 
to these molecules (Eriksen et al., 2004), is a crucial detoxification process in mammalian 
metabolism, for which the microflora of the digestive tract is responsible (Karlovsky, 
1999). The epoxide group remained intact and unconjugated in all tentatively annotated 
metabolites of Studies III and IV. In fact, there is experimental evidence that loss of the 
C-12,13 epoxide ring in type A trichothecenes generally increases phytotoxic activity 
(Abbas et al., 2013). Additionally, whilst the epoxide ring of type A trichothecenes 
appears to have little effect on plants, complete detoxification of these mycotoxins to 
render them safe for humans and animals would require edible plants to be genetically 
equipped with the ability to remove the epoxide ring (Desjardins and Proctor, 2007). 
However, de-epoxidation of trichothecenes has not yet been reported in planta. In 
another experiment utilising an identical study design to investigate the metabolism of 
DON in wheat, GSH conjugation was reported as one of the major metabolic routes 
together with glucosylation (Kluger et al., 2015a). The authors proposed that GSH either 
formed a Michael adduct at C-10 or GSH conjugation resulted in the opening of the 
epoxide ring after nucleophilic attack of the SH group to the C-12 atom of DON. If the 
latter hypothesis is proven by NMR analysis, it could be worth further exploring as an 
alternative approach to inactivate the toxicologically relevant epoxide ring of 
trichothecenes and produce modified mycotoxins with reduced mammalian toxicity, as 
GSH conjugations of epoxides are likely to be irreversible (Berthiller et al., 2013). Herein, 
no conjugations to GSH and/or sulfur-containing HT2/T2 metabolites such as glutathione 
S-cysteinyl-glycine or S-cysteine were identified. Another significant difference between 
HT2/T2 and DON tested was that no di-glucosylation of DON was detected, although in 
other studies, multiple glucosylations of DON have been documented in cereals 
(Zachariasova et al., 2012). Therefore, toxin structure and physiological aspects such 
cereal varieties, cultivation conditions and the severity of fungal infections can strongly 
influence the outcome of different experiments. 
Time course kinetics of quantified HT2, T2 and HT2-3-Glc for barley and wheat 
(Remus and CM-82036) are depicted in Figure 13. In both cereal types, T2 was efficiently 
hydrolysed to HT2 and, in turn, roughly half of it was conjugated into HT2-3-Glc within a 
day, regardless of whether it was directly applied HT2 or a product of T2 metabolism. 
Indeed, rapid in planta biotransformation of T2 into HT2 has previously been 
demonstrated for a number of cereals, including maize, wheat, oats and barley, with 
different conversion rates (Lattanzio et al., 2009). From the wheat experiments (Study IV), 
which incorporated a more frequent sampling schedule, it was already evident that HT2-
3-Glc was the major metabolite 6 h after exposure. This metabolite reached its maximum 
after between one day and one week, followed by a clear downward trend denoting 
further metabolism. Meng-Reiterer et al. (2016), reported that oats were more efficient in 
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this regard, displaying the highest turnover from HT2 and T2 into HT2-3-Glc of the three 
cereal plants. Taking a closer look at the biotransformation of HT2 metabolites over time, 
hydroxy-HT2-glucoside, hydroxy-HT2-malonyl-glucoside, HT2-di-glucoside, HT2-
malonyl-glucoside and T2-triol-glucoside reached their maximal relative abundances at 
the ripening timepoint, making them the most relevant for food/feed safety. Due to the 
lack of analytical standards for these compounds their absolute amount could not be 
determined, but from comparison of the EIC peak areas, HT2-malonyl-glucoside can be 
classified as a major metabolite. 3Ac-T2 and ferulyol-T2 attained their highest levels at 
day one, supporting the assumption that besides glucosylation, alternative metabolic 
plant responses were activated without necessitating hydrolysis of T2 to HT2. The decline 
of 3Ac-T2 could potentially be attributed to the reverse reaction back to T2 (de-
acetylation) and the decrease of ferulyol-T2 may have been linked to the incorporation of 
this modified mycotoxin into the plant cell wall (Iiyama et al., 1994; Meng-Reiterer et al., 
2016). Only minor deviations were identified between the susceptible (Remus) and 
resistant (CM-82036) to FHB wheat lines, with no marked disparities being observed in 
their kinetics profiles. In summary, barley and wheat metabolised HT2 and T2 with typical 
phase I and II reactions, but the latter were faster and more dominant. 
 
6.3.2 Metabolism by yeast 
 
In Study V, HT2, T2, DON and DON3Glc did not generally interfere with the growth and 
viability, sugar utilisation or alcohol production of A15 lager yeast, even at levels much 
higher than normally found in naturally contaminated wort. In particular, the yeast cells 
were able to tolerate HT2 and DON up to 10,000 μg/L, DON3Glc at 400 μg/L and the 
mixture of HT2 and T2 (5000 μg/L each) throughout the 96-h fermentation. Resistance 
of yeast to DON has also been documented in a study by Boeira et al. (1999), who 
observed no significant inhibition of growth in lager and ale S. cerevisiae strains after 24 
h, at concentrations approximating those commonly found in naturally contaminated 
grains (100–2000 μg/L). In the same experiments, significant inhibition of growth only 
occurred at 100,000 μg/L and inhibition of viability at 200,000 μg/L DON after only 6 h 
of exposure. Similar adverse effects in cell numbers, dry mass and total protein have 
been documented in a 24-h fermentation of S. cerevisiae treated with 50,000 μg/L DON 
(Whitehead and Flannigan, 1989). These toxin amounts, however, were much greater 
than those that the A15 yeast was exposed to in Study V. T2 in the high-dose group was 
the only toxin that appeared to slightly influence viability in comparison to controls (96% 
vs. 99.5%), but alcohol production was not negatively affected. This mycotoxin is known 
to cause a temporary reduction in the rate of yeast fermentation at high concentrations, 
possibly due to its inhibitory effects on mitochondrial function by hindering oxygen 
utilisation and causing slowed log phase growth (Wolf-Hall, 2007). In this experiment, 
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apart from the slightly reduced yeast viability, no similar severe effects were recorded at 
levels of up to 10,000 μg/L T2. 
Overall, faster and more efficient toxin reduction was noted in the samples 
spiked with 100 μg/L HT2 or T2 compared to samples spiked with 10,000 μg/L. At the 
low dosing level, there was an immediate decrease (5–13%) in the studied compounds 
within the first 4 h of fermentation, which could be ascribed to binding of the toxins to 
the cell walls of yeast, a rapid process that reaches saturation relatively fast (Pfliegler et 
al., 2015). Based on the chemical composition of yeast cell walls, it is reasonable to 
assume that this structural layer presents innumerable sites for physical adsorption of 
molecules such as mycotoxins (Shetty and Jespersen, 2006). Nevertheless, after the 
initial 24 h, clear differences in the kinetic profiles between type A and type B 
trichothecenes were seen. At the last sample collection point (96 h), 66% and 69% of 
the initially dosed HT2 and T2, respectively, were determined in wort, whereas about 
85% of DON was measured at the end of the study; a similar adsorption of 11.6% DON 
by S. cerevisiae has been reported (Campagnollo et al., 2015). DON3Glc followed 
identical kinetic behaviour to DON. It is worth mentioning that in a paper by Scott et al. 
(1992), DON remained completely intact during a 9-day fermentation by 3 strains of S. 
cerevisiae. Altogether, the findings of Study V are in agreement with most past 
experiments of similar or longer fermentation durations, showing considerable 
reductions in trichothecene levels, but nonetheless having high residual mycotoxin 
amounts at termination (Garda et al., 2005; Inoue et al., 2013). Differences between the 
present results and those of other publications in the literature could be related to the 
yeast strains used, toxin concentrations, incubation length and conditions, as well as 
changes in the physico-chemical properties of mycotoxins (polarity, chemical structure, 
dissociation constant, etc.). All these parameters can influence the binding, adsorption 
and metabolism of mycotoxins (Boeira et al., 1999; Faucet-Marquis et al., 2014). 
A seminal finding of this study was that no DON was found in the DON3Glc 
group, indicating that de-conjugation of the glucoside moiety did not occur during 
fermentation. As a matter of fact, A15 yeast was able to glucosylate DON to DON3Glc, 
which was confirmed with analytical standard measurements. Traces of DON3Glc were 
detected in samples collected at the last two time points (72 and 96 h). This was further 
supported by the detection of small toxin amounts in the yeast biomass, also indicating 
the uptake of mycotoxins into the cells and biotransformation. Several other papers have 
documented glucosylation of mycotoxins by fungi as a means of detoxification, e.g., 
HT2 to HT2-3-Glc and T2 to T2-Glc (Busman et al., 2011; McCormick et al., 2012) or 
DON to DON3Glc (Tian et al., 2016). Optimisation of the culture conditions to 
intentionally enhance glucosylation of mycotoxins during brewing fermentation could 
prove to be a promising mitigation strategy, as according to current knowledge, 
trichothecene glucosides are considered less toxic than their precursors (Broekaert et 
al., 2015; Section 2.3). 
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Nevertheless, acetylation was the dominant biotransformation taking place. A 
plethora of microorganisms, alongside both trichothecene- and non-trichothecene-
producing fungi, are equipped with acetyltransferases that can convert Fusarium 
trichothecenes into less toxic C-3 acetyl derivatives (McCormick et al., 2011). This 
strategy is employed during the biosynthesis of trichothecenes by mycotoxin-producing 
organisms for self-protection (Kimura et al., 1998), and is possibly one of the main 
reasons for the high resistance of yeast to trichothecenes. Indeed, for all three 
mycotoxins (DON, HT2 and T2), acetylated metabolites were putatively identified by 
MetaboLynx XS and follow-up LC–MS/MS measurements (detailed MS/MS spectra in 
Study V), although it was not possible to discern the exact location of the acetylation 
site for DON (C-3 or C-15) or HT2 (C-3 or C-4). Consequently, acetylation of HT2 may 
have produced T2 or 3-acetyl-HT2, or even both, as was previously discussed for Study 
IV. Acetylation of T2 could only have occurred at C-3, as this is the only available site on 
its chemical backbone accessible for direct acetylation. As in plants and other organisms, 
yeast was also capable of de-acetylating T2 by hydrolysis at C-4, leading to the 
formation of HT2 (Studies III and IV; EFSA, 2011). This type of detoxification reaction 
was only detected in the T2 high-dose group, and the conversion only accounted for 
0.2% of the initially dosed toxin with no further de-acetylated metabolites such as T2-
triol being detected. 
Lastly, a novel modified mycotoxin was putatively identified as HT2-sulfate. It 
was initially captured by MetaboLynx XS as its sodium adduct (m/z 527.1536, [M+Na]+) 
matched the theoretical accurate m/z value of the metabolite in question. Follow-up LC–
MS/MS analysis revealed a fragment ion corresponding to the [M+H]+ precursor of HT2 
and two of its characteristic fragments. This metabolite was only present in samples 
collected after 72 h in the high-exposure HT2 group, and at such low concentrations 
that it became very challenging to obtain a proper LC–MS/MS spectrum (presented in 
Study V). It also appeared to have a shorter chromatographic retention time compared 
to HT2 (10.43 vs. 12.85 min), indicating higher hydrophilicity that would be expected 
from a polar metabolite. A number of sulfate conjugates of mycotoxins have been 
characterized in fungi and plants, including ZEN14Sulf (Engelhardt et al., 1988; El-
Sharkaway et al., 1991; Plasencia and Mirocha, 1991; Berthiller et al., 2006), DON-3-
sulfate, DON-15-sulfate (Warth et al., 2015), alternariol-3-sulfate, alternariol-9-sulfate 
and alternariol-9-O-methyl ether-3-sulfate (Soukup et al., 2016). 
 
6.4 Methodological considerations 
 
In spite of tremendous advances in analytical sciences and the existence of methods able 
to simultaneously determine hundreds of contaminants, each measurement is still the 
outcome of a series of compromises, starting from sampling all the way to quantification. 
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Analysis of mycotoxins and modified forms constitutes a major challenge because of the 
broad variability in their physico-chemical properties, as well as due to the heterogeneity 
and complexity of matrices from which they have to be extracted, preventing a one-size-
fits-all approach (Shephard, 2016). Additionally, mycotoxins and their derivatives are 
typically encountered at relatively low levels in most samples, thus further complicating 
matters. Modern advanced analytical techniques, despite these complications, can 
facilitate determinations with high selectivity and sensitivity and permit retrospective 
identification of non-target analytes (Anfossi et al., 2016). 
A challenge for most LC–MS/MS-based methods, including those developed and 
used herein, is unequivocally sample preparation and specifically analyte extraction. 
Efficient extraction, with its importance previously highlighted in Subsections 2.2.1 and 
6.1.1, is largely dependent on analyte chemical structures and their compatibility with the 
extraction solution applied. As a consequence, insufficient extraction of modified 
mycotoxins from the matrices analysed may have hindered the detection of certain forms. 
Although brief trials to select the most appropriate extraction solutions were conducted 
in all the studies, more intensive investigations to optimise the balance between minimal 
matrix interference and maximum analyte recovery may have yielded superior results 
(Zhou et al., 2012). Bound non-extractable mycotoxins, incorporated/attached to plant or 
yeast cellular macromolecules, also elude determination (Berthiller et al., 2013). The 
absence of any dedicated clean-up procedure in all metabolomics studies in order to 
attenuate analyte losses could have rendered undetectable certain low intensity 
metabolite ion signals due to matrix effects (Krska et al., 2008). Underestimation of 
modified mycotoxin species/content may also have occurred to some extent in the survey 
study, as more modified mycotoxins could have been present for which no analytical 
standards were available at the time of measurement. 
One important drawback of any type of metabolomics experiment is the reporting 
of false positives, i.e. incorrect hits. In the SIL-based experiments, identification of 
metabolites based on the distinct ? m/z difference between monoisotopic and 13C-
labelled isotopologues from HRMS data may have led to the detection of false positives, 
e.g. due to inaccurate pairings of artefacts, isotope and complex adducts peaks (Brown 
et al., 2011). Thus, to significantly reduce the number of false positives, the isotope 
pattern of both native and labelled metabolite ions and chromatographic co-elution are 
taken into account. Inevitably, a few false positives were picked up by MetExtract from 
data generated in Studies III and IV. These were manually excluded from further 
processing based on certain criteria such as higher than expected 12C/13C mass shifts than 
the number of C atoms contained in the intact toxins, or implausible isotopologue 
intensity ratios. Furthermore, LC–HRMS/MS spectra that did not contain any HT2 and T2 
characteristic fragment ions were also disregarded. It should be mentioned that 
considering the multiplicity of substances often present in biological samples, in this case 
barley and wheat ears, and without having applied any sort of sample clean-up, a very 
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low rate of false positives was observed. This alone demonstrates the exceptionally high 
selectivity and effectiveness of the utilised SIL-assisted metabolomics approach. 
In addition, because of methodological limitations (e.g. LOD of the analytical 
methods) and the strict selection criteria applied to MetExtract software, in an attempt to 
reduce the incidence of false positives, some metabolites with a low abundance may have 
remained undetected. To some extent, the high degree of 13C-isotopic enrichment of the 
precursor toxins, resulting in the absence of M’–1 isotopologues of the labelled 
metabolites, could have contributed to this. Hence, MetExtract hits detected from even 
a single replicate were investigated in order to avoid having any lost metabolites. In Study 
III, there was an issue with the automated identification of 15-acetyl-T2-tetraol-based 
metabolites in the T2-treated barley samples because of the unexpectedly high 12C/13C 
signal ratios. This irregularity was attributed to an impurity in the T2 inoculation solution, 
which after purity assessment was found to contain 3% non-labelled neosolaniol. This 
impurity was then probably transformed into 15-acetyl-T2-tetraol by de-acetylation at C-
4 from the plants, enhancing the 12C-mass signal and hampering its detection. Emphasis 
thus should be given to the use of tracer toxins of the highest possible purity when 
conducting state-of-the-art metabolomics experiments to achieve optimal performance 
and accurate results. It should be noted that prior to the application of SIL-assisted 
metabolomics in mycotoxin research, the only modified HT2 and T2 mycotoxins identified 
were their glucosylated forms, which shows that apart from a few unavoidable limitations, 
this experimental framework is a very powerful tool and even more so in its latest iteration 
(Bueschl et al., 2017), offering tremendous possibilities to “unmask” modified mycotoxins 
in planta. Lastly, in Study V, where only targeted metabolite screening was performed, 
additional unpredicted modified forms could have been formed by yeast and were never 
detected. 
Although all modified mycotoxins reported in Studies II–IV are assumed to have 
been produced as a result of plant metabolism, given the fact that fungi are 
autonomously capable of their biosynthesis, their true origin cannot be definitively 
ascertained, and some metabolites may have been (partially) synthesised by indigenous 
fungi residing on plants. Examples of common phase II metabolic processes between 
plants and fungi are glucosylation, acetylation and sulfation (Freire and Sant’Ana, 2017). 
From a food/feed safety perspective, what actually matters is not the origin of toxins but 
the type and content. Importantly, the modified Fusarium mycotoxins reported in this 
thesis are not exhaustive and additional modifications may be materialised by different 
cereal varieties. Thus, the assembly of all available literature is necessary to fully describe 
the in planta metabolism of every mycotoxin. Again, annotated metabolites in Studies III–
V for which no analytical standard was available should be considered as putative until 
NMR analyses are performed. NMR measurements, however, were outside the scope of 
this work.  
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6.5 Outlook 
 
The risks associated with the presence of mycotoxins in food and feed have prompted 
many countries of the developed world to implement modern agricultural practices and 
set in place legislatively regulated food processing and marketing systems, which have 
greatly reduced mycotoxin exposure in these populations (Milićević et al., 2010). In the 
past few decades, however, mycotoxin production and associated problems with crop 
quality and safety have undeniably been affected by the manifold implications of climate 
change and other human activities (Paterson and Lima, 2010; Parikka et al., 2012). 
Literature data suggest that global warming is having a profound effect on cereal 
cultivation, and this phenomenon has a large impact on plant–pathogen interactions, 
causing changes in host physiology and morphology (Chakraborty et al., 2000), earlier 
flowering (Van der Fels-Klerx et al., 2012; Olesen et al., 2012) and reduced yields (Lesk 
et al., 2016). The geographical distribution of mycotoxigenic fungi is also adjusting to the 
new conditions, and there are reasons to believe that the composition of these species 
and pre-harvest levels of mycotoxins will change (Yli-Mattila, 2010; Wu et al., 2011). As a 
consequence, alterations in the fungal infection patterns of staple crops will arise, leading 
to unique mycotoxin contamination profiles and, in turn, the formation of novel modified 
mycotoxins with unpredictable toxicological manifestations. A constantly evolving 
mycotoxin landscape begets enormous challenges for routine surveillance programmes 
and compels researchers to devise high throughput, robust and accurate analytical 
approaches for monitoring mycotoxin contamination. 
Methods that can accommodate a wide range of chemistries for the concurrent 
determination of precursor and modified forms, and which are capable of structurally 
elucidating novel modified mycotoxins, are essential for ensuring the safety of food- and 
feedstuffs (Krska et al., 2017). The downside of direct approaches is the requirement for 
analytical standards for quantification, which are seldom available for modified 
mycotoxins. The synthesis of modified mycotoxin standards with the aspiration to 
become commercially accessible will bolster research related to their formation, toxicity, 
stability and fate along the manufacturing and food chains. Nevertheless, whenever 
analytical standards are not readily available, indirect quantification by conversion of 
conjugated mycotoxins to their parents through chemical or enzymatic hydrolysis can be 
a useful alternative (Cirlini et al., 2012). As far as their formation is concerned, SIL-assisted 
metabolomics in combination with computational LC–HRMS data processing embodies 
a powerful workflow for identifying novel modified mycotoxins, and it would be ideal to 
exploit its utilisation for all major mycotoxins. Having said that, such experiments are 
costly, time-consuming and require a high level of multidisciplinary expertise and 
resources. In this context, computational modelling to predict the metabolism of 
mycotoxins could become valuable. Although still in its infancy, predictive modelling 
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based on a combination of functional genomics and ecological data would empower 
researchers to understand the transcriptomic responses of fungi to climatic changes and 
predict the progression of fungal infections and mycotoxin production (Magan et al., 
2011; Gilbert et al., 2016). In silico tools can also be used to predict plant–pathogen 
interactions and the resulting modified mycotoxins based on the type of crops, 
environmental conditions and expected fungal populations (e.g. Steinmetz et al., 2009).  
Human exposure to mycotoxins and modified derivatives may arise from the 
consumption of contaminated edible crops and from carryover of these compounds to 
animal-derived food. According to occurrence surveys, the ubiquitous presence of 
single modified mycotoxins in plants and processed foods can frequently reach 30% of 
the precursor form, and on occasion even surpass it. An aggregate summation of all 
mycotoxin derivatives present in the diet is anticipated to contribute a significantly 
higher (modified) mycotoxin burden. The worldwide tendencies to use oats and other 
cereals as meat substitutes and to promote the intake of fibre-rich foods as part of a 
healthy diet may increase exposure to mycotoxins for certain groups of the population 
that heavily rely on plant-based foods to fulfil their daily dietary requirements. Therefore, 
exposure data used by regulatory authorities for risk assessment may warrant re-
evaluation to cover new food consumption scenarios. 
At the same time, it is of outmost importance to investigate the ADME properties 
and inherent toxicological effects of modified mycotoxins in order to devise appropriate 
risk management measures. To date, the toxicological relevance of modified Fusarium 
mycotoxins for food and feed safety has remained largely obscure. Adequate 
information has only been generated for a select few well-studied derivatives of DON 
and ZEN; for some other modified mycotoxins, scarce toxicity data can also be found in 
the literature. Even so, the general consensus is that modified mycotoxins as a whole 
are as yet poorly studied from a toxicological perspective and significant data gaps exist. 
The governing perception of the scientific community is that DON3Glc, the most 
toxicologically examined modified mycotoxin, can be regarded as a detoxification 
product with reduced bioavailability and toxicological activity in living organisms (Gratz, 
2017). However, the release of parent toxins along the mammalian GIT (e.g. ZEN14Sulf) 
may pose a threat to human and animal health, albeit largely dependent on the digestive 
phase in which it may take place (De Boevre et al., 2015). Early de-conjugation might 
exert toxicity on the upper digestive system and renders toxic aglycones more prone to 
intestinal absorption and in turn, increased systemic uptake. As digestion progresses 
and chyme reaches the large intestine, the absorption of toxins decreases dramatically, 
with local toxicity to intestinal epithelium and disturbances to microbial flora constituting 
the major risks (Nathanail et al., 2016). The relevance of novel modified forms to food 
and feed safety require thorough assessment with targeted toxicity testing, primarily 
focusing on those modified mycotoxins that are expected to be present at high 
concentrations in edible plants at harvest and not on those appearing only as 
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intermediates during cultivation or degraded on the field. This last point alone, 
embodies a fundamental justification why metabolomics studies, such as the ones 
performed in this Ph.D. thesis, are pivotal for guiding toxicologists to test the most 
relevant compounds. 
From a legislative perspective, modified mycotoxins are currently not covered by 
any regulatory framework in the EU. The potential risks associated with these substances 
have been under evaluation by EFSA during the past years, with a number of scientific 
opinions already published (EFSA, 2014; EFSA, 2016; EFSA, 2017a; EFSA, 2017b; EFSA, 
2017c), and are now in the pipeline of the EU legislation (Dall'Asta and Berthiller, 2016). 
According to the CONTAM Panel of EFSA, the presence of modified forms is considered 
a non-negligible additional risk, assuming the complete release of aglycones from 
conjugated metabolites. As an example, more than 30 modified forms of ZEN have been 
described in the literature, and the establishment of a group-TDI for certain mycotoxins 
and their modified derivatives in food and feed thus seems inevitable. To estimate the 
risk to animal and human health of parent Fusarium mycotoxins together with their 
modified forms, EFSA assessed them together and established a group-TDI for the sum 
of these compounds and estimated the cumulative risk of exposure to them. Even 
though this is a pragmatic approach, and some of the values are based on experimental 
data (e.g. uterotrophic activity of certain ZEN modified forms), the majority all these 
suppositions may add significant ambiguity in the risk assessment. There are several 
parameters that could contribute to a high overall uncertainty, including exposure 
estimates, the lack of proper validation of analytical methods, limited toxicological data 
and assignment of inappropriate relative potency factors, which according to EFSA are 
more likely to over- than under-estimate the risk. Precautionary safety approaches, 
however, without the support of sound risk-benefit analyses, may not be practically 
applicable, resulting in unnecessary, unfavourable risk assessments with potentially 
destructive repercussions on trade, food/feed producers and distributors worldwide 
(Dellafiora and Dall’Asta, 2016). Therefore, coordinated actions at an international level 
to prioritise and address all sources of uncertainty via efficient resource allocation and 
collaborations between academia, research organisations and regulatory authorities is 
the future of food/feed safety to ensure consumer protection from mycotoxins and toxic 
derivatives based on pragmatic approaches and reliable exposure and toxicity data. 
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7 CONCLUSIONS 
 
The research carried out in Studies I–V revolved around modified Fusarium mycotoxins 
produced by plants and fungi and generated fundamental information concerning their 
formation, natural occurrence and metabolic fate. Quantitative LC–MS/MS analytical 
techniques for rapid, accurate and sensitive determination of Fusarium mycotoxins and 
modified derivatives, as well as state-of-the-art qualitative methodology allowing for the 
annotation and identification of novel modified forms, were developed and applied.  
In Study I, an inter-laboratory comparison was conducted between online sample 
clean-up and four conventional sample preparation techniques for the analysis of DON 
and its major modified form, DON3Glc, in barley and wheat. The automated sample 
clean-up (TurboFlow chromatography), together with extract and shoot, were the most 
user-friendly approaches and offered the best all-around performance in accordance with 
legislative criteria. On the other hand, the MycoSep 227 clean-up column yielded 
satisfactory performance for DON but was unable to accommodate the more polar 
DON3Glc, even with an additional acetonitrile elution step. Likewise, inadequate results 
were obtained with centrifugal filtration, which did not achieve sufficiently low LOQ 
values for the target analytes and required an additional evaporation-reconstitution step 
that may not be compatible with unstable analytes. Overall, on-line clean-up showed high 
potential for use in both research and routine analytical applications for analytes with 
varying physico-chemical properties. 
A multi-mycotoxin LC–MS/MS method was developed and validated to 
investigate the natural occurrence of Fusarium mycotoxins and modified forms in Finnish 
barley, oats and wheat grains of the 2013 harvest (Study II). Data gathered from this 
survey revealed the presence of a multitude of modified mycotoxins, of which DON3Glc 
was the most abundant, followed by HT2-3-Glc and NIV3Glc. This was the first report of 
modified mycotoxin contamination in Finland, and the presence of some of the analytes 
(e.g. ZEN16Glc and NIV3Glc) was documented for the first time worldwide in one or more 
of the crops analysed. Of the precursor mycotoxins, DON, NIV and HT2 were most 
prevalent and present at the highest concentrations, especially in oats. The very high 
contamination levels of DON can be attributed to favourable climatic conditions for 
Fusarium mycotoxin production, the emergence of more prolific DON-producing fungal 
species, as a result of climatic changes, and due to the fact that sampling was 
concentrated in high risk areas. 
According to the findings from the SIL-assisted in planta untargeted 
metabolomics (Studies III and IV), barley and wheat extensively biotransformed HT2 and 
T2 to polar metabolites by employing both phase I and II reactions. There was a 
considerable overlap between HT2 and T2 metabolites between the two cereal grains, 
because of the rapid conversion of a substantial proportion of T2 into HT2, which was 
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further metabolised into several common novel modified mycotoxins. Metabolic 
processes involved the hydrolysis of acetyl and isovaleryl groups, hydroxylation, as well 
as covalent binding of glucose, malonic acid, acetic acid and ferulic acid. Kinetic data 
revealed that HT2-3-Glc was the major modified metabolite for both mycotoxins, already 
reaching its maximum abundance one day after toxin treatment, and was it eventually 
metabolised into different glucosylated derivatives. The qualitative data evaluation 
utilising SIL toxin tracers, LC–HRMS instrumentation and MetExtract software proved to 
be a powerful experimental setup to unravel in planta HT2 and T2 metabolism and 
identify modified mycotoxins potentially relevant to food and feed safety. 
Lastly, in the brewing fermentation (Study V), S. pastorianus A15 lager yeast 
displayed high tolerance to HT2, T2, DON and DON3Glc at concentrations far in excess 
of those occurring in naturally contaminated wort. After 4 days of fermentation, yeast 
was able to reduce the initially dosed mycotoxin levels by 15% to 34% via physical 
binding and/or metabolisation. LC–MS/MS data revealed the formation of glucose and 
sulfate conjugates along with (de)-acetylation metabolic products. Most importantly, 
DON3Glc remained stable under the experimental conditions and did not revert back 
to its parent form. The fundamental significance of these results to the brewing industry 
is that the influence of mycotoxins on yeast appeared to be less relevant than the impact 
of yeast on the concentration and composition of mycotoxins in beer. Therefore, 
brewing fermentation bears great potential for augmentation as an effective mitigation 
strategy, as long as derivatives with reduced toxicity and bioavailability emerge and 
concomitantly preserve their stability during brewing and digestion. 
As a closing statement, and in an attempt to address the cover page question, 
whether modified Fusarium mycotoxins pose a threat in disguise to human and/or animal 
safety –in the view of the author– this query must be split into two parts. On the one hand, 
analytical methodologies and experimental setups relying on targeted/untargeted 
metabolomics, such as those developed and presented in this dissertation, proved more 
than competent in unveiling previously unknown “disguised” modified mycotoxins and 
deciphering the metabolic pathways involved. On the other, without compound-specific 
toxicological data for the vast majority of modified mycotoxins, the risks (threat) 
associated with them still remain largely uncertain. For now, the primary focus of research 
activities and risk management measures should remain on precursor mycotoxins, which 
are among the most noxious food and feed contaminants, causing adverse effects in 
humans and animals in addition to colossal economic and food losses worldwide. 
However, if mycotoxins could become efficiently converted into chemically stable and 
toxicologically inert substances, in the field or during food manufacturing, modified 
Fusarium mycotoxins could be then deemed as a precious ally (instead of a threat) for 
food and feed safety and as catalyst for accomplishing global food security. 
 
 
 
 104 
REFERENCES 
 
Abbas, H.K., Yoshizawa, T. and Shier, W.T., 2013. Cytotoxicity and phytotoxicity of trichothecene 
mycotoxins produced by Fusarium spp. Toxicon 74, 68-75. 
Alexander, N.J., McCormick, S.P., Waalwijk, C., Van Der Lee, T. and Proctor, R.H., 2011. The genetic basis 
for 3-ADON and 15-ADON trichothecene chemotypes in Fusarium. Fungal Genet. and Biol. 48, 485-
495. 
Alizadeh, A., Braber, S., Akbari, P., Kraneveld, A., Garssen, J. and Fink-Gremmels, J., 2016. Deoxynivalenol 
and its modified forms: are there major differences? Toxins 8, 334. 
Anfossi, L., Giovannoli, C. and Baggiani, C., 2016. Mycotoxin detection. Curr. Opin. Biotechnol. 37, 120-
126. 
Ates, E., Mittendorf, K., Stroka, J. and Senyuva, H., 2013. Determination of Fusarium mycotoxins in wheat, 
maize and animal feed using on-line clean-up with high resolution mass spectrometry. Food Addit. 
Contam. Part A 30, 156-165. 
Ates, E., Godula, M., Stroka, J. and Senyuva, H., 2014. Screening of plant and fungal metabolites in wheat, 
maize and animal feed using automated on-line clean-up coupled to high resolution mass spectrometry. 
Food Chem. 142, 276-284. 
Berthiller, F., Cramer, B., Iha, M.H., Krska, R., Lattanzio, V., MacDonald, S., Malone, R.J., Maragos, C., 
Solfrizzo, M. and Stranska-Zachariasova, M., 2018. Developments in mycotoxin analysis: an update for 
2016-2017. World Mycotoxin J 11, 5-32. 
Berthiller, F., Brera, C., Iha, M.H., Krska, R., Lattanzio, V., MacDonald, S., Malone, R.J., Maragos, C., Solfrizzo, 
M. and Stranska-Zachariasova, M., 2017. Developments in mycotoxin analysis: an update for 2015–2016. 
World Mycotoxin J. 10, 5-29. 
Berthiller, F., Maragos, C.M. and Dall'Asta, C., 2016. Introduction to Masked Mycotoxins, in: Dall'Asta, C., 
Berthiller, F. (Eds). The Royal Society of Chemistry, Cambridge, UK, pp. 1-13. 
Berthiller, F., Werner, U., Sulyok, M., Krska, R., Hauser, M. and Schuhmacher, R., 2006. Liquid 
chromatography coupled to tandem mass spectrometry (LC-MS/MS) determination of phase II 
metabolites of the mycotoxin zearalenone in the model plant Arabidopsis thaliana. Food Addit. Contam. 
23, 1194-1200. 
Berthiller, F., Crews, C., Dall'Asta, C., Saeger, S.D., Haesaert, G., Karlovsky, P., Oswald, I.P., Seefelder, W., 
Speijers, G. and Stroka, J., 2013. Masked mycotoxins: A review. Mol. Nutr. Food Res. 57, 165-186. 
Berthiller, F., Krska, R., Domig, K.J., Kneifel, W., Juge, N., Schuhmacher, R. and Adam, G., 2011. Hydrolytic 
fate of deoxynivalenol-3-glucoside during digestion. Toxicol. Lett. 206, 264-267. 
Berthiller, F., Hametner, C., Krenn, P., Schweiger, W., Ludwig, R., Adam, G., Krska, R. and Schuhmacher, R., 
2009. Preparation and characterization of the conjugated Fusarium mycotoxins zearalenone-4 O-?-D-
glucopyranoside, ?-zearalenol-4 O-?-D-glucopyranoside and ?-zearalenol-4 O-?-D-glucopyranoside by 
MS/MS and two-dimensional NMR. Food Addit. Contam. A 26, 207-213. 
 105 
Berthiller, F., Schuhmacher, R., Adam, G. and Krska, R., 2009. Formation, determination and significance of 
masked and other conjugated mycotoxins. Anal. Bioanal. Chem. 395, 1243-1252. 
Berthiller, F., Dall'Asta, C., Schuhmacher, R., Lemmens, M., Adam, G. and Krska, R., 2005. Masked 
mycotoxins: determination of a deoxynivalenol glucoside in artificially and naturally contaminated wheat 
by liquid chromatography−tandem mass spectrometry. J. Agric. Food Chem. 53, 3421-3425. 
Bertuzzi, T., Camardo Leggieri, M., Battilani, P. and Pietri, A., 2014. Co-occurrence of type A and B 
trichothecenes and zearalenone in wheat grown in northern Italy over the years 2009–2011. Food Addit. 
Contam. B 7, 273-281. 
Bhat, R., Rai, R.V. and Karim, A.A., 2010. Mycotoxins in food and feed: present status and future concerns. 
Compr. Rev. Food Sci. F. 9, 57-81. 
Binder, S., Schwartz-Zimmermann, H., Varga, E., Bichl, G., Michlmayr, H., Adam, G. and Berthiller, F., 2017. 
Metabolism of zearalenone and its major modified forms in pigs. Toxins 9, 56. 
Boeira, L.S., Bryce, J.H., Stewart, G.G. and Flannigan, B., 2000. The effect of combinations of Fusarium 
mycotoxins (deoxynivalenol, zearalenone and fumonisin B1) on growth of brewing yeasts. J. Appl. 
Microbiol. 88, 388-403. 
Boeira, L.S., Bryce, J.H., Stewart, G.G. and Flannigan, B., 1999. Inhibitory effect of Fusarium mycotoxins on 
growth of brewing yeasts. 2. Deoxynivalenol and nivalenol. J. Inst. Brewing 105, 376-381. 
Bottalico, A., 1998. Fusarium diseases of cereals: species complex and related mycotoxin profiles, in Europe. 
J. Plant Pathol. 80, 85-103. 
Bottalico, A. and Perrone, G., 2002. Toxigenic Fusarium species and mycotoxins associated with head blight 
in small-grain cereals in Europe. Eur. J. Plant Pathol. 108, 611-624. 
Bottalico, A., Visconti, A., Logrieco, A., Solfrizzo, M. and Mirocha, C.J., 1985. Occurrence of zearalenols 
(diastereomeric mixture) in corn stalk rot and their production by associated Fusarium species. Appl. 
Environ. Microbiol. 49, 547-551. 
Boutigny, A., Richard-Forget, F. and Barreau, C., 2008. Natural mechanisms for cereal resistance to the 
accumulation of Fusarium trichothecenes. Eur. J. Plant Pathol. 121, 411-423. 
Bowles, D., Lim, E., Poppenberger, B. and Vaistij, F.E., 2006. Glycosyltransferases of lipophilic small 
molecules. Annu. Rev. Plant Biol. 57, 567-597. 
Boyd, R.K., Basic, C. and Bethem, R.A., 2011. Trace Quantitative Analysis by Mass Spectrometry. John Wiley 
& Sons. 
Brera, C. and Miraglia, M., 1996. Quality assurance in mycotoxin analysis. Microchem. J. 54, 465-471. 
Brodehl, A., Möller, A., Kunte, H., Koch, M. and Maul, R., 2014. Biotransformation of the mycotoxin 
zearalenone by fungi of the genera Rhizopus and Aspergillus. FEMS Microbiol. Lett. 359, 124-130. 
Broekaert, N., Devreese, M., Demeyere, K., Berthiller, F., Michlmayr, H., Varga, E., Adam, G., Meyer, E. and 
Croubels, S., 2016. Comparative in vitro cytotoxicity of modified deoxynivalenol on porcine intestinal 
epithelial cells. Food Chem. Toxicol. 95, 103-109. 
 106 
Broekaert, N., Devreese, M., De Baere, S., De Backer, P. and Croubels, S., 2015. Modified Fusarium 
mycotoxins unmasked: From occurrence in cereals to animal and human excretion. Food Chem. Toxicol. 
80, 17-31. 
Brown, M., Wedge, D.C., Goodacre, R., Kell, D.B., Baker, P.N., Kenny, L.C., Mamas, M.A., Neyses, L. and 
Dunn, W.B., 2011. Automated workflows for accurate mass-based putative metabolite identification in 
LC/MS-derived metabolomic datasets. Bioinformatics 27, 1108-1112. 
Bryła, M., Ksieniewicz-Woźniak, E., Yoshinari, T., Waśkiewicz, A. and Szymczyk, K., 2019. Contamination of 
Wheat Cultivated in Various Regions of Poland during 2017 and 2018 Agricultural Seasons with Selected 
Trichothecenes and Their Modified Forms. Toxins 11, 88. 
Bryła, M., Waśkiewicz, A., Podolska, G., Szymczyk, K., Jędrzejczak, R., Damaziak, K. and Sułek, A., 2016. 
Occurrence of 26 mycotoxins in the grain of cereals cultivated in Poland. Toxins 8, 160. 
Bueschl, C., Kluger, B., Neumann, N.K., Doppler, M., Maschietto, V., Thallinger, G.G., Meng-Reiterer, J., 
Krska, R. and Schuhmacher, R., 2017. MetExtract II: A software suite for stable isotope-assisted 
untargeted metabolomics. Anal. Chem. 89, 9518-9526. 
Bueschl, C., Kluger, B., Lemmens, M., Adam, G., Wiesenberger, G., Maschietto, V., Marocco, A., Strauss, 
J., Bödi, S. and Thallinger, G.G., 2014. A novel stable isotope labelling assisted workflow for improved 
untargeted LC–HRMS based metabolomics research. Metabolomics 10, 754-769. 
Bueschl, C., Kluger, B., Berthiller, F., Lirk, G., Winkler, S., Krska, R. and Schuhmacher, R., 2012. MetExtract: 
a new software tool for the automated comprehensive extraction of metabolite-derived LC/MS signals 
in metabolomics research. Bioinformatics 28, 736-738. 
Bullerman, L.B., 1979. Significance of Mycotoxins to Food Safety and Human Health 1, 2. J. Food Prot. 42, 
65-86. 
Bullock, J.D. and Khamis, H.J., 2010. A retrospective statistical analysis of the Fusarium keratitis epidemic 
of 2004–2006. Ophthalmic Epidemiol. 17, 179-184. 
Bunner, D.L. and Morris, E.R., 1988. Alteration of multiple cell membrane functions in L-6 myoblasts by T-2 
toxin: an important mechanism of action. Toxicol. Appl. Pharmacol. 92, 113-121. 
Busman, M., Poling, S.M. and Maragos, C.M., 2011. Observation of T-2 toxin and HT-2 toxin glucosides 
from Fusarium sporotrichioides by liquid chromatography coupled to tandem mass spectrometry (LC-
MS/MS). Toxins 3, 1554-1568. 
Buszewski, B. and Noga, S., 2012. Hydrophilic interaction liquid chromatography (HILIC) – A powerful 
separation technique. Anal. Bioanal. Chem. 402, 231-247. 
Cajka, T., Vaclavikova, M., Dzuman, Z., Vaclavik, L., Ovesna, J. and Hajslova, J., 2014. Rapid LC?MS?based 
metabolomics method to study the Fusarium infection of barley. J. Sep. Sci. 37, 912-919. 
Campagnollo, F.B., Franco, L.T., Rottinghaus, G.E., Kobashigawa, E., Ledoux, D.R., Daković, A. and Oliveira, 
C.A., 2015. In vitro evaluation of the ability of beer fermentation residue containing Saccharomyces 
cerevisiae to bind mycotoxins. Food Res. Int. 77, 643-648. 
Cano, P.M., Seeboth, J., Meurens, F., Cognie, J., Abrami, R., Oswald, I.P. and Guzylack-Piriou, L., 2013. 
Deoxynivalenol as a new factor in the persistence of intestinal inflammatory diseases: an emerging 
hypothesis through possible modulation of Th17-mediated response. PLoS One 8, e53647. 
 107 
Capriotti, A.L., Caruso, G., Cavaliere, C., Foglia, P., Samperi, R. and Laganà, A., 2012. Multiclass mycotoxin 
analysis in food, environmental and biological matrices with chromatography/mass spectrometry. Mass 
Spectrom. Rev. 31, 466-503. 
Casale, W.L. and Hart, L.P., 1988. Inhibition of 3H-leucine incorporation by trichothecene mycotoxins in 
maize and wheat tissue. Phytopathology 78, 1673-1677. 
Catteuw, A., Broekaert, N., De Baere, S., Lauwers, M., Gasthuys, E., Huybrechts, B., Callebaut, A., Ivanova, 
L., Uhlig, S. and De Boevre, M., 2019. Insights into In Vivo Absolute Oral Bioavailability, 
Biotransformation, and Toxicokinetics of Zearalenone, ?-Zearalenol, ?-Zearalenol, Zearalenone-14-
glucoside, and Zearalenone-14-sulfate in Pigs. J. Agric. Food Chem. 67, 3448-3458. 
Chakraborty, S. and Newton, A.C., 2011. Climate change, plant diseases and food security: an overview. 
Plant Pathol. 60, 2-14. 
Chakraborty, S., Tiedemann, A.V. and Teng, P.S., 2000. Climate change: potential impact on plant diseases. 
Environ. Pollut. 108, 317-326. 
Cirlini, M., Dall’Asta, C. and Galaverna, G., 2012. Hyphenated chromatographic techniques for structural 
characterization and determination of masked mycotoxins. J. Chromatogr. A 1255, 145-152. 
Cirlini, M., Barilli, A., Galaverna, G., Michlmayr, H., Adam, G., Berthiller, F. and Dall’Asta, C., 2016. Study 
on the uptake and deglycosylation of the masked forms of zearalenone in human intestinal Caco-2 cells. 
Food Chem. Toxicol. 98, 232-239. 
Cole, R.J., Jarvis, B.B. and Schweikert, M.A., 2003. Handbook of Secondary Fungal Metabolites. Academic 
Press, New York, USA. 
Coleman, J., Blake-Kalff, M. and Davies, E., 1997. Detoxification of xenobiotics by plants: chemical 
modification and vacuolar compartmentation. Trends Plant Sci. 2, 144-151. 
Crews, C. and MacDonald, S.J., 2016. Natural Occurrence of Masked Mycotoxins, in: Introduction to 
Masked Mycotoxins, in: Dall'Asta, C., Berthiller, F. (Eds). The Royal Society of Chemistry, Cambridge, 
UK, pp. 14-31. 
D’mello, J., Placinta, C.M. and Macdonald, A., 1999. Fusarium mycotoxins: a review of global implications 
for animal health, welfare and productivity. Anim. Feed Sci. Technol. 80, 183-205. 
Dall’Erta, A., Cirlini, M., Dall’Asta, M., Del Rio, D., Galaverna, G. and Dall’Asta, C., 2013. Masked mycotoxins 
are efficiently hydrolyzed by human colonic microbiota releasing their aglycones. Chem. Res. Toxicol. 
26, 305-312. 
Dall'Asta, C. and Berthiller, F., 2016. Concluding Remarks, in: Introduction to Masked Mycotoxins, in: 
Dall'Asta, C., Berthiller, F. (Eds). The Royal Society of Chemistry, Cambridge, UK, pp. 189-193. 
De Boevre, M., Ediage, E.N., Van Poucke, C. and De Saeger, S., 2015. Untargeted analysis of modified 
mycotoxins using high-resolution mass spectrometry, in: Introduction to Masked Mycotoxins, in: 
Dall'Asta, C., Berthiller, F. (Eds). The Royal Society of Chemistry, Cambridge, UK, pp. 50-72. 
De Boevre, M., Graniczkowska, K. and De Saeger, S., 2015. Metabolism of modified mycotoxins studied 
through in vitro and in vivo models: An overview. Toxicol. Lett. 233, 24-28. 
 108 
De Boevre, M., Jacxsens, L., Lachat, C., Eeckhout, M., Di Mavungu, J.D., Audenaert, K., Maene, P., Haesaert, 
G., Kolsteren, P. and De Meulenaer, B., 2013. Human exposure to mycotoxins and their masked forms 
through cereal-based foods in Belgium. Toxicol. Lett. 218, 281-292. 
De Boevre, M., Di Mavungu, J.D., Maene, P., Audenaert, K., Deforce, D., Haesaert, G., Eeckhout, M., 
Callebaut, A., Berthiller, F. and Van Peteghem, C., 2012. Development and validation of an LC-MS/MS 
method for the simultaneous determination of deoxynivalenol, zearalenone, T-2-toxin and some masked 
metabolites in different cereals and cereal-derived food. Food Addit. Contam. A 29, 819-835. 
de Loubresse, N.G., Prokhorova, I., Holtkamp, W., Rodnina, M.V., Yusupova, G. and Yusupov, M., 2014. 
Structural basis for the inhibition of the eukaryotic ribosome. Nature 513, 517. 
De Nijs, M., Van den Top, H J, Portier, L., Oegema, G., Kramer, E., Van Egmond, H.P. and Hoogenboom, 
L., 2012. Digestibility and absorption of deoxynivalenol-3-?-glucoside in in vitro models. World 
Mycotoxin J. 5, 319-324. 
Dellafiora, L., Ruotolo, R., Perotti, A., Cirlini, M., Galaverna, G., Cozzini, P., Buschini, A. and Dall’Asta, C., 
2017. Molecular insights on xenoestrogenic potential of zearalenone-14-glucoside through a mixed in 
vitro/in silico approach. Food Chem. Toxicol. 108, 257-266. 
Dellafiora, L. and Dall’Asta, C., 2016. Masked mycotoxins: An emerging issue that makes renegotiable what 
is ordinary. Food Chem. 213, 534-535. 
Desjardins, A.E. and Proctor, R.H., 2007. Molecular biology of Fusarium mycotoxins. Int. J. Food Microbiol. 
119, 47-50. 
Desjardins, A.E., 2006. Fusarium Mycotoxins Chemistry, Genetics, and Biology. APS Press, Minnesota, USA. 
Desjardins, A.E. and Hohn, T.M., 1997. Mycotoxins in plant pathogenesis. Mol. Plant-Microbe Interact. 10, 
147-152. 
Desmond, O.J., Manners, J.M., Stephens, A.E., Maclean, D.J., Schenk, P.M., Gardiner, D.M., Munn, A.L. 
and Kazan, K., 2008. The Fusarium mycotoxin deoxynivalenol elicits hydrogen peroxide production, 
programmed cell death and defence responses in wheat. Mol. Plant Pathol. 9, 435-445. 
Dixon, D.P., Cummins, I., Cole, D.J. and Edwards, R., 1998. Glutathione-mediated detoxification systems in 
plants. Curr. Opin. Plant Biol. 1, 258-266. 
Drzymala, S.S., Binder, J., Brodehl, A., Penkert, M., Rosowski, M., Garbe, L. and Koch, M., 2015. 
Estrogenicity of novel phase I and phase II metabolites of zearalenone and cis-zearalenone. Toxicon 105, 
10-12. 
Du, P., Kibbe, W.A. and Lin, S.M., 2006. Improved peak detection in mass spectrum by incorporating 
continuous wavelet transform-based pattern matching. Bioinformatics 22, 2059-2065. 
Dunn, W.B., Erban, A., Weber, R.J., Creek, D.J., Brown, M., Breitling, R., Hankemeier, T., Goodacre, R., 
Neumann, S. and Kopka, J., 2013. Mass appeal: metabolite identification in mass spectrometry-focused 
untargeted metabolomics. Metabolomics 9, 44-66. 
EC, 2018. European Commission, The Rapid Alert System for Food and Feed (RASFF). 2017 – Annual Report. 
EC, 2015. European Commission Decision C (2015)2453 of 17 April 2015 Horizon 2020 Work Programme 
2014–2015: Food security, sustainable agriculture and forestry, marine and maritime and inland water 
research and bioeconomy (revised).  
 109 
EC, 2013. Commission Recommendation of 27 March 2013 on the presence of T-2 and HT-2 toxin in cereals 
and cereal products (2013/165/EU). OJ L91/12-15.  
EC, 2006a. Commission Regulation (EC) No 401/2006 of 23 February 2006 laying down the methods of 
sampling and analysis for the official control of the levels of mycotoxins in foodstuffs. OJ L70/12–34.  
EC, 2006b. Commission Regulation (EC) No 1881/2006 of 19 December 2006 setting maximum levels for 
certain contaminants in foodstuff. OJ L334/5-28.  
EC, 2006c. Commission Recommendation of 17 August 2006 on the presence of deoxynivalenol, 
zearalenone, ochratoxin A, T-2 and HT-2 and fumonisins in products intended for animal feeding 
(2006/576/EC). OJ L229/7-9.  
EC, 2002a. Commission Decision 2002/657/EC of 12 August 2002 implementing Council Directive 
96/23/EC concerning the performance of analytical methods and the interpretation of results. OJ 
L221/8-36.  
EC, 2002b. Directive 2002/32 of The European Parliament and of the Council of 7 May 2002 on undesirable 
substances in animal feed. OJ L140/1-22.  
Edwards, R., Dixon, D.P. and Walbot, V., 2000. Plant glutathione S-transferases: enzymes with multiple 
functions in sickness and in health. Trends Plant Sci. 5, 193-198. 
EFSA, 2017a. Appropriateness to set a group health based guidance value for T2 and HT2 toxin and its 
modified forms. EFSA J. 15. 
EFSA, 2017b. Risks to human and animal health related to the presence of deoxynivalenol and its acetylated 
and modified forms in food and feed. EFSA J. 15, 4718. 
EFSA, 2017c. Appropriateness to set a group health based guidance value for nivalenol and its modified 
forms. EFSA J. 15, 4751. 
EFSA, 2016. Appropriateness to set a group health-based guidance value for zearalenone and its modified 
forms. EFSA J. 14, 4425. 
EFSA, 2014. Scientific Opinion on the risks for human and animal health related to the presence of modified 
forms of certain mycotoxins in food and feed. EFSA J. 12, 3916. 
EFSA, 2013. Scientific Opinion on risks for animal and public health related to the presence of nivalenol in 
food and feed. EFSA J. 11, 3262. 
EFSA, 2012. Risk assessment of contaminants in food and feed. EFSA J. 10, s1004. 
EFSA, 2011a. Scientific Opinion on the risks for animal and public health related to the presence of T-2 and 
HT-2 toxin in food and feed. EFSA J. 9, 2481. 
EFSA, 2011b. Scientific Opinion on the risks for public health related to the presence of zearalenone in food. 
EFSA J. 9, 2197. 
El-Sharkaway, S.H., Selim, M.I., Afifi, M.S. and Halaweish, F.T., 1991. Microbial transformation of 
zearalenone to a zearalenone sulfate. Appl. Environ. Microbiol. 57, 549-552. 
El-Sharkawy, S.H. and Abul-Hajj, Y.J., 1988. Microbial transformation of zearalenone. 2. Reduction, 
hydroxylation, and methylation products. J. Org. Chem. 53, 515-519. 
 110 
Engelhardt, G., Zill, G., Wohner, B. and Wallnöfer, P.R., 1988. Transformation of the Fusarium mycotoxin 
zearalenone in maize cell suspension cultures. Naturwissenschaften 75, 309-310. 
Eriksen, G.S., Pettersson, H. and Lundh, T., 2004. Comparative cytotoxicity of deoxynivalenol, nivalenol, 
their acetylated derivatives and de-epoxy metabolites. Food Chem. Toxicol. 42, 619-624. 
Eskola, M., Kos G., Elliott C.T., Hajšlová J., Mayar S., Krska R., 2019. Worldwide contamination of food-
crops with mycotoxins: Validity of the widely cited ‘FAO estimate’ of 25%. Crit. Rev. Food Sci. Nutr., 1-
17. 
FAO, 2004. Worldwide Regulations for Mycotoxins in Food and Feed in 2003, FAO Food and Nutrition 
Paper 81 ed. Food and Agriculture Organization of the United Nations, Rome, Italy. 
Faucet-Marquis, V., Joannis-Cassan, C., Hadjeba-Medjdoub, K., Ballet, N. and Pfohl-Leszkowicz, A., 2014. 
Development of an in vitro method for the prediction of mycotoxin binding on yeast-based products: 
case of aflatoxin B 1, zearalenone and ochratoxin A. Appl. Microbiol. Biotechnol. 98, 7583-7596. 
Fitzpatrick, D.W., Picken, C.A., Murphy, L.C. and Buhr, M.M., 1989. Measurement of the relative binding 
affinity of zearalenone, alpha-zearalenol and beta-zearalenol for uterine and oviduct estrogen receptors 
in swine, rats and chickens: an indicator of estrogenic potencies. Comp. Biochem. Physiol. C, Comp. 
Toxicol. Pharmacol. 94, 691-694. 
Fleck, S.C., Hildebrand, A.A., Müller, E., Pfeiffer, E. and Metzler, M., 2012. Genotoxicity and inactivation of 
catechol metabolites of the mycotoxin zearalenone. Mycotoxin Res. 28, 267-273. 
Fredlund, E., Gidlund, A., Olsen, M., Börjesson, T., Spliid, N.H.H. and Simonsson, M., 2008. Method 
evaluation of Fusarium DNA extraction from mycelia and wheat for down-stream real-time PCR 
quantification and correlation to mycotoxin levels. J. Microbiol. Methods 73, 33-40. 
Freire, L. and Sant’Ana, A.S., 2017. Modified mycotoxins: An updated review on their formation, detection, 
occurrence, and toxic effects. Chem. Toxicol. 111, 189-205. 
Frizzell, C., Ndossi, D., Verhaegen, S., Dahl, E., Eriksen, G., Sørlie, M., Ropstad, E., Muller, M., Elliott, C.T. 
and Connolly, L., 2011. Endocrine disrupting effects of zearalenone, alpha-and beta-zearalenol at the 
level of nuclear receptor binding and steroidogenesis. Toxicol. Lett. 206, 210-217. 
Garda, J., Macedo, R.M., Faria, R., Bernd, L., Dors, G.C. and Badiale-Furlong, E., 2005. Alcoholic 
fermentation effects on malt spiked with trichothecenes. Food Control 16, 423-428. 
Gareis, M., Bauer, J., Thiem, J., Plank, G., Grabley, S. and Gedek, B., 1990. Cleavage of Zearalenone?
Glycoside, a “Masked” Mycotoxin, during Digestion in Swine. Zoonoses and Public Health 37, 236-240. 
Gilbert, M.K., Mack, B.M., Payne, G.A. and Bhatnagar, D., 2016. Use of functional genomics to assess the 
climate change impact on Aspergillus flavus and aflatoxin production. World Mycotoxin J. 9, 665-672. 
Gosetti, F., Mazzucco, E., Zampieri, D. and Gennaro, M.C., 2010. Signal suppression/enhancement in high-
performance liquid chromatography tandem mass spectrometry. J. Chromatogr. A 1217, 3929-3937. 
Gratz, S.W., 2017. Do Plant-Bound Masked Mycotoxins Contribute to Toxicity? Toxins 9, 85. 
Gratz, S.W., Dinesh, R., Yoshinari, T., Holtrop, G., Richardson, A.J., Duncan, G., MacDonald, S., Lloyd, A. 
and Tarbin, J., 2017. Masked trichothecene and zearalenone mycotoxins withstand digestion and 
absorption in the upper GI tract but are efficiently hydrolyzed by human gut microbiota in vitro. Mol. 
Nutr. Food Res. 61, 1600680. 
 111 
Grovey, J.F., 2007. The trichothecenes and their biosynthesis, in: Herz, W., Falk, H., Kirby, G.W. (Eds). 
Springer, Vienna, Austria, pp. 63-130. 
Gupta, A.K., Baran, R. and Summerbell, R.C., 2000. Fusarium infections of the skin. Curr. Opin. Infect. Dis. 
13, 121-128. 
Gutleb, A.C., Morrison, E. and Murk, A.J., 2002. Cytotoxicity assays for mycotoxins produced by Fusarium 
strains: a review. Environ. Toxicol. Pharmacol. 11, 309-320. 
Habler, K. and Rychlik, M., 2016. Multi-mycotoxin stable isotope dilution LC-MS/MS method for Fusarium 
toxins in cereals. Anal. Bioanal. Chem. 408, 307-317. 
Hagler, W.M., Mirocha, C.J., Pathre, S.V. and Behrens, J.C., 1979. Identification of the naturally occurring 
isomer of zearalenol produced by Fusarium roseum 'Gibbosum' in rice culture. Appl. Environ. Microbiol. 
37, 849-853. 
Harris, L.J., Desjardins, A.E., Plattner, R.D., Nicholson, P., Butler, G., Young, J.C., Weston, G., Proctor, R.H. 
and Hohn, T.M., 1999. Possible role of trichothecene mycotoxins in virulence of Fusarium graminearum 
on maize. Plant Dis. 83, 954-960. 
Hazel, C.M. and Patel, S., 2004. Influence of processing on trichothecene levels. Toxicol. Lett. 153, 51-59. 
Hietaniemi, V., Rämö, S., Koivisto, T., Kartio, M., Sieviläinen Elina and Peltonen Sari, 2014. Viljan 
Turvallisuustietoseuranta 2013, Raportti 15.04.2014, 1-13. 
Hildebrand, A.A., Kohn, B.N., Pfeiffer, E., Wefers, D., Metzler, M. and Bunzel, M., 2015. Conjugation of the 
mycotoxins alternariol and alternariol monomethyl ether in tobacco suspension cells. J. Agric. Food 
Chem. 63, 4728-4736. 
Holčapek, M., Jirásko, R. and Lísa, M., 2012. Recent developments in liquid chromatography–mass 
spectrometry and related techniques. J. Chromatogr. A 1259, 3-15. 
Iiyama, K., Lam, T.B. and Stone, B.A., 1994. Covalent cross-links in the cell wall. Plant Physiol. 104, 315. 
Inoue, T., Nagatomi, Y., Uyama, A. and Mochizuki, N., 2013. Fate of mycotoxins during beer brewing and 
fermentation. Biosci. Biotechnol. Biochem. 77, 1410-1415. 
Ismaiel, A. and Papenbrock, J., 2015. Mycotoxins: producing fungi and mechanisms of phytotoxicity. 
Agriculture 5, 492-537. 
JECFA, 2011. Evaluation of Certain Contaminants in Food: Seventy-Second Report of the Joint FAO/WHO 
Expert Committee on Food Additives. WHO Technical Report Series 959, Geneva, Switzerland. 
JECFA, 2000. Zearalenone. Joint FAO/WHO Expert Committee on Food Additives. Safety Evaluation of 
Certain Food Additives and Contaminants. WHO/FAO Food Additives Series: 44. IPCS - International 
Programme on Chemical Safety, Geneva, Switzerland. 
Jestoi, M., 2008. Emerging Fusarium-mycotoxins fusaproliferin, beauvericin, enniatins, and moniliformin – 
A review. Crit. Rev. Food Sci. Nutr. 48, 21-49. 
Jones, P. and Vogt, T., 2001. Glycosyltransferases in secondary plant metabolism: tranquilizers and stimulant 
controllers. Planta 213, 164-174. 
 112 
Kamimura, H., 1986. Conversion of zearalenone to zearalenone glycoside by Rhizopus sp. Appl. Environ. 
Microbiol. 52, 515-519. 
Karlovsky, P., Suman, M., Berthiller, F., De Meester, J., Eisenbrand, G., Perrin, I., Oswald, I.P., Speijers, G., 
Chiodini, A. and Recker, T., 2016. Impact of food processing and detoxification treatments on mycotoxin 
contamination. Mycotoxin Res. 32, 179-205. 
Karlovsky, P., 1999. Biological detoxification of fungal toxins and its use in plant breeding, feed and food 
production. Nat. Toxins 7, 1-23. 
Katase, T., 1981. Stereoisomerization of p-coumaric and ferulic acids during their incubation in peat soil 
extract solution by exposure to fluorescent light. Soil Sci. Plant Nutr. 27, 421-427. 
Kessner, D., Chambers, M., Burke, R., Agus, D. and Mallick, P., 2008. ProteoWizard: open source software 
for rapid proteomics tools development. Bioinformatics 24, 2534-2536. 
Kimura, M., Kaneko, I., Komiyama, M., Takatsuki, A., Koshino, H., Yoneyama, K. and Yamaguchi, I., 1998. 
Trichothecene 3-O-acetyltransferase protects both the producing organism and transformed yeast from 
related mycotoxins cloning and characterization of Tri101. J. Biol. Chem. 273, 1654-1661. 
Kliebenstein, D.J., 2004. Secondary metabolites and plant/environment interactions: a view through 
Arabidopsis thaliana tinged glasses. Plant, Cell Environ. 27, 675-684. 
Kluger, B., Bueschl, C., Lemmens, M., Michlmayr, H., Malachova, A., Koutnik, A., Maloku, I., Berthiller, F., 
Adam, G. and Krska, R., 2015a. Biotransformation of the mycotoxin deoxynivalenol in Fusarium resistant 
and susceptible near isogenic wheat lines. PLoS One 10, e0119656. 
Kluger, B., Lehner, S. and Schuhmacher, R., 2015b. Biosynthesis and Molecular Genetics of Fungal 
Secondary Metabolites in: Zellinger, S., Martin, J-F., Garcia-Estrada, C. (Eds). Springer, USA, pp. 81-101. 
Kluger, B., Bueschl, C., Neumann, N., Stückler, R., Doppler, M., Chassy, A.W., Waterhouse, A.L., Rechthaler, 
J., Kampleitner, N. and Thallinger, G.G., 2014. Untargeted profiling of tracer-derived metabolites using 
stable isotopic labeling and fast polarity-switching LC–ESI-HRMS. Anal. Chem. 86, 11533-11537. 
Kokkonen, M., Ojala, L., Parikka, P. and Jestoi, M., 2010. Mycotoxin production of selected Fusarium species 
at different culture conditions. Int. J. Food Microbiol. 143, 17-25. 
Köppen, R., Koch, M., Siegel, D., Merkel, S., Maul, R. and Nehls, I., 2010. Determination of mycotoxins in 
foods: current state of analytical methods and limitations. Appl. Microbiol. Biotechnol. 86, 1595-1612. 
Kościelniak, J., Biesaga-Kościelniak, J., Janeczko, A., Filek, W. and Kalaji, H.M., 2009. Can the Giberella 
zeae toxin zearalenone affect the photosynthetic productivity and increase yield formation in spring 
wheat and soybean plants? Photosynthetica 47, 586-594. 
Kostelanska, M., Zachariasova, M., Lacina, O., Fenclova, M., Kollos, A. and Hajslova, J., 2011. The study of 
deoxynivalenol and its masked metabolites fate during the brewing process realised by UPLC–TOFMS 
method. Food Chem. 126, 1870-1876. 
Kovalsky Paris, M.P., Schweiger, W., Hametner, C., Stückler, R., Muehlbauer, G.J., Varga, E., Krska, R., 
Berthiller, F. and Adam, G., 2014. Zearalenone-16-O-glucoside: a new masked mycotoxin. J. Agric. Food 
Chem. 62, 1181-1189. 
Kralj Cigić, I. and Prosen, H., 2009. An overview of conventional and emerging analytical methods for the 
determination of mycotoxins. Int. J. Mol. Sci. 10, 62-115. 
 113 
Krska, R., De Nijs, M., McNerney, O., Pichler, M., Gilbert, J., Edwards, S., Suman, M., Magan, N., Rossi, V. 
and van der Fels-Klerx, H J, 2016. Safe food and feed through an integrated toolbox for mycotoxin 
management: the MyToolBox approach. World Mycotoxin J. 9, 487-495. 
Krska, R., Sulyok, M., Berthiller, F. and Schuhmacher, R., 2017. Mycotoxin testing: From multi-toxin analysis 
to metabolomics. JSM Mycotoxins 67, 11-16. 
Krska, R., Schubert-Ullrich, P., Molinelli, A., Sulyok, M., MacDonald, S. and Crews, C., 2008. Mycotoxin 
analysis: An update. Food Addit. Contam. A 25, 152-163. 
Kuhl, C., Tautenhahn, R., Bottcher, C., Larson, T.R. and Neumann, S., 2011. CAMERA: an integrated strategy 
for compound spectra extraction and annotation of liquid chromatography/mass spectrometry data sets. 
Anal. Chem. 84, 283-289. 
Lancova, K., Hajslova, J., Poustka, J., Krplova, A., Zachariasova, M., Dostálek, P. and Sachambula, L., 2008. 
Transfer of Fusarium mycotoxins and ‘masked’ deoxynivalenol (deoxynivalenol-3-glucoside) from field 
barley through malt to beer. Food Addit. Contam. A 25, 732-744. 
Lattanzio, V.M., Ciasca, B., Terzi, V., Ghizzoni, R., McCormick, S.P. and Pascale, M., 2015. Study of the 
natural occurrence of T-2 and HT-2 toxins and their glucosyl derivatives from field barley to malt by high-
resolution Orbitrap mass spectrometry. Food Addit. Contam. A 32, 1647-1655. 
Lattanzio, V.M., Visconti, A., Haidukowski, M. and Pascale, M., 2012. Identification and characterization of 
new Fusarium masked mycotoxins, T2 and HT2 glycosyl derivatives, in naturally contaminated wheat 
and oats by liquid chromatography–high?resolution mass spectrometry. J. Mass Spectrom. 47, 466-475. 
Lattanzio, V.M., Solfrizzo, M. and Visconti, A., 2009. Enzymatic hydrolysis of T-2 toxin for the quantitative 
determination of total T-2 and HT-2 toxins in cereals. Anal. Bioanal. Chem. 395, 1325-1334. 
Lesk, C., Rowhani, P. and Ramankutty, N., 2016. Influence of extreme weather disasters on global crop 
production. Nature 529, 84. 
Li, D., Steimling, J.A., Konschnik, J.D., Grossm, S.L. and Kahler, T.W., 2019. Quantitation of mycotoxins in 
four food matrices comparing stable isotope dilution assay (SIDA) with matrix-matched calibration 
methods by LC–MS/MS. J. AOAC Int. in press. 
Li, X., Shin, S., Heinen, S., Dill-Macky, R., Berthiller, F., Nersesian, N., Clemente, T., McCormick, S. and 
Muehlbauer, G.J., 2015. Transgenic wheat expressing a barley UDP-glucosyltransferase detoxifies 
deoxynivalenol and provides high levels of resistance to Fusarium graminearum. Mol. Plant-Microbe 
Interact. 28, 1237-1246. 
Li, Y., Wang, Z., Beier, R.C., Shen, J., Smet, D.D., De Saeger, S. and Zhang, S., 2011. T-2 toxin, a 
trichothecene mycotoxin: review of toxicity, metabolism, and analytical methods. J. Agric. Food Chem. 
59, 3441-3453. 
Link, H.F., 1809. Observationes in Ordines plantarum naturales. Berlin Ges. NatKde 3, 1-42. 
Lu, W., Bennett, B.D. and Rabinowitz, J.D., 2008. Analytical strategies for LC–MS-based targeted 
metabolomics. J. Chromatogr. B 871, 236-242. 
Magan, N., Medina, A. and Aldred, D., 2011. Possible climate?change effects on mycotoxin contamination 
of food crops pre?and postharvest. Plant Pathol. 60, 150-163. 
 114 
Magan, N. and Aldred, D., 2007. Why do fungi produce mycotoxins?, in: Dijksterhuis, J., Samson, R.A. (Eds). 
CRC Press, Boca Raton, Florida, USA, pp. 121-134. 
Maier, F.J., Miedaner, T., Hadeler, B., Felk, A., Salomon, S., Lemmens, M., Kassner, H. and Schaefer, W., 
2006. Involvement of trichothecenes in fusarioses of wheat, barley and maize evaluated by gene 
disruption of the trichodiene synthase (Tri5) gene in three field isolates of different chemotype and 
virulence. Mol. Plant Pathol. 7, 449-461. 
Malachová, A., Stránská, M., Václavíková, M., Elliott, C.T., Black, C., Meneely, J., Hajšlová, J., Ezekiel, C.N., 
Schuhmacher, R. and Krska, R., 2017. Advanced LC–MS-based methods to study the co-occurrence and 
metabolization of multiple mycotoxins in cereals and cereal-based food. Anal. Bioanal. Chem. 410, 1-
25. 
Malachová, A., Štočková, L., Wakker, A., Varga, E., Krska, R., Michlmayr, H., Adam, G. and Berthiller, F., 
2015. Critical evaluation of indirect methods for the determination of deoxynivalenol and its conjugated 
forms in cereals. Anal. Bioanal. Chem. 407, 6009-6020. 
Malachová, A., Sulyok, M., Beltrán, E., Berthiller, F. and Krska, R., 2014. Optimization and validation of a 
quantitative liquid chromatography–tandem mass spectrometric method covering 295 bacterial and 
fungal metabolites including all regulated mycotoxins in four model food matrices. J. Chromatogr. A 
1362, 145-156. 
Maresca, M., 2013. From the gut to the brain: Journey and pathophysiological effects of the food-associated 
trichothecene mycotoxin deoxynivalenol. Toxins 5, 784-820. 
Matthäus, K., Dänicke, S., Vahjen, W., Simon, O., Wang, J., Valenta, H., Meyer, K., Strumpf, A., Ziesenib, H. 
and Flachowsky, G., 2004. Progression of mycotoxin and nutrient concentrations in wheat after 
inoculation with Fusarium culmorum. Arch. of Anim. Nutr. 58, 19-35. 
Maul, R., Müller, C., Rieß, S., Koch, M., Methner, F. and Irene, N., 2012. Germination induces the 
glucosylation of the Fusarium mycotoxin deoxynivalenol in various grains. Food Chem. 131, 274-279. 
McCormick, S.P., Kato, T., Maragos, C.M., Busman, M., Lattanzio, V.M., Galaverna, G., Dall-Asta, C., Crich, 
D., Price, N.P. and Kurtzman, C.P., 2015. Anomericity of T-2 toxin-glucoside: masked mycotoxin in cereal 
crops. J. Agric. Food Chem. 63, 731-738. 
McCormick, S.P., Price, N.P. and Kurtzman, C.P., 2012. Glucosylation and other biotransformations of T-2 
toxin by yeasts of the Trichomonascus clade. Appl. Environ. Microbiol. 78, 8694-8702. 
McCormick, S.P., Stanley, A.M., Stover, N.A. and Alexander, N.J., 2011. Trichothecenes: from simple to 
complex mycotoxins. Toxins 3, 802-814. 
McLean, M., 1995. The phytotoxicity of selected mycotoxins on mature, germinating Zea mays embryos. 
Mycopathologia 132, 173-183. 
Medina, A. and Magan, N., 2011. Temperature and water activity effects on production of T-2 and HT-2 by 
Fusarium langsethiae strains from north European countries. Food Microbiol. 28, 392-398. 
Meneely, J.P., Ricci, F., van Egmond, H.P. and Elliott, C.T., 2011. Current methods of analysis for the 
determination of trichothecene mycotoxins in food. Trends Anal. Chem. 30, 192-203. 
Meng-Reiterer, J., Bueschl, C., Rechthaler, J., Berthiller, F., Lemmens, M. and Schuhmacher, R., 2016. 
Metabolism of HT-2 toxin and T-2 toxin in oats. Toxins 8, 364. 
 115 
Meng-Reiterer, J., Varga, E., Nathanail, A.V., Bueschl, C., Rechthaler, J., McCormick, S.P., Michlmayr, H., 
Malachovà, A., Fruhmann, P. and Adam, G., 2015. Tracing the metabolism of HT-2 toxin and T-2 toxin 
in barley by isotope-assisted untargeted screening and quantitative LC-HRMS analysis. Anal. Bioanal. 
Chem. 407, 8019-8033. 
Michlmayr, H., Varga, E., Malachová, A., Fruhmann, P., Piątkowska, M., Hametner, C., Šofrová, J., Jaunecker, 
G., Häubl, G. and Lemmens, M., 2018. UDP-glucosyltransferases from rice, Brachypodium, and barley: 
substrate specificities and synthesis of type A and B trichothecene-3-O-?-D-glucosides. Toxins 10, 111. 
Mikula, H., Sohr, B., Skrinjar, P., Weber, J., Hametner, C., Berthiller, F., Krska, R., Adam, G. and Fröhlich, J., 
2013. Sulfation of ?-resorcylic acid esters – First synthesis of zearalenone-14-sulfate. Tetrahedron Lett. 
54, 3290-3293. 
Milićević, D.R., Škrinjar, M. and Baltić, T., 2010. Real and perceived risks for mycotoxin contamination in 
foods and feeds: challenges for food safety control. Toxins 2, 572-592. 
Miller, J.D., Young, J.C. and Trenholm, H.L., 1983. Fusarium toxins in field corn. I. Time course of fungal 
growth and production of deoxynivalenol and other mycotoxins. Can. J. Bot. 61, 3080-3087. 
Minervini, F., Fornelli, F. and Flynn, K.M., 2004. Toxicity and apoptosis induced by the mycotoxins nivalenol, 
deoxynivalenol and fumonisin B1 in a human erythroleukemia cell line. Toxicol. In Vitro 18, 21-28. 
Minervini, F. and Dell’Aquila, M.E., 2008. Zearalenone and reproductive function in farm animals. Int. J. Mol. 
Sci. 9, 2570-2584. 
Mirocha, C.J., Abbas, H.K., Treeful, L. and Bean, G., 1988. T-2 toxin and diacetoxyscirpenol metabolism by 
Baccharis spp. Appl. Environ. Microbiol. 54, 2277-2280. 
Murray, K.K., Boyd, R.K., Eberlin, M.N., Langley, G.J., Li, L. and Naito, Y., 2013. Definitions of terms relating 
to mass spectrometry (IUPAC Recommendations 2013). Pure Appl. Chem. 85, 1515-1609. 
Nagl, V., Woechtl, B., Schwartz-Zimmermann, H.E., Hennig-Pauka, I., Moll, W., Adam, G. and Berthiller, F., 
2014. Metabolism of the masked mycotoxin deoxynivalenol-3-glucoside in pigs. Toxicol. Lett. 229, 190-
197. 
Nagl, V., Schwartz, H., Krska, R., Moll, W., Knasmüller, S., Ritzmann, M., Adam, G. and Berthiller, F., 2012. 
Metabolism of the masked mycotoxin deoxynivalenol-3-glucoside in rats. Toxicol. Lett. 213, 367-373. 
Nakagawa, H., Sakamoto, S., Sago, Y., Kushiro, M. and Nagashima, H., 2012. The use of LC-Orbitrap MS 
for the detection of Fusarium masked mycotoxins: the case of type A trichothecenes. World Mycotoxin 
J. 5, 271-280. 
Nakagawa, H., Sakamoto, S., Sago, Y. and Nagashima, H., 2013. Detection of type A trichothecene di-
glucosides produced in corn by high-resolution liquid chromatography-orbitrap mass spectrometry. 
Toxins 5, 590-604. 
Nakagawa, H., Ohmichi, K., Sakamoto, S., Sago, Y., Kushiro, M., Nagashima, H., Yoshida, M. and Nakajima, 
T., 2011. Detection of a new Fusarium masked mycotoxin in wheat grain by high-resolution LC–
Orbitrap™ MS. Food Addit. Contam. A 28, 1447-1456. 
Nathanail, A.V., Gibson, B., Han, L., Peltonen, K., Ollilainen, V., Jestoi, M. and Laitila, A., 2016. The lager 
yeast Saccharomyces pastorianus removes and transforms Fusarium trichothecene mycotoxins during 
fermentation of brewer’s wort. Food Chem. 203, 448-455. 
 116 
Nathanail, A.V., Jestoi, M., Jonsson, M. and Peltonen, K., 2016. In Vitro Assays to Estimate the Toxicological 
Effects of Masked Mycotoxins, in: Dall'Asta, C., Berthiller, F. (Eds). The Royal Society of Chemistry, 
Cambridge, UK, pp. 97-136. 
Nathanail, A.V., Syvähuoko, J., Malachová, A., Jestoi, M., Varga, E., Michlmayr, H., Adam, G., Sieviläinen, 
E., Berthiller, F. and Peltonen, K., 2015. Simultaneous determination of major type A and B 
trichothecenes, zearalenone and certain modified metabolites in Finnish cereal grains with a novel liquid 
chromatography–tandem mass spectrometric method. Anal. Bioanal. Chem. 407, 4745-4755. 
Nathanail, A.V., Varga, E., Meng-Reiterer, J., Bueschl, C., Michlmayr, H., Malachová, A., Fruhmann, P., Jestoi, 
M., Peltonen, K. and Adam, G., 2015. Metabolism of the Fusarium mycotoxins T-2 toxin and HT-2 toxin 
in wheat. J. Agric. Food Chem. 63, 7862-7872. 
Nathanail, A.V., Sarikaya, E., Jestoi, M., Godula, M. and Peltonen, K., 2014. Determination of deoxynivalenol 
and deoxynivalenol-3-glucoside in wheat and barley using liquid chromatography coupled to mass 
spectrometry: on-line clean-up versus conventional sample preparation techniques. J. Chromatogr. A 
1374, 31-39. 
Naz, S., Vallejo, M., García, A. and Barbas, C., 2014. Method validation strategies involved in non-targeted 
metabolomics. J. Chromatogr. A 1353, 99-105. 
Nicholson, P., Chandler, E., Draeger, R.C., Gosman, N.E., Simpson, D.R., Thomsett, M. and Wilson, A.H., 
2003. Molecular tools to study epidemiology and toxicology of Fusarium head blight of cereals. Eur. J. 
Plant Pathol. 109, 691-703. 
Nielsen, L.K., Jensen, J.D., Nielsen, G.C., Jensen, J.E., Spliid, N.H., Thomsen, I.K., Justesen, A.F., Collinge, 
D.B. and Jørgensen, L.N., 2011. Fusarium head blight of cereals in Denmark: species complex and 
related mycotoxins. Phytopathology 101, 960-969. 
Niessen, L., Böhm-Schrami, M., Vogel, H. and Donhauser, S., 1993. Deoxynivalenol in commercial beer – 
Screening for the toxin with an indirect competitive ELISA. Mycotoxin Res. 9, 99-109. 
Nirenberg, H.I., 1989. Identification of Fusaria occurring in Europe on cereals and potatoes, in: Chelkowski, 
J. (Ed). Elsevier, the Netherlands, pp. 179-193. 
Nishiuchi, T., Masuda, D., Nakashita, H., Ichimura, K., Shinozaki, K., Yoshida, S., Kimura, M., Yamaguchi, I. 
and Yamaguchi, K., 2006. Fusarium phytotoxin trichothecenes have an elicitor-like activity in Arabidopsis 
thaliana, but the activity differed significantly among their molecular species. Mol. Plant-Microbe Interact. 
19, 512-520. 
Olesen, J.E., Børgesen, C.D., Elsgaard, L., Palosuo, T., Rötter, R.P., Skjelvåg, A.O., Peltonen-Sainio, P., 
Börjesson, T., Trnka, M. and Ewert, F., 2012. Changes in time of sowing, flowering and maturity of cereals 
in Europe under climate change. Food Addit. Contam. A 29, 1527-1542. 
Oliver, S.G., Winson, M.K., Kell, D.B. and Baganz, F., 1998. Systematic functional analysis of the yeast 
genome. Trends Biotechnol. 16, 373-378. 
Parikka, P., Hakala, K. and Tiilikkala, K., 2012. Expected shifts in Fusarium species’ composition on cereal 
grain in Northern Europe due to climatic change. Food Addit. Contam. A 29, 1543-1555. 
Parry, D.W., Jenkinson, P. and McLeod, L., 1995. Fusarium ear blight (scab) in small grain cereals – A review. 
Plant Pathol. 44, 207-238. 
 117 
Pascari, X., Ramos, A.J., Marin, S. and Sanchis, V., 2018. Mycotoxins and beer. Impact of beer production 
process on mycotoxin contamination. A review. Food Res. Int. 103, 121-129. 
Paterson, R.R.M. and Lima, N., 2010. How will climate change affect mycotoxins in food? Food Res. Int. 43, 
1902-1914. 
Patti, G.J., Yanes, O. and Siuzdak, G., 2012. Innovation: Metabolomics: the apogee of the omics trilogy. 
Nat. Rev. Mol. Cell Biol. 13, 263. 
Patti, G.J., 2011. Separation strategies for untargeted metabolomics. J. Sep. Sci. 34, 3460-3469. 
Payros, D., Alassane-Kpembi, I., Pierron, A., Loiseau, N., Pinton, P. and Oswald, I.P., 2016. Toxicology of 
deoxynivalenol and its acetylated and modified forms. Arch. Toxicol. 90, 2931-2957. 
Pedrioli, P.G., Eng, J.K., Hubley, R., Vogelzang, M., Deutsch, E.W., Raught, B., Pratt, B., Nilsson, E., 
Angeletti, R.H. and Apweiler, R., 2004. A common open representation of mass spectrometry data and 
its application to proteomics research. Nat. Biotechnol. 22, 1459-1466. 
Pestka, J.J., 2010. Deoxynivalenol: mechanisms of action, human exposure, and toxicological relevance. 
Arch. Toxicol. 84, 663-679. 
Pestka, J.J., Zhou, H., Moon, Y. and Chung, Y.J., 2004. Cellular and molecular mechanisms for immune 
modulation by deoxynivalenol and other trichothecenes: unraveling a paradox. Toxicol. Lett. 153, 61-
73. 
Peters, J., van Dam, R., van Doorn, R., Katerere, D., Berthiller, F., Haasnoot, W. and Nielen, M.W., 2017. 
Mycotoxin profiling of 1000 beer samples with a special focus on craft beer. PLoS One 12, e0185887. 
Pfliegler, W.P., Pusztahelyi, T. and Pócsi, I., 2015. Mycotoxins–prevention and decontamination by yeasts. 
J. Basic Microbiol. 55, 805-818. 
Pierron, A., Mimoun, S., Murate, L.S., Loiseau, N., Lippi, Y., Bracarense, A.F., Liaubet, L., Schatzmayr, G., 
Berthiller, F. and Moll, W., 2016. Intestinal toxicity of the masked mycotoxin deoxynivalenol-3-?-D-
glucoside. Arch. Toxicol. 90, 2037-2046. 
Pinton, P., Tsybulskyy, D., Lucioli, J., Laffitte, J., Callu, P., Lyazhri, F., Grosjean, F., Bracarense, A.P., Kolf-
Clauw, M. and Oswald, I.P., 2012. Toxicity of deoxynivalenol and its acetylated derivatives on the 
intestine: differential effects on morphology, barrier function, tight junction proteins, and mitogen-
activated protein kinases. Toxicol. Sci. 130, 180-190. 
Plasencia, J. and Mirocha, C.J., 1991. Isolation and characterization of zearalenone sulfate produced by 
Fusarium spp. Appl. Environ. Microbiol. 57, 146-150. 
Poppenberger, B., Berthiller, F., Bachmann, H., Lucyshyn, D., Peterbauer, C., Mitterbauer, R., Schuhmacher, 
R., Krska, R., Glössl, J. and Adam, G., 2006. Heterologous expression of Arabidopsis UDP-
glucosyltransferases in Saccharomyces cerevisiae for production of zearalenone-4-O-glucoside. Appl. 
Environ. Microbiol. 72, 4404-4410. 
Poppenberger, B., Berthiller, F., Lucyshyn, D., Sieberer, T., Schuhmacher, R., Krska, R., Kuchler, K., Glössl, 
J., Luschnig, C. and Adam, G., 2003. Detoxification of the Fusarium mycotoxin deoxynivalenol by a UDP-
glucosyltransferase from Arabidopsis thaliana. J. Biol. Chem. 278, 47905-47914. 
 118 
Proctor, R.H., Desjardins, A.E., McCormick, S.P., Plattner, R.D., Alexander, N.J. and Brown, D.W., 2002. 
Genetic analysis of the role of trichothecene and fumonisin mycotoxins in the virulence of Fusarium. Eur. 
J. Plant Pathol. 108, 691-698. 
Ramirez, M.L., Chulze, S. and Magan, N., 2006. Temperature and water activity effects on growth and 
temporal deoxynivalenol production by two Argentinean strains of Fusarium graminearum on irradiated 
wheat grain. Int. J. Food Microbiol. 106, 291-296. 
Repka, V., Fiala, R., Luxová, M. and Pavlovkin, J., 2014. Responses of maize root cells to zearalenone and 
its derivatives ?-zearalenol and ?-zearalenol. Eur. J. Plant Pathol. 138, 787-797. 
Righetti, L., Dall’Asta, C., Hajslova, J. and Rubert, J., 2016. Metabolomics Approaches and their Hidden 
Potential for Explaining the Mycotoxin Contamination Problem. Metabolomics: Fundamentals and 
Applications, in: Prasain, J.K. (Ed). InTech, Croatia, pp 119-137. 
Righetti, L., Paglia, G., Galaverna, G. and Dall’Asta, C., 2016. Recent Advances and Future Challenges in 
Modified Mycotoxin Analysis: Why HRMS Has Become a Key Instrument in Food Contaminant Research. 
Toxins 8, 361. 
Rocha, O., Ansari, K. and Doohan, F.M., 2005. Effects of trichothecene mycotoxins on eukaryotic cells: a 
review. Food Addit. Contam. 22, 369-378. 
Rotter, B.A., 1996. Invited review: Toxicology of deoxynivalenol (vomitoxin). J. Toxicol. Env. Heal. A 48, 1-
34. 
Rychlik, M., Humpf, H., Marko, D., Dänicke, S., Mally, A., Berthiller, F., Klaffke, H. and Lorenz, N., 2014. 
Proposal of a comprehensive definition of modified and other forms of mycotoxins including “masked” 
mycotoxins. Mycotoxin Res. 30, 197-205. 
Ryu, D., Hanna, M.A., Eskridge, K.M. and Bullerman, L.B., 2003. Heat stability of zearalenone in an aqueous 
buffered model system. J. Agric. Food Chem. 51, 1746-1748. 
Sandermann Jr, H., 1992. Plant metabolism of xenobiotics. Trends Biochem. Sci. 17, 82-84. 
Savard, M.E., 1991. Deoxynivalenol fatty acid and glucoside conjugates. J. Agric. Food Chem. 39, 570-574. 
Scalbert, A., Brennan, L., Fiehn, O., Hankemeier, T., Kristal, B.S., van Ommen, B., Pujos-Guillot, E., Verheij, 
E., Wishart, D. and Wopereis, S., 2009. Mass-spectrometry-based metabolomics: limitations and 
recommendations for future progress with particular focus on nutrition research. Metabolomics 5, 435. 
SCF, 2002. Opinion of the Scientific Committee on Food on Fusarium toxins. Part 6: Group evaluation of T-
2 toxin, HT-2 toxin, nivalenol and deoxynivalenol. SCF/CS/CNTM/MYC/27 Final, 1-12. 
SCF, 2000. Opinion of the Scientific Committee on Food on Fusarium toxins. Part 2: Zearalenone (ZEA). 
SCF/CS/CNTM/MYC/22 Rev 3 Final, 1-12. 
Schatzmayr, G. and Streit, E., 2013. Global occurrence of mycotoxins in the food and feed chain: facts and 
figures. World Mycotoxin J. 6, 213-222. 
Schneweis, I., Meyer, K., Engelhardt, G. and Bauer, J., 2002. Occurrence of zearalenone-4-?-D-
glucopyranoside in wheat. J. Agric. Food Chem. 50, 1736-1738. 
Schrimpe-Rutledge, A.C., Codreanu, S.G., Sherrod, S.D. and McLean, J.A., 2016. Untargeted metabolomics 
strategies – Challenges and emerging directions. J. Am. Soc. Mass Spectrom. 27, 1897-1905. 
 119 
Schuhmacher, R., Krska, R., Weckwerth, W. and Goodacre, R., 2013. Metabolomics and metabolite profiling. 
Anal. Bioanal. Chem. 15, 5003-5004. 
Schuler, M.A., 1996. Plant cytochrome P450 monooxygenases. Crit. Rev. Plant Sci. 15, 235-284. 
Schwarz, P.B., Casper, H.H. and Beattie, S., 1995. Fate and Development of Naturally Occurring Fusarium 
Mycotoxins During Malting and Brewing1. J. Am. Soc. Brew. Chem. 53, 121-127. 
Scott, P.M., Kanhere, S.R., Daley, E.F. and Farber, J.M., 1992. Fermentation of wort containing 
deoxynivalenol and zearalenone. Mycotoxin Res. 8, 58-66. 
Scott, P.M., Nelson, K., Kanhere, S.R., Karpinski, K.F., Hayward, S., Neish, G.A. and Teich, A.H., 1984. 
Decline in deoxynivalenol (vomitoxin) concentrations in 1983 Ontario winter wheat before harvest. Appl. 
Environ. Microbiol. 48, 884-886. 
Sewald, N., von Gleissenthall, J.L., Schuster, M., Müller, G. and Aplin, R.T., 1992. Structure elucidation of a 
plant metabolite of 4-desoxynivalenol. Tetrahedron: Asymmetry 3, 953-960. 
Shephard, G.S., 2016. Current status of mycotoxin analysis: a critical review. J. AOAC Int. 99, 842-848. 
Shetty, P.H. and Jespersen, L., 2006. Saccharomyces cerevisiae and lactic acid bacteria as potential 
mycotoxin decontaminating agents. Trends Food Sci. Technol. 17, 48-55. 
Shifrin, V.I. and Anderson, P., 1999. Trichothecene mycotoxins trigger a ribotoxic stress response that 
activates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase and induces apoptosis. J. 
Biol. Chem. 274, 13985-13992. 
Snyder, L.R., Kirkland, J.J. and Dolan, J.W., 2010. Introduction to Modern Liquid Chromatography, A John 
Willey & Sons. Inc. Publication, USA, pp. 20-83. 
Soleimany, F., Jinap, S. and Abas, F., 2012. Determination of mycotoxins in cereals by liquid 
chromatography tandem mass spectrometry. Food Chem. 130, 1055-1060. 
Songsermsakul, P. and Razzazi-Fazeli, E., 2008. A review of recent trends in applications of liquid 
chromatography–mass spectrometry for determination of mycotoxins. J. Liq. Chrom. Relat. Tech. 31, 
1641-1686. 
Sosulski, F., Krygier, K. and Hogge, L., 1982. Free, esterified, and insoluble-bound phenolic acids. 3. 
Composition of phenolic acids in cereal and potato flours. J. Agric. Food Chem. 30, 337-340. 
Soukup, S.T., Kohn, B.N., Pfeiffer, E., Geisen, R., Metzler, M., Bunzel, M. and Kulling, S.E., 2016. 
Sulfoglucosides as novel modified forms of the mycotoxins alternariol and alternariol monomethyl ether. 
J. Agric. Food Chem. 64, 8892-8901. 
Stadler, D., Lambertini, F., Bueschl, C., Wiesenberger, G., Hametner, C., Schwartz-Zimmermann, H., 
Hellinger, R., Sulyok, M., Lemmens, M. and Schuhmacher, R., 2019. Untargeted LC–MS based 13C 
labelling provides a full mass balance of deoxynivalenol and its degradation products formed during 
baking of crackers, biscuits and bread. Food Chem. 279, 303-311. 
Steinmetz, W.E., Rodarte, C.B. and Lin, A., 2009. 3D QSAR study of the toxicity of trichothecene mycotoxins. 
Eur. J. Med. Chem. 44, 4485-4489. 
Steyn, P.S., 1995. Mycotoxins, general view, chemistry and structure. Toxicol. Lett. 82, 843-851. 
 120 
Sulyok, M., Krska, R. and Schuhmacher, R., 2010. Application of an LC–MS/MS based multi-mycotoxin 
method for the semi-quantitative determination of mycotoxins occurring in different types of food 
infected by moulds. Food Chem. 119, 408-416. 
Sulyok, M., Berthiller, F., Krska, R. and Schuhmacher, R., 2006. Development and validation of a liquid 
chromatography/tandem mass spectrometric method for the determination of 39 mycotoxins in wheat 
and maize. Rapid Commun. Mass Spectrum. 20, 2649-2659. 
Suman, M. and Generotti, S., 2016. Transformation of mycotoxins upon food processing: masking, binding 
and degradation phenomena. in: Dall'Asta, C., Berthiller, F. (Eds). The Royal Society of Chemistry, 
Cambridge, UK, pp. 73-96. 
Sumner, L.W., Amberg, A., Barrett, D., Beale, M.H., Beger, R., Daykin, C.A., Fan, T.W., Fiehn, O., Goodacre, 
R. and Griffin, J.L., 2007. Proposed minimum reporting standards for chemical analysis. Metabolomics 
3, 211-221. 
Taylor, P.J., 2005. Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography–
electrospray–tandem mass spectrometry. Clin. Biochem. 38, 328-334. 
Thompson, W.L. and Wannemacher Jr, R.W., 1986. Structure-function relationships of 12, 13-
epoxytrichothecene mycotoxins in cell culture: comparison to whole animal lethality. Toxicon 24, 985-
994. 
Tian, Y., Tan, Y., Liu, N., Yan, Z., Liao, Y., Chen, J., De Saeger, S., Yang, H., Zhang, Q. and Wu, A., 2016. 
Detoxification of deoxynivalenol via glycosylation represents novel insights on antagonistic activities of 
Trichoderma when confronted with Fusarium graminearum. Toxins 8, 335. 
Tittlemier, S.A., Cramer, B., Dall’Asta, C., Iha, M.H., Lattanzio, V., Malone, R.J., Maragos, C., Solfrizzo, M., 
Stranska-Zachariasova, M. and Stroka, J., 2019. Developments in mycotoxin analysis: an update for 
2017-2018. World Mycotoxin J. 12, 3-29. 
Torp, M. and Langseth, W., 1999. Production of T-2 toxin by a Fusarium resembling Fusarium poae. 
Mycopathologia 147, 89-96. 
Trufelli, H., Palma, P., Famiglini, G. and Cappiello, A., 2011. An overview of matrix effects in liquid 
chromatography–mass spectrometry. Mass Spectrom. Rev. 30, 491-509. 
Turner, N.W., Subrahmanyam, S. and Piletsky, S.A., 2009. Analytical methods for determination of 
mycotoxins: a review. Anal. Chim. Acta 632, 168-180. 
Ueno, Y., Sato, N., Ishii, K., Sakai, K., Tsunoda, H. and Enomoto, M., 1973. Biological and chemical detection 
of trichothecene mycotoxins of Fusarium species. Appl. Microbiol. 25, 699. 
Ueno, Y., 1980. Trichothecene mycotoxins mycology, chemistry, and toxicology, in: Draper, H.H. (Ed). 
Springer, USA, pp. 301-353. 
Urry, W.H., Wehrmeister, H.L., Hodge, E.B. and Hidy, P.H., 1966. The structure of zearalenone. Tetrahedron 
Lett. 7, 3109-3114. 
Van der Fels-Klerx, H J, Olesen, J.E., Madsen, M.S. and Goedhart, P.W., 2012. Climate change increases 
deoxynivalenol contamination of wheat in north-western Europe. Food Addit. Contam. A 29, 1593-1604. 
van der Werf, Mariët J, 2005. Towards replacing closed with open target selection strategies. Trends 
Biotechnol. 23, 11-16. 
 121 
van Egmond, H.P., Schothorst, R.C. and Jonker, M.A., 2007. Regulations relating to mycotoxins in food. 
Anal. Bioanal. Chem. 389, 147-157. 
Varga, E., Wiesenberger, G., Hametner, C., Ward, T.J., Dong, Y., Schöfbeck, D., McCormick, S., Broz, K., 
Stückler, R. and Schuhmacher, R., 2015. New tricks of an old enemy: isolates of Fusarium graminearum 
produce a type A trichothecene mycotoxin. Environ. Microbiol. 17, 2588-2600. 
Varga, E., Malachova, A., Schwartz, H., Krska, R. and Berthiller, F., 2013. Survey of deoxynivalenol and its 
conjugates deoxynivalenol-3-glucoside and 3-acetyl-deoxynivalenol in 374 beer samples. Food Addit. 
Contam. A 30, 137-146. 
Varga, E., Glauner, T., Köppen, R., Mayer, K., Sulyok, M., Schuhmacher, R., Krska, R. and Berthiller, F., 2012. 
Stable isotope dilution assay for the accurate determination of mycotoxins in maize by UHPLC-MS/MS. 
Anal. Bioanal. Chem. 402, 2675-2686. 
Vendl, O., Berthiller, F., Crews, C. and Krska, R., 2009. Simultaneous determination of deoxynivalenol, 
zearalenone, and their major masked metabolites in cereal-based food by LC–MS–MS. Anal. Bioanal. 
Chem. 395, 1347-1354. 
Vendl, O., Crews, C., MacDonald, S., Krska, R. and Berthiller, F., 2010. Occurrence of free and conjugated 
Fusarium mycotoxins in cereal-based food. Food Addit. Contam. A 27, 1148-1152. 
Veprikova, Z., Vaclavikova, M., Lacina, O., Dzuman, Z., Zachariasova, M. and Hajslova, J., 2012. Occurrence 
of mono-and di-glycosylated conjugates of T-2 and HT-2 toxins in naturally contaminated cereals. World 
Mycotoxin J. 5, 231-240. 
Veršilovskis, A., Geys, J., Huybrechts, B., Goossens, E., De Saeger, S. and Callebaut, A., 2012. Simultaneous 
determination of masked forms of deoxynivalenol and zearalenone after oral dosing in rats by LC-MS/MS. 
World Mycotoxin J. 5, 303-318. 
Waalwijk, C., Kastelein, P., De Vries, I., Kerényi, Z., Van Der Lee, T., Hesselink, T., Köhl, J. and Kema, G., 
2003. Major changes in Fusarium spp. in wheat in the Netherlands. Eur. J. Plant Pathol. 109, 743-754. 
Wannemacher Jr, R.W., Wiener, S.L., Sidell, F.R., Takafuji, E.T. and Franz, D.R., 1997. Trichothecene 
mycotoxins. Medical aspects of chemical and biological warfare 6, 655-676. 
Warth, B., Fruhmann, P., Wiesenberger, G., Kluger, B., Sarkanj, B., Lemmens, M., Hametner, C., Fröhlich, 
J., Adam, G. and Krska, R., 2015. Deoxynivalenol-sulfates: Identification and quantification of novel 
conjugated (masked) mycotoxins in wheat. Anal. Bioanal. Chem.  407, 1033-1039. 
Wegulo, S., 2012. Factors influencing deoxynivalenol accumulation in small grain cereals. Toxins 4, 1157-
1180. 
Whitaker, T.B., 2006. Sampling foods for mycotoxins. Food Addit. Contam. 23, 50-61. 
Whitehead, M.P. and Flannigan, B., 1989. The Fusarium mycotoxin deoxynivalenol and yeast growth and 
fermentation. J. Inst. Brewing 95, 411-413. 
Willaert, R., 2007. The beer brewing process: Wort production and beer. Handbook of Food Products 
Manufacturing, 2 Volume Set 443. 
Wolf-Hall, C.E., 2007. Mold and mycotoxin problems encountered during malting and brewing. Int. J. Food 
Microbiol. 119, 89-94. 
 122 
Wu, F., Bhatnagar, D., Bui-Klimke, T., Carbone, I., Hellmich, R., Munkvold, G., Paul, P., Payne, G. and Takle, 
E., 2011. Climate change impacts on mycotoxin risks in US maize. World Mycotoxin J. 4, 79-93. 
Wu, Q., Dohnal, V., Kuca, K. and Yuan, Z., 2013. Trichothecenes: structure-toxic activity relationships. Curr. 
Drug Metab. 14, 641-660. 
Wu, W., He, K., Zhou, H., Berthiller, F., Adam, G., Sugita-Konishi, Y., Watanabe, M., Krantis, A., Durst, T. 
and Zhang, H., 2014a. Effects of oral exposure to naturally-occurring and synthetic deoxynivalenol 
congeners on proinflammatory cytokine and chemokine mRNA expression in the mouse. Toxicol. Appl. 
Pharmacol. 278, 107-115. 
Wu, W., Zhou, H., Bursian, S.J., Pan, X., Link, J.E., Berthiller, F., Adam, G., Krantis, A., Durst, T. and Pestka, 
J.J., 2014b. Comparison of anorectic and emetic potencies of deoxynivalenol (vomitoxin) to the plant 
metabolite deoxynivalenol-3-glucoside and synthetic deoxynivalenol derivatives EN139528 and 
EN139544. Tox. Sci. 142, 167-181. 
Yang, S., Zhang, H., Zhang, J., Li, Y., Jin, Y., Zhang, S., De Saeger, S., Li, Y., Zhou, J. and Sun, F., 2018. 
Deglucosylation of zearalenone-14-glucoside in animals and human liver leads to underestimation of 
exposure to zearalenone in humans. Arch. Toxicol. 92, 2779-2791. 
Yang, S., Zhang, H., Sun, F., De Ruyck, K., Zhang, J., Jin, Y., Li, Y., Wang, Z., Zhang, S. and De Saeger, S., 
2017. Metabolic profile of zearalenone in liver microsomes from different species and its in vivo 
metabolism in rats and chickens using ultra high-pressure liquid chromatography-quadrupole/time-of-
flight mass spectrometry. J. Agric. Food Chem. 65, 11292-11303. 
Yang, S., Li, Y., Cao, X., Hu, D., Wang, Z., Wang, Y., Shen, J. and Zhang, S., 2013. Metabolic pathways of 
T-2 toxin in in vivo and in vitro systems of Wistar rats. J. Agric. Food Chem. 61, 9734-9743. 
Yli-Mattila, T., 2010. Ecology and evolution of toxigenic Fusarium species in cereals in northern Europe and 
Asia. J. Plant Pathol. 92, 7-18. 
Yli-Mattila, T., Paavanen-Huhtala, S., Jestoi, M., Parikka, P., Hietaniemi, V., Gagkaeva, T., Sarlin, T., Haikara, 
A., Laaksonen, S. and Rizzo, A., 2008. Real-time PCR detection and quantification of Fusarium poae, F. 
graminearum, F. sporotrichioides and F. langsethiae in cereal grains in Finland and Russia. Arch. 
Phytopathology Plant Protect. 41, 243-260. 
Yoshinari, T., Sakuda, S., Furihata, K., Furusawa, H., Ohnishi, T., Sugita-Konishi, Y., Ishizaki, N. and Terajima, 
J., 2014. Structural determination of a nivalenol glucoside and development of an analytical method for 
the simultaneous determination of nivalenol and deoxynivalenol, and their glucosides, in wheat. J. Agric. 
Food Chem. 62, 1174-1180. 
Yoshizawa, T., Onomoto, C. and Morooka, N., 1980. Microbial acetyl conjugation of T-2 toxin and its 
derivatives. Appl. Environ. Microbiol. 39, 962-966. 
Yoshizawa, T. and Morooka, N., 1973. Deoxynivalenol and its monoacetate: new mycotoxins from Fusarium 
roseum and moldy barley. Agric. Biol. Chem. 37, 2933-2934. 
Zachariasova, M., Lacina, O., Malachova, A., Kostelanska, M., Poustka, J., Godula, M. and Hajslova, J., 2010. 
Novel approaches in analysis of Fusarium mycotoxins in cereals employing ultra performance liquid 
chromatography coupled with high resolution mass spectrometry. Anal. Chim. Acta 662, 51-61. 
Zachariasova, M., Vaclavikova, M., Lacina, O., Vaclavik, L. and Hajslova, J., 2012. Deoxynivalenol 
oligoglycosides: new “masked” Fusarium toxins occurring in malt, beer, and breadstuff. J. Agric. Food 
Chem. 60, 9280-9291. 
 123 
Zhang, K., Schaab, M.R., Southwood, G., Tor, E.R., Aston, L.S., Song, W., Eitzer, B., Majumdar, S., Lapainis, 
T. and Mai, H., 2017. A collaborative study: Determination of mycotoxins in corn, peanut butter, and 
wheat flour using stable isotope dilution assay (SIDA) and liquid chromatography–tandem mass 
spectrometry (LC-MS/MS). J. Agric. Food Chem. 65, 7138-7152. 
Zhang, Y., Han, J., Zhu, C., Tang, F., Cui, X., Kim, N. and Sun, S., 2016. Exposure to HT-2 toxin causes 
oxidative stress induced apoptosis/autophagy in porcine oocytes. Sci. Rep. 6, 1-8. 
Zhou, B., Xiao, J.F., Tuli, L. and Ressom, H.W., 2012. LC-MS-based metabolomics. Mol. BioSyst. 8, 470-481. 
Zinedine, A., Soriano, J.M., Molto, J.C. and Manes, J., 2007. Review on the toxicity, occurrence, metabolism, 
detoxification, regulations and intake of zearalenone: an oestrogenic mycotoxin. Food Chem. Toxicol. 
45, 1-18. 
 

